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vAbstract
In patients with symptomatic severe knee osteoarthritis (OA), total knee arthroplasty 
(TKA) has good long-term outcomes and results in greater pain relief and increased 
functional improvement compared with nonsurgical treatment. Because of good long-term 
implant survivorship, TKA also become a common treatment for severe knee OA among 
younger patients. However, the outcomes and implant survivorship of TKA have been 
reported to be inferior in younger patients. To date, cemented fixation has been regarded as 
the gold standard fixation method in TKA, but there has been controversy regarding the 
optimal fixation method among working-age patients.
In many countries, reported increases in the rate of TKAs and estimates of future 
demand predict a substantial increase in the incidence of TKAs. Both a broadening of 
indications for younger patients and an increase in the total incidence of TKA have raised 
concerns over a possible increase in revision burden in the long-term. Differences between 
geographic location and age groups have been observed in the incidences of TKA. The 
major increase in incidence has been found in patients from the “baby boomer” (born 
between 1946 and 1964) generation.
Working-age patients have high expectations for the outcome of TKA, and between 11 
and 25% of these patients have been reported to be dissatisfied after the operation. These 
results, however, have been derived from studies without a true prospective observational 
set-up.
Adequate postoperative pain management plays a key role in enabling proper early 
recovery after TKA. However, the effect of postoperative pain management on the final 
outcome of this operation in terms of function and quality of life is not well known.
The aim of this study was to evaluate the incidence and outcomes of contemporary knee 
arthroplasty with special reference to working-age patients. Both the implant survivorship 
of different fixation methods of TKA and also patient-reported outcome measures 
(PROMs) were assessed. Secondly, we aimed to study the efficacy of local infiltration 
analgesia (LIA) and the effect of early pain management on the outcomes of TKA.
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In the study I, based on Nordic Arthroplasty Register Association (NARA) data, a total 
of 385 310 primary knee arthroplasties in patients aged 30 years or older performed in 4 
Nordic countries were analyzed from 1997 to 2012 in Denmark, Norway, and Sweden, and 
from 2000 to 2012 in Finland.
In the study II, 115 177 TKAs selected from NARA data in patients aged less than 65 
years of age who had undergone an unconstrained primary TKA for primary OA from 
2000 to 2016 were included to assess the survivorship of cemented, uncemented, hybrid, 
and inverse hybrid TKAs.
In the study III, based on Finnish Arthroplasty Register (FAR) data, 1 151 TKAs that 
were performed between 2003 and 2010 using an uncemented porous tantalum metal 
(TM) tibial component were analyzed.
In the study IV a total of 232 (254 knees) patients were enrolled between March 1st, 
2012 and October 30th, 2014 for a prospective observational study to analyze the outcomes 
of knee arthroplasty using PROMs.
In the study V a total of 60 patients who underwent unilateral TKA between March 
2011 and March 2012 were enrolled into a randomized, double-blinded, placebo-controlled 
study to analyze the effect of LIA on early pain management and also on PROMs over a 
1-year follow-up.
There was an equal increase in total incidence, comprising both TKAs and unicondylar knee 
arthroplasties (UKA), in all countries. The increase in surgical procedures in Finland from 
2004 to 2006 may be explained by the new social and health care law that forced hospitals 
to shorten patient waiting times for surgery. Despite having comparable socio-economic 
situations and health care systems, the differences in the incidence of knee arthroplasties 
between countries were notable. The total increase in the number of arthroplasties in 
all countries was mainly due to an increased incidence of TKAs. In Sweden, there was 
a significant decrease in the incidence of UKAs in patients 65 years or older. In Finland, 
Denmark, and Norway, variations in the incidences of UKAs were more heterogeneous.
Both cemented and hybrid TKAs evinced excellent 10-year survival rates in patients 
aged less than 65 years in the Nordic countries. Even though hybrid/inverse hybrid versions 
of the well-performing contemporary TKA designs provided younger patients with a good 
mid-term outcome in our study, they were still only used in a limited number of patients. In 
the inverse hybrid group, one single TKA design comprised the vast majority of the whole 
group.
An uncemented porous TM monoblock tibial component had excellent mid-term 
survivorship in a population-based setting in Finland. The most common reasons for 
revisions were instability and prosthetic joint infection (PJI). During the study period, 
only one revision was performed due to aseptic loosening of the tantalum monoblock tibial 
component. Neither age nor any of the other variables showed any effect on the risk of 
revision in the multivariate regression analyses.
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The mean Oxford Knee Score (OKS) and all the Knee Injury and Osteoarthritis 
Outcome Score (KOOS) subscales increased significantly (p<0.001) from the preoperative 
situation to 2-year follow-up in working-age patients who underwent knee arthroplasty at 
our institution. A significant increase (p<0.001) in physical activity was detected in High-
Activity Arthroplasty Score (HAAS) and in RAND-36 Physical Component Score (PCS). 
Pain was also significantly (p<0.001) relieved during the follow-up. However, the total 
disappearance of pain was rare at 2 years. Patients with milder Kellgren-Lawrence (KL) 
grade 2 osteoarthritis (OA) were less satisfied and reported poorer PROM outcomes than 
those with advanced OA (KL 3–4). There was no difference in the outcome (any PROM) 
between patients who underwent total knee arthroplasty (TKA) and those who received 
unicondylar knee arthroplasty (UKA).
A single intraoperative drug infiltration containing levobupivacaine, ketorolac, 
and adrenaline decreased the total consumption of oxycodone during the first 48 
hours postoperatively. The effect of LIA was most pronounced during the first 6 hours 
postoperatively. LIA also improved the early knee ROM, but no long-term functional 
benefit was observed in PROMs.
The increase in the overall incidence of knee arthroplasties was the consequence of an 
increase in incidence of TKAs, whereas the incidence of UKAs varied between countries. 
The proportional growth in incidence of TKAs during the study period was highest in 
patients younger than 65 years. Despite this, the incidence of knee arthroplasty in the 
youngest age group was clearly lower than in patients aged 65 years or older. Based on this 
finding, the majority of knee arthroplasties will probably be performed on elderly patients 
also in future. Even though knee arthroplasties were still performed clearly more often on 
patients aged 65 or older in Nordic countries, working-age patients should be considered as 
an important subgroup because of their higher physical activity, demands for surgery, and 
the multi-factorial reasons behind the success of TKA.
Cemented TKA still merits the status of gold standard in TKA irrespective of 
the patients’ age. Even though hybrid/inverse hybrid versions of the well performing 
contemporary TKA designs provided younger patients with a good mid-term outcomes 
in our study, these results do not support the systematic use of these more expensive 
components in younger patients.
Early loosening of uncemented TM tibial component was very rare and the risks for 
revision for other reasons were as rare as with contemporary cemented TKAs.
TKA provided patients aged 65 years or less with clinically significant pain relief as 
well as improvements in ADL and quality of life. The patients´  physical activity was low 
or moderate preoperatively but improved significantly during the 2-year follow-up. Some 
pain and functional deficiencies remained after knee arthroplasty, and this should be 
emphasized in the preoperative guidance given to patients who are considering or who are 
scheduled for such surgery. Mild radiographic OA preoperatively is a clear risk factor for 
patient dissatisfaction after knee arthroplasty.
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A single perioperative infiltration of LIA reduced opiate consumption until 48 hours 
after TKA, and the routine use of perioperative infiltration analgesia as an adjunct to oral 
pain medication may be recommended in patients undergoing TKA. The use of LIA did 
not have any effect on the functional outcome of TKA over the first postoperative year.
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Tiivistelmä
Pitkälle edenneen oireisen polvinivelrikon hoidossa tekonivelleikkauksen tulokset ovat 
erinomaiset: kipu lievittyy, ja sekä toimintakyky että myös elämänlaatu parantuvat 
merkittävästi. Tekonivelen hyvä pitkäaikaispysyvyys on lisännyt tämän hoitomenetelmän 
käyttöä pitkälle edenneen polven nivelrikon hoidossa myös nuoremmilla potilailla, vaikka 
toiminnalliset tulokset ja tekonivelen pysyvyys onkin raportoitu huonommaksi verrattuna 
vanhempiin potilaisiin.
Sementtikiinnitystä voidaan pitää kultaisena standardina polven kokotekonivelleik-
kauksessa. Nuoremmilla, työikäisillä potilailla paras komponenttien kiinnitysmenetelmä 
on kuitenkin edelleen kiistanalainen.
Polven tekonivelleikkausten ilmaantuvuus on lisääntynyt viimeisten vuosikymmenten 
aikana, ja ilmaantuvuuden kasvun on ennustettu edelleen jatkuvan lähitulevaisuudessa. 
Sekä leikkausaiheiden laajentuminen nuorempiin potilaisiin että toisaalta leikkausmää-
rien lisääntyminen nuoremmilla potilailla ovat lisänneet huolta siitä, että kasvaako myös 
uusintaleikkausten määrä merkittävästi lähivuosikymmeninä. Ilmaantuvuudessa on ha-
vaittu lisäksi eroja sekä maantieteellisesti että potilaiden ikäryhmien välillä. Suurin polven 
tekonivelleikkausten ilmaantuvuuden kasvu on havaittu nk. suurissa ikäluokissa.
Työikäisillä potilailla on korkeat odotukset polven tekonivelleikkauksen tuloksesta, ja 
noin 11–25 % potilaista on tähänastisissa tutkimuksissa ollut tyytymättömiä leikkauksen 
tulokseen. Prospektiivista seurantatutkimusta aiheesta on kuitenkin julkaistu vain vähän.
Leikkauksen yhteydessä annettava kipulääkitys sekä leikkauksen jälkeinen kivun hoito 
on yksi avaintekijä polven tekonivelleikkauksen onnistumissa. Hyvä kivun hoito mahdol-
listaa kunnollisen kuntoutusharjoittelun, vähentää leikkauksen jälkeisiä välittömiä komp-
likaatioita ja voi myös heijastua tuloksissa ja tyytyväisyydessä pitkällä aikavälillä.
Tässä tutkimuksessa arvioitiin nykyisten polven tekonivelleikkausten ilmaantuvuutta, 
eri kiinnitysmenetelmien kestävyyttä ja työikäisten potilaiden tuloksia potilaiden rapor-
toimilla vaikutusmittareilla. Lisäksi arvioitiin paikallispuudutuksen vaikutusta kivun hoi-
toon ja leikkauksen pitkäaikaistuloksiin.
xI:ssä ja II:ssa osatyössä käytettiin tutkimusaineistona Pohjoismaista tekonivelrekiste-
riä (NARA), joka koostuu Suomen, Ruotsin, Norjan ja Tanskan yhdistyneistä tekonivel-
rekistereistä. I osatyö sisälsi 358  310 potilasta ja II osatyö 115  177 potilasta. III osatyön 
materiaali koostui Suomen tekonivelrekisterin aineistosta sisältäen 1  151 potilasta. IV 
osatyö oli puolestaan etenevä seurantatutkimus, jossa Tekonivelsairaala Coxassa polven 
tekonivelleikkauksen läpikäyneiden 232 potilaan leikkaustulokset arvioitiin 2 vuoden seu-
rannassa. V osatyössä 60 potilasta satunnaistettiin Tekonivelsairaala Coxassa polven teko-
nivelleikkauksessa saamaan joko LIA-puudute tai plaseboinjektio, ja heidän toipumistaan 
leikkauksesta seurattiin vuoden ajan tulokset rekisteröiden. 
Tässä tutkimuksessa todettiin, että polven tekonivelleikkausten kokonaisilmaantu-
vuus lisääntyi kaikissa Pohjoismaissa. Suomessa ilmaantuvuus oli erityisen suurta vuosina 
2004–2006, mikä selittyy tuolloin voimaan tulleella hoitotakuulailla, joka ohjasi sairaa-
loita lyhentämään leikkausjonoja. Vaikka Pohjoismaissa väestön elintaso ja terveyden-
huoltojärjestelmä ovat verrattavissa toisiinsa, olivat erot ilmaantuvuuksissa huomattavia. 
Ilmaantuvuuden lisääntyminen johtui pääosin nimenomaan kokotekonivelleikkausten 
lisääntymisestä. Osatekonivelleikkausten ilmaantuvuudessa oli maiden välillä huomatta-
vaa vaihtelua, ja yli 65-vuotiaiden osatekonivelleikkausten ilmaantuvuus väheni selvästi 
Ruotsissa,.
Sementtikiinnitteisillä ja nk. hybridi polvitekonivelillä oli erinomaiset pysyvyydet 
10-vuoden seurannassa. Kaikilla kiinnitysmenetelmillä saavutettiin hyväksyttävät pysy-
vyydet, mutta muiden kuin sementtikiinnitteisten polven tekonivelten määrät tutkimuk-
sessa olivat vähäisemmät, mikä vaikeuttaa ryhmien vertailua.
Sementittömällä tantaalimetallisella säärikomponentilla todettiin erinomainen pysy-
vyys eikä tekonivelen irtoamisen riski eronnut vastaavasta sementtikiinnitteisestä tekoni-
velmallista.
Kaikissa PROM-mittareissa todettiin merkittävä paraneminen 2 vuoden seurannassa 
ja sekä fyysinen että psyykkinen toimintakyky lisääntyivät merkittävästi. Oireettomuus oli 
harvinaista. Potilaat, joiden radiologinen nivelrikko oli ennen leikkausta lievempi (KL2), 
olivat tyytymättömämpiä leikkauksen tulokseen kuin ne potilaat, joiden nivelrikko luo-
kiteltiin pitkälle edenneeksi (KL3–4). Kokotekonivelellä ja osatekonivelellä hoidettujen 
potilaiden tuloksissa ei ollut eroa.
Polven tekonivelleikkauksen yhteydessä annettu paikallispuudutus vähensi opiaattilää-
kityksen määrää merkittävimmin ensimmäisen 6 tunnin aikana. Se paransi myös polven 
liikelaajuutta heti leikkauksen jälkeen, mutta pitkäaikaisia vaikutuksia toiminnallisilla 
mittareilla ei havaittu 1 vuoden seurannassa.
Vaikka polven tekonivelleikkausten ilmaantuvuus lisääntyi suhteessa eniten alle 
65-vuotiailla potilailla, oli kokonaisilmaantuvuus kuitenkin edelleen selvästi suurempaa 
yli 65-vuotiailla. Tämän johdosta suurin osa polven tekonivelleikkauksista tehdään tule-
vaisuudessakin vanhemmille ikäryhmille. Kuitenkin nuorempien potilaiden fyysinen ak-
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tiivisuus, vaatimustaso sekä moniulotteiset taustatekijät tyytyväisyyden taustalla muodos-
tavat erityispiirteensä nuoremmilla potilailla.
Kaikilla kiinnitysmenetelmillä saavutettiin erinomainen pysyvyys 10 vuoden seuran-
nassa. Sementtikiinnitteistä polven tekoniveltä voidaan edelleen pitää kultaisena standar-
dina huolimatta hybridin ja käänteisen hybridin hyvistä tuloksista työikäisillä potilailla. 
Tantaalimetallisella sementittömällä säärikomponentilla irtoaman riski on sementtikiin-
nitteistä vastaava.
Polven tekonivelleikkauksella saavutetaan yleisesti ottaen merkittävä kivun lievitys ja 
toimintakyvyn parantuminen työikäisillä potilailla. Osalle potilaista voi kuitenkin jäädä 
sekä kipua että myös toimintakyvyn rajoitteita, ja erityisesti lieväasteinen nivelrikko ennen 
leikkausta on selkeä leikkaustulokseen tyytymättömyyttä lisäävä riskitekijä.
Leikkauksen aikana annettava paikallispuudutus on tehokas lisä polven tekonivelleik-
kauksen jälkeiseen kivun hoitoon. Puudutuksella ei kuitenkaan ole vaikutusta leikkauksen 
lopputulokseen kivun ja toimintakyvyn osalta.
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1 Introduction
In patients with severe symptomatic knee OA, TKA has good long-term outcomes 
and results in greater pain relief and increased functional improvement compared with 
nonsurgical treatment (Carr et al. 2012, Skou et al. 2015). Options for operative treatment 
of knee OA are high tibial osteotomy (HTO), UKA and TKA. The use of UKA has been 
focused on mainly medial, unicondylar disease in patients of all ages whereas HTO has 
mainly been offered to younger and more physically active patients. In the selected cases 
HTO and UKA have been reported to be less extensive and bone sparing compared to 
TKA (W-Dahl et al. 2010a). Because of good long-term implant survivorship, TKA has 
also become a common treatment for severe knee OA among younger patients. However, 
the outcomes and implant survivorship of TKA have been reported to be inferior in 
younger patients (Lonner et al. 2000a, Rand et al. 2003, Julin et al. 2010, Price et al. 2010a). 
Reported increases in the rate of TKAs and estimates of future demand predict a 
substantial increase in the incidence of TKAs in many countries (Jain et al. 2005, Kurtz 
et al. 2007, Kim et al. 2008a, W-Dahl et al. 2010a, Culliford et al. 2010a, Nemes et al. 
2015a, Singh et al. 2019). Both the broadening of indications for younger patients and an 
increase in the total incidence of TKA have raised concerns over a possible increase in 
revision burden in the long-term (Kurtz et al. 2007, Gioe et al. 2007a). Differences between 
geographic location and age groups have been observed in the incidences of TKA (Katz et 
al. 1996, Wells et al. 2002).
Previous studies have reported both the proportionally highest increase in incidence of 
TKAs and also the highest risk for revision in patients younger than 65 years of age (Julin 
et al. 2010, W-Dahl et al. 2010a, Carr et al. 2012, Leskinen et al. 2012, Meehan et al. 2014, 
Nemes et al. 2015a, Dyrhovden et al. 2017). This has led to an increased interest in finding 
a more durable fixation method for TKA. A previous systematic review did not report any 
differences in survival or functional outcome between cemented and uncemented TKAs 
in patients aged 60 years or less (Franceschetti et al. 2017). A meta-analysis without age 
limit showed better survival rates with cemented TKAs when all studies were combined. 
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In randomized studies, however, survival rates were equivocal (Gandhi et al. 2009). In a 
few studies, uncemented fixation in TKA has been reported to offer similar outcomes to 
cemented TKA, but the higher costs of uncemented components has meant that cemented 
TKA remains the gold standard fixation method (Dalury. 2016, Miller et al. 2018, Zhou 
et al. 2018). 
A previous study using radiostereometric analysis (RSA) showed that the early 
migration seen with uncemented tibial components settled within two years, whereas 
cemented tibial components continued to migrate (Wilson et al. 2012a, Henricson and 
Nilsson. 2016a). The failures of uncemented TKAs have traditionally been mostly due 
to uncemented metal-back patellar resurfacing, but also to aseptic loosening of the tibial 
component (Lombardi et al. 1988, Stulberg et al. 1988). Aseptic loosening is characterized 
by poorly vascularized connective tissue dominated by fibroblasts and macrophages that 
forms the interface tissue between the bone and implant or cement (Gallo et al. 2002). 
As aseptic loosening occurs as a reactive process to wear debris from polyethylene inserts, 
ways of reducing volumetric wear have been sought (Odland et al. 2011). To date, the use of 
uncemented TKAs has been limited, but previous studies have reported an increased risk 
for aseptic loosening of the tibial component in patients treated with uncemented TKA 
(Collins et al. 1991, Bassett. 1998, Duffy et al. 1998a, Berger et al. 2001a, Barrack et al. 
2004, Goldberg and Kraay. 2004, Carlsson et al. 2005). However, due to the evolvement 
of designs and materials, uncemented fixation has become an interesting choice, especially 
for younger patients with good bone quality (Hu et al. 2017). The trabecular metal (TM) 
tibial component has shown promising results in both prospective observational and RCT 
studies (Henricson et al. 2013a, Pulido et al. 2015). Although significant differences have 
been observed between different fixation concepts in terms of revision rates, functional 
outcomes have been equivalent irrespective of the fixation method (Gandhi et al. 2009, 
Gao et al. 2009, Demey et al. 2011, Arnold et al. 2013). The most optimal fixation method 
in TKA still remains controversial for younger patients, however.
An uncemented porous tantalum tibial component has a highly porous tantalum tray 
with a fixed polyethylene (PE) insert which eliminates backside wear and may thus reduce 
the long-term PE particle burden. The PE insert is molded into the trabecular metal cells 
to a depth of about 1.5 mm. The biological incorporation of trabecular metal implants has 
been well documented (O’Keefe et al. 2010, Wilson et al. 2010a, Unger and Duggan. 2011, 
Kamath et al. 2011a), and the elastic properties of this implant are comparable to those of 
normal bone structure (Patil et al. 2009). The lower stiffness of the tantalum implant may 
cause less stress shielding than in conventional metal-backed components. However, the 
increased surface area of the extremely porous tantalum metal and also a lack of antibiotics-
loaded bone cement may, in theory, increase the risk of periprosthetic joint infections (PJIs).
Younger patients have high expectations for the outcome of total knee arthroplasty 
(TKA), and this may predispose them to dissatisfaction after the operation (Noble et 
al. 2006a, Parvizi et al. 2014, Scott et al. 2016). Arthroscopic surgery of the degenerative 
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knee has been shown to be ineffective (Sihvonen et al. 2013), and the incidence of high 
tibial osteotomy has also steadily decreased (W-Dahl et al. 2010a, Niinimaki et al. 2012). 
Hence, increasing numbers of younger patients with mild knee OA are being offered knee 
arthroplasty. As both young age (Julin et al. 2010, Meehan et al. 2014) and mild knee OA 
(Niinimaki et al. 2011) are known to be risk factors for revision surgery, it is of critical 
importance to assess the outcome of knee arthroplasty within this demanding patient 
group. 
A few recent studies have reported the outcome of TKA measured with patient-reported 
outcome measures (PROMs) in younger patients (Klit et al. 2014, Scott et al. 2016, Goh et 
al. 2016a). However, only one of these previous trials was a true prospective observational 
study (Klit et al. 2014). Further, patient physical activity was not assessed with a specific 
activity score in any of these studies. All of them reported the overall positive effect of 
TKA on symptoms, activities of daily living, and quality of life. However, a variable 
proportion of patients (11–25%) were dissatisfied with the outcome of their surgery. Scott 
et al. reported that dissatisfaction was also related to a low grade of radiographic OA, 
previous surgery, and obesity (Scott et al. 2016). Thus, there is an obvious need for valid 
observational (real-world) data on the actual performance of knee arthroplasty in routine 
settings, and especially among younger working-age patients (Malmivaara. 2013).
The goal of local infiltration analgesia (LIA) after TKA is to provide simple, effective 
and safe pain relief during the first postoperative days with reduced opiate consumption 
(Kerr and Kohan. 2008a). Adequate postoperative pain control is usually achieved using 
multimodal pain management. However, the control of pain continues to be a challenge 
in many TKA patients and disturbs postoperative rehabilitation. Therefore, in addition 
to providing better pain relief, multimodal analgesia aims to reduce the amount of opiate 
medication. 
There is a scarcity of studies that have analyzed the long-term influence of infiltration 
analgesia on functional outcome. The only previous study evaluating this effect found no 
difference in functional outcome between placebo and drug infiltration groups at 3 months 
postoperatively measured with TUG test, OKS, or EQ5D (Essving et al. 2010a). Another 
review reported the poor documentation of the long-term effects of LIA on knee function 
and quality of life (Ganapathy et al. 2011). 
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2 Review of the Literature
2.1 Concept of knee arhtroplasty
2.1.1 The history of knee arthroplasty
The first modern type of total knee arthroplasty (TKA) involved replacing the knee joint 
with ivory components attached to the bone using a cement made from copper amalgam, 
plaster of Paris, and stone putty. This technique was introduced by the German surgeon 
Themistocles Gluck in 1890 (Figure 1). He was also the first to introduce the term 
arthroplasty in 1902. Unfortunately, his technique was unsuccessful in most cases, and 
septic infections were a major problem (Brand et al. 2011).
Figure 1. Gluck’s knee prosthesis
(Reprinted from Gluck T. Arch klin chir. 1891; 41:187–239.)
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In 1951, the Walldius hinge joint was introduced. Originally made from acrylic, in 1958, 
it began to be made from cobalt and chrome. Walldius published a comparison of hinge 
knee prostheses and resection arthroplasties in 1957. The results of his work led to a new era 
in knee replacements. Before his study, a limited range of motion was the only acceptable 
indication for an artificial joint. Moreover, this was the first study to introduce pain as 
an indication for joint replacement. The modern era of total knee replacement began 
with Gunston who followed the example of the work of Charnley. In 1968, he designed 
a surface replacing unicondylar prosthesis with a metal component articulating against a 
polyethylene component. Both components were attached to the bone using bone cement 
made from polymethyl-methacrylate (PMMA) (Figure 2) (Gunston. 1971). In his design, 
he concentrated on the kinematics of the knee, but the lack of an appropriate fixation 
method resulted in early failures. However, the design of the unicondylar prosthesis was 
suitable for either the medial or the lateral compartment of the knee or both. 
Freeman and Swanson (1972) designed a bi-condylar total knee prosthesis of the condylar 
type and inserted the first one in 1970. Modifications of this design are still in use today 
(Swanson and Freeman. 1974, Robertsson et al. 2000). They noticed that many of the knees 
with OA had a significant angular deformity. Therefore, they concluded that mechanical 
alignment could be achieved by sacrificing the cruciate ligaments, and thus the implants 
were placed in mechanical alignment. The first design lacked the anterior flange. 
Figure 2. Gunston unicondylar prosthesis
(Gunston, Frank H.: Polycentric knee arthoplasty: Prosthetic simulation of normal knee movement J. Bone Jt. Surg., 53 B. 
London, Messers E. & Livingstone, 1971)
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In 1973, Freeman and Swanson produced the next generation of their implant named 
ICLH (Imperial College London Hospital) and added an anterior flange to the femoral 
component and a patellar button to resurface the patella.
In 1971, John Insall, Chitranjan Ranawat, and Peter Walker developed the first design 
of a knee arthroplasty called the Duocondylar Knee.  In contrast to the Freeman-Swanson 
implant, the Duocondylar knee was based on preserving the cruciate ligaments in order to 
mimic the native kinematics of the knee. The tibial component comprised two flat pads 
that were allowed free movements (Figure 3). This design relied on native soft tissue balance 
(Ranawat and Shine. 1973, Insall and Walker. 1976).
In 1974, Insall et al. developed the Total Condylar prosthesis, which was the first true 
TKA with reliable and reproducible functional outcomes and long-term survivorship. 
This design was an improvement on the ICLH because it used both articular geometry 
and soft tissue tension to provide stability and kinematic guidance. All the components 
were cemented. Short-term good results were reported in 1979 (Insall et al. 1979). With the 
Total Condylar prosthesis, the cruciate ligaments were sacrificed (posterior-stabilized) and 
a monoblock type of tibial component was used. The name “Total Condylar” described the 
total replacement of all of the condylar bearing surfaces in the knee. This concept is still 
considered to be “the gold standard” of total knee arthroplasty (Figure 4).
Figure 3. Duocondylar knee
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2.1.1.1 Different concepts of TKA
Knee stability is one of the most important factors affecting the long-term durability of 
TKA. In most cases, ligament and soft tissue asymmetry may be corrected by soft tissue 
balancing techniques that allow symmetric tension in both flexion and extension, which 
enables the use of standard implants (cruciate retaining=CR or posterior stabilized=PS). 
Constrained implants (Constrained Condylar Knee=CCK) may be used if persistent 
laxity occurs despite the soft tissue balancing. Constrained implants improve stability 
and are useful in the treatment of severe malalignment and laxity. In the case of absent 
ligament support, a rotating-type hinge TKA may also be needed to restore stabilization of 
the knee (Sculco. 2006). Examples of the different constrained implant designs are shown 
in figure 5. The routinely used implants are made of titanium or cobalt-chromium based 
alloys where former is used in the tibial side and latter in the tibial or femoral side. There 
are also implants available which are made of ceramics or ceramic coated metals and these 
may be utilized in the patients with known hypersensitivity with metals, e.g. nickel (Heyse 
et al. 2012). The plastic parts are made of ultra high molecular weight polyethylene which 
are processed to reduce free radicals to lenghthen the durability of polyethylene. These 
prosecces include irradiation, melting, annealing and incorporating of vitamin E as anti-
oxidant (Chakravarty et al. 2015, Lambert et al. 2019).
Figure 4. Total Condylar 
Prosthesis mark I (Vince et 
al. 1989)
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2.1.1.2 Unicondylar arthroplasty
The work of Charnley and Gunston with the unicondylar knee prosthesis preceded the idea 
of using unicondylar designs. The first versions, which were models for modern unicondylar 
arthroplasties, were the St Georg (1969) and the Marmor (1972) implants (Figure 6). These 
models had polycentric metal femoral condyles and the tibial articulation was made of 
polyethylene that was nearly flat to avoid constraint of the articulation (Marmor. 1985, 
Heinert and Engelbrecht. 1988). Because of the thinness of the polyethylene component, 
wear was a common problem, and thus metal backed tibial implants were introduced to 
solve this problem (Palmer et al. 1998).
In 1974, the first Oxford unicondylar knee was introduced. It had a metal femoral 
component with a spherical articular surface, a metal flat tibial component, and a 
polyethylene mobile bearing insert. The design was fully congruent at both surfaces, and 
Figure 5. Examples of different constrained implants: CR (far left), PS (left middle), CCK (right middle), 
hinge (far right)
Figure 6. The St Georg (left) and Marmor (right) unicondylar prostheses
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because of the mobile bearing it was fully unconstrained to allow unrestricted movement 
(Goodfellow et al. 1987). 
In 1987, the Oxford phase 2 design was introduced that could be used both medially and 
laterally. This design was followed in 1998 by the Oxford phase 3 design, which introduced 
the minimally invasive approach (Price et al. 2001) (Figure 7).
2.2 Indications for knee arthroplasty
2.2.1 Osteoarthritis of the knee in general
Osteoarthritis (OA) is a whole joint disease which involves hyaline articular cartilage, 
subchondral bone, ligaments, capsular structures, synovium, and periarticular muscles. 
The disease is an active dynamic mixture of imbalanced repair and destruction of joint 
tissues, and not only a simple, passive wear-and-tear disease. OA is typically described as a 
heterogeneous disease with a wide range of underlying pathways that lead to similar joint 
destruction as the end-point (Hunter and Bierma-Zeinstra. 2019). 
According to EULAR criteria, OA of the knee includes knee pain, no morning stiffness 
or stiffness <30 minutes, and functional limitation as symptoms and crepitus, restricted 
ROM, and bone enlargement as clinical signs. 
Risk factors for OA include age, female sex, obesity, previous knee injury (Silverwood 
et al. 2015a), knee malalignment (Brouwer et al. 2007), and knee extensor muscle weakness 
(Oiestad et al. 2015). The heritable contribution to primary OA susceptibility has been 
established by twin and sibling studies to be about 50% (Zengini et al. 2016). Bone mineral 
Figure 7. The Oxford unicondylar knee prosthesis (phase 3)
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density may also have effect on development of symptomatic knee OA (Multanen et al. 
2015, Barbour et al. 2017).
2.2.2 Primary idiopathic osteoarthritis
Primary knee osteoarthritis is inflammatory process which results progressive loss of 
articular cartilage without any known reason, leading to wear and tear of the cartilage 
(Glyn-Jones et al. 2015). The main clinical indication for TKA is primary osteoarthritis, 
which accounts for between 94 and 97% of operations (Robertsson et al. 2010a) (NJR 
annual report 2018). The development of knee osteoarthritis involves a complex mixture 
of constitutional and mechanical factors. These factors include bone density, bone 
morphology, meniscal derangement, sex, sex hormones, and trauma. However, the largest 
risk factors for knee osteoarthritis are age, obesity and genetic components (Arden and 
Nevitt. 2006, Zengini et al. 2016). Both obesity and the size of the aging populations of the 
developed countries are increasing the burden of knee osteoarthritis (Cross et al. 2014a).
2.2.3 Secondary osteoarthritis
Secondary osteoarthritis  is the result of articular cartilage degeneration due to a known 
reason which may also be, for example, the consequence of an abnormal concentration of 
force across the joint. The listed reasons for secondary OA are posttraumatic, postsurgical, 
congenital or malformation of the limb, malposition (varus/valgus), scoliosis, rickets, 
hemochromatosis, chondrocalcinosis, ochronosis, Wilson disease, acromegaly, avascular 
necrosis, hemophilia, Paget disease, sickle cell disease, gout, pseudogout, and infectious 
arthritis (Doherty et al. 1983, Altman et al. 1986, Manlapaz et al. 2019).
 ,QÀDPPDWRU\DUWKULWLV
Rheumatoid arthritis (RA) is the most common inflammatory arthritis. 
Spondyloarthropathies, which include psoriatic arthritis, reactive arthritis, and ankylosing 
spondylitis, are less common (Ledingham et al. 2017). Rheumatoid arthritis is a progressive 
inflammatory disease that multidimensionally affects the synovial joints, leading to erosion, 
destruction, and disability (Scott et al. 2010). The disease primarily involves the joints, 
but it is also a syndrome that involves extra-articular manifestations, such as rheumatoid 
nodules, pulmonary involvement, vasculitis, and systemic comorbidities (Smolen et al. 
2016). New biological agents have been developed to decrease inflammatory processes and 
prevent joint destruction, i.e., the late-stage of the disease (Scott et al. 2010). RA patients 
with multiorgan disease involvement are often treated with multiple pharmacological 
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drugs. They are likely to use several immune-modulatory medications, such as TNF-alpha 
inhibitors, glucocorticoids, and disease-modifying antirheumatic drugs (Smolen et al. 
2016). RA affects the knee in about 27% of all joints (Tanaka et al. 2005). 
TKA is a highly successful procedure for advanced RA destruction of the knee joint, and 
it both enhances functionality and increases the quality of life of patients (Lee and Choi. 
2012, Goodman et al. 2016). The risk for complications after TKA, however, is increased 
in patients with RA because of the complex systemic nature of the disease (Jauregui et al. 
2016).
2.3 Epidemiology of knee arthroplasty
2.3.1 Patient demographics
The epidemiology of knee arthroplasty can be evaluated based on incidence, prevalence, or 
lifetime risk of arthroplasty. The lifetime risk for TKA refers to the probability of having 
this surgical procedure over an individual’s lifetime. Lifetime risk estimates provide a 
complementary approach to quantifying population-level disease burden and related use of 
health-care services (Ackerman et al. 2017). In 2010, the global prevalence of radiographically 
confirmed symptomatic knee OA was estimated to be 3.8% (95% CI 3.6% to 4.1%) (Cross 
et al. 2014b). At the patient level, discordance between OA symptoms and radiographic 
findings exists, meaning that some patients may not experience symptoms even if they are 
showing osteoarthritic changes in imaging tests (Glyn-Jones et al. 2015). OA of the knee 
contributes to most of the treatment burden resulting in the need for knee replacement 
surgery (Carr et al. 2012, Price et al. 2018). It is known that OA is more common in women 
than in men, and the prevalence of OA increases with age (Busija et al. 2010). With the 
aging of the population and an increase in obesity throughout the world, it is anticipated 
that the burden of OA will increase the number of knee arthroplasties globally (Cross et 
al. 2014b). Toivanen et al. analyzed possible risk factors for the prediction of the incidence 
of knee OA in the long-term based on the nationwide Mini-Finland Health Survey. They 
found that obesity, heavy work load, and prior knee injury were associated with the risk of 
developing knee OA (Toivanen et al. 2010). 
2.3.1.1 Gender
In a study on regional variations in the USA by Katz et al., TKAs were almost twice as 
likely to be performed on women than on men (odds-ratio (OR) = 1.95). Furthermore, 
differences between races were reported. On average, TKAs were over one and a half times 
more likely for African American women than for African American men (OR= 1.66), 
whereas the difference was only 24 percent for white women versus white men (OR = 
1.24) (Katz et al. 1996). In a national register-based study by Kim et al., the rate of TKA 
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increased over the 4 years (2002–2005) of the study and was much higher in women than 
in men. Compared with men, the age-standardized rate ratios for TKA in women were 8.0 
(95% CI: 7.4–8.6) for 2002, 7.9 (95% CI: 7.4–8.4) for 2003, 7.5 (95% CI: 7.0–7.9) for 2004, 
and 7.4 (95% CI: 7.0–7.8) for 2005, respectively (Kim et al. 2008b). In a register- based 
analysis, females consistently demonstrated the greatest lifetime risk for TKA (Ackerman 
et al. 2017). The prevalence of knee OA was higher in females (mean 4.8%; 95% UI 4.4% to 
5.2%) than in males (mean 2.8%; 95% UI 2.6% to 3.1%). Moreover, there was no evidence of 
a change in age-standardized prevalence between 1990 (mean 3.8%; 95% UI 3.6% to 4.0%) 
and 2010 (mean 3.8%; 95% UI 3.6% to 4.1%) for either males or females (Cross et al. 2014b). 
In a study based on the General Practice Research Database in the UK, the female-to-male 
ratio for the estimated incidence rates remained stable at between 1.18:1 and 1.42:1 for 
knees between 1995 and 2006 (Culliford et al. 2010b). In the same study, the estimated age-
standardized primary TKA rates increased in the UK from 42.5 (95% CI 37.0 to 48.0) to 
138.7 (95% CI 132.3 to 145.0) for women and from 28.7 (95% CI 23.9 to 33.6) to 99.4 (95% 
CI 93.9 to 104.8) for men between 1991 and 2006.
2.3.1.2 Age
The increasing incidence of OA with age is the result of cumulative exposure to various 
risk factors and biological age-related changes in the joint structures (Hunter and Bierma-
Zeinstra. 2019). In an older nation-wide study by Katz et al., TKAs were reported to be 
consistently more likely to be performed on individuals aged between 70 and 84 years than 
younger patients between 1985 and 1990 (Katz et al. 1996). In a study from South Korea 
during the study period 2002 to 2005, the rate of TKA increased with age and reached a 
peak over the age of 65 to 70 years for women and 70 to 75 years for men, after which it 
levelled off (Kim et al. 2008b). In a study from British data the mean age at operation for 
TKA was 70.1 years (95% CI 69.6 to 70.5) for women and 69.2 years (95% CI 68.6 to 69.7) 
for men in 2006 (Culliford et al. 2010b). In a Swedish study based on SKAR data, the 
number of TKAs in patients younger than 55 year of age started to increase in 2000. This 
increase continued so that in 2007 the number had become 5 times that at the beginning 
of the study period in 1998 (W-Dahl et al. 2010a). In a study comparing epidemiology of 
3 different Nordic countries, there was an increase in the proportion of younger patients 
(between 55 and 64 years of age) in all countries, particularly in Denmark (Robertsson et 
al. 2010a).
2.3.1.3 BMI
In a study from the UK that analyzed future projections of the numbers of TKAs, obesity 
was assumed to increase TKA count 9% by 2035 compared with patients with normal BMI. 
The same effect was not, however, shown with total hip arthroplasty (THA) (Culliford et 
al. 2015). Kremers et al. analyzed 6 475 primary TKAs with study end points as length 
of stay in hospital and direct medical costs. The mean age of patients was 68 years. The 
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proportion of obese patients (BMI>30 kg/m2) increased between 2000 and 2008 from 49% 
to 59% in primary TKAs. Length of stay and costs were lowest for normal BMI or slightly 
overweight patients and highest for patients at the extreme ends of the BMI spectrum. They 
calculated that beyond 30 kg/m2, every 5-unit increase in BMI was associated with higher 
hospitalization costs of approximately $250 to $300 for patients undergoing primary TKA 
(Kremers et al. 2014). A case-control study from the USA reported a strong association 
between increasing BMI and amount of replacement surgery in both primary THAs and 
TKAs. In males, the highest risk was associated with a BMI of 37.50–39.99, whereas in 
females the highest risk was reported when BMI was >40. An association between obesity 
and risk for revision of TKA or THA was not found in this analysis (Wendelboe et al. 
2003).
2.3.1.4 Indications
In a register-based study from Sweden, Norway, and Denmark, primary OA was the 
cause of surgery in 88% of all cases and RA in 5% of all cases between 1997 and 2007. The 
relative proportion of surgeries for RA decreased during the study period in all 3 countries 
(Robertsson et al. 2010a). In a Finnish study, the unadjusted occurrence of primary TKA 
increased from 17 to 187 / 100 000 persons in non-rheumatoid arthritis women and from 6 
to 76 / 100 000 persons in men between 1986 and 2003. In 2003, the age-adjusted incidence 
rate ratios (95% CI) were 1.2 (0.6 to 2.3) for TKA in female patients and 0.7 (0.2 to 3.6) 
in male patients with RA. In patients with non-rheumatoid arthritis, the age-adjusted 
incidence rate ratios (95% CI) were 9.8 (6 to 15.8) for TKA in female and 9.8 (4.3 to 22.5) 
in male patients. Patients with rheumatoid arthritis were a few years younger than patients 
with other diagnoses, 67 vs 71 years (Sokka et al. 2007). In this study, the occurrence of 
TKA in patients with rheumatoid arthritis did not increase. This was possibly due to the 
improved treatment of rheumatoid arthritis, which is in line with other reports (Robertsson 
et al. 2010a, Price et al. 2018). The same effect was reported in a study of patients with 
rheumatoid arthritis in California, where the relative risk for total knee arthroplasty was 
9% higher between 1993 and 1997 than between 1983 and 1987, but was significantly lower 
by 8% between 1998 and 2002 (Louie and Ward. 2010). Indications for knee arthroplasty 
according to the New Zealand Joint Registry (NZJR) and the National Joint Registry for 
England and Wales (NJR) are listed in Table 1.
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Table 1. Indications for knee arthroplasty in the NZJR and the NJR annual reports 2017
Indication NZJR NJR
Osteoarthritis 94.7% 96.1%
Rheumatoid arthritis 2.3% 2.1%
Post fracture 1.0% 0.1%
2WKHULQÀDPPDWRU\ 0.8% -
Post ligament disruption 0.8% 0.6%
Avascular necrosis 0.4% 0.4%
Tumor 0.1% -
2.3.1.5 Prevalence
The prevalence of total knee replacement is the proportion of individuals who are alive on a 
certain date and who have undergone a total knee replacement, regardless of the timing of 
the initial procedure. Kremers et al. reported prevalence in the USA estimated from data 
between 1969 and 2010. They estimated that the prevalence of TKAs among the total US 
population was 1.52% in 2010. The prevalence of total knee replacement at 50 years of age 
was 0.68%, and increased to 2.92% at 60 years, 7.29% at 70 years, 10.38% at 80 years, and 
8.48% at 90 years of age. Prevalence was higher among women than among men (Maradit 
Kremers et al. 2015).
2.3.1.6 Incidence
In an Australian study, the incidence of primary TKA in 1994 was 56.4/105 and it increased 
to 76.8/105 in 1998 (Wells et al. 2002). In a study of the US population, information on 443 
008 patients who underwent TKA between 1990 and 2000 was analyzed based on the 
Nationwide Inpatient Sample databases. They found that even if the majority of TKAs were 
performed on patients over 70 years of age, the proportion of younger patients undergoing 
TKA also significantly increased during the study period. The rates of TKA increased 
from 40.4/104 persons to 54.7/104 persons between 1990 and 2000 for patients over 70 
years of age. They also reported a difference in the rates of TKA between white and ethnic 
minority patients. White patients comprised the vast majority of those receiving TKAs 
throughout the 1990s, with black patients making up the next largest group, followed by 
Hispanics. White patients comprised 93% of TKA recipients in the early 1990s, but this 
proportion decreased to 87.5% by the end of study period (Jain et al. 2005). In a Swedish 
study, information on all knee arthroplasties performed in Sweden from 1975 to 2013 was 
analyzed based on SKAR data. In the study, the magnitude of the growth rate changed 
in 1988. Before 1988, the incidence increased by 2.8 (CI 1.1–4.7) per year, and thereafter 
the increase in incidence was higher and amounted to 9.1 (CI 8.4–9.7) per year (Nemes et 
al. 2015b). Also in Finland incidences have increased both in females and males. Based on 
FAR, incidences in Finland are shown in Figure 8.
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2.3.1.6.1 Future trends
A study of predictions of future trends estimated the future incidence rate and volume of 
primary TKA in the United States from 2015 to 2050 using both a conservative projection 
model and a model assuming exponential growth. This study reported a 143% projected 
increase in TKA volume using the conservative model and an 855% projected increase 
using the Poisson model (Inacio et al. 2017). Another future projection study from the 
United States based on Nationwide Inpatient Sample and United States Census Bureau 
data from the period 1990 to 2003 estimated future trends until 2030. They concluded 
that if the number of TKAs performed continues at the same rate as during the data 
period, the demand for primary TKA is projected to grow by 673%, from 450 000 (CI 
425 000–477 000) in 2005 to 3.48 million procedures (CI 2.95x106–4.14 x106) by 2030 
(Kurtz et al. 2007). Another study, based on the UK Clinical Practice Research Datalink 
(CPRD) between 1991 and 2010, projected future numbers of TKAs in 2035 using two 
models: static and exponential. In the static model the number of TKAs increased from 
85 019 (2015) to 118 666 (2035). By comparison, an exponential extrapolation of historical 
rates using a log-linear model produced much higher estimates of TKA counts in 2035 at 
1 219 362 (Culliford et al. 2015). However, a study by Singh et al. showed that the method 
of analysis may be reflected in the results. They used polynomial regression with a Poisson 
distribution in their analysis, and they reported 10 to 30% higher TKA estimates in 2030 
than Kurtz et al. (Singh et al. 2019).
2.3.1.7 Regional variations
Katz el al. described variations in the numbers of TKAs in patients older than 65 years 
from 1985 to 1990. They analyzed data from hospitals in the United States that performed 
TKA on the Medicare system. The increase in TKA rates differed among different 
regions. For example, the regions of New York and Atlanta had the largest increases 
Figure 8. Annual incidences of knee arthroplasty in Finland from 1987 (FAR report). Incidences are 
shown as operations 105/ person year. Green line for females and purple line for males
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while the Seattle region had the smallest relative increase. They reported an 18.45% total 
annual rate of increase. Even after adjusting for demographic factors, significant regional 
variation remained and much of this variation remained unexplained (Katz et al. 1996). 
In a study from Australia, large regional variations between states were reported between 
1994 and 1998, with an incidence of 4.8/105 in the Northern Territory and 104.5/105 in 
South Australia. This variation was explained by the Northern Territory having fewer 
orthopaedic surgeons and a younger population (Wells et al. 2002). 
A study by Pabinger at al. analyzed economic and medical data on knee arthroplasty 
performed in OECD countries from 1990 to 2011. The analysis was based on the OECD 
Health Data 2013 database relating to knee arthroplasty for 28 countries. In addition, they 
divided the results into groups of patients aged 65 years or over and 64 years or younger. 
The mean compound annual growth rate for knee arthroplasty from 2005 to 2011 was 
5.5% (range 1.2–26.7) for the total population. They observed a 10-fold variation in knee 
arthroplasty utilization between the different OECD countries. Patients aged 64 years or 
younger showed a considerably higher annual growth rate of 7.1% (range 4.4–27) than those 
patients aged 65 years or older who had a rate of 4.4% (range 0.3–26.2). This growth rate 
led to an absolute increase in total implants of 38% between 2005 and 2011. The highest 
growth rate, 63%, was found in patients aged 64 years or less compared with a growth rate 
of 29% in patients aged 65 years or older. These variations were explained by differences in 
economic power and medical conditions. Obesity in earlier years (1991–2006) correlated 
very strongly with the need for knee arthroplasty 5 to 20 years later. Moreover, obesity was 
underlined as a major cause for late knee OA (Pabinger et al. 2015).
2.4 Evaluation of outcomes of knee arthroplasty
2.4.1 Clinical evaluation
Pain and stiffness of the knee are the main clinical symptoms in patients with knee OA, and 
knee arthroplasty should effectively alleviate these symptoms. Range of motion (ROM) 
and stability of the joint are basic evaluation methods both pre- and postoperatively. 
Moreover, there are a vast variety of performance-based tests to assess knee function, and 
one of the most commonly used is the Timed Up and GO, (TUG), test (Podsiadlo and 
Richardson. 1991). In the TUG test, the patient stands up from a chair, walks 3 meters, 
turns around, walks back to the chair and sits down. The time taken is measured and the 
result is evaluated using reference times. 
In a review, 26 performance-based methods used for the evaluation of knee and/or hip 
OA pre- and postoperatively were evaluated and multi-activity tests were found to be more 
valid than single-activity tests. However, the review could not make any conclusions as to 
which tests might be the most useful because no consensus on what activities and functional 
parameters should be included exists (Terwee et al. 2006). Kennedy et al. compared the 
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reliability and sensitivity of the six-minute walk test (6MWT), timed up and go test 
(TUG), stair measure (ST), and a fast self-paced walk test (SPWT), and all measurements 
were found to be responsive to detecting improvements in the early postoperative period 
(Kennedy et al. 2005). Boonstra et al. aimed to study the most selective test between the 
TUG test and the sit-to-stand test, and both were reported to be selective and functionally 
valid (Boonstra et al. 2008).
It would be interesting if the outcome of a TKA could be predicted preoperatively with 
scoring system. Previous studies have shown that satisfaction after TKA may be associated 
with the expectations of the patient (Hepinstall et al. 2011, Styron et al. 2011, Yoo et al. 
2011).
2.4.2 Surgeon-reported outcome measures
Traditional clinical rating systems report the functions of the joint, i.e., the range of 
motion or stability assessed by the clinician. One of these tools that is still widely used 
in evaluating the outcome of knee arthroplasty is the Knee Society Score (KSS) (Insall et 
al. 1989). Because clinical measurements are not robust, criticism of the reliability of this 
rating system has been reported (Ryd et al. 1997). In many studies, the sensitivity of the 
KSS has been shown to be inadequate, and it lacks the power to distinguish differences 
between outcomes (Bullens et al. 2001, Harrington et al. 2009, Rahman et al. 2010, Choi 
et al. 2010, Becker et al. 2011). 
2.4.3 Patient-reported outcome measures
Patient-reported outcome measures (PROMs) are standardized questionnaires which 
are completed by the patients to analyze their perception of health, level of impairment, 
disability, and health-related quality of life. PROMs may also allow the measurement of 
the efficacy of medical, i.e., surgical, intervention. PROMs can be either generic or disease 
specific and both types are often used for evaluation.
2.4.3.1 OKS
The Oxford Knee Score (OKS) comprises 12 items regarding pain and activities of daily 
living (ADL). The assessment of the reliability and validity of the OKS has been thoroughly 
carried out (Dawson et al. 1998, Davies. 2002, Murray et al. 2007a, Jenny and Diesinger. 
2012). The minimal clinically important difference (MCID) for the OKS score is 5 points 
when comparing 2 different patient cohorts, 7–8 points when comparing the change in 1 
patient, and 9 points when comparing the change in the same patient cohort (Murray et al. 
2007a, Beard et al. 2015). 
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2.4.3.2 KOOS
The Knee injury and Osteoarthritis Outcome Score (KOOS) comprises 5 subscales: pain, 
other symptoms, activities in daily living (ADL), function in sport and recreation (Sport/
Rec), and knee-related Quality of life (QOL). The MCID is suggested to be 8 to 10 (Roos 
and Toksvig-Larsen. 2003).
2.4.3.3 RAND 36-Item Health Survey
The RAND 36-item health survey (RAND-36) comprises 36 items that assess eight general 
health concepts. The Physical Component Scale (PCS) and the Mental Component Scale 
(MCS) are also derived from the eight RAND-36 scales (Kantz et al. 1992, Ware and 
Sherbourne. 1992, Ware et al. 1995). The MCID for the subscales is suggested to be 3 to 5 
points (Hays and Morales. 2001).
2.4.3.4 HAAS
The High-Activity Arthroplasty Score (HAAS) was specifically developed to assess the 
subtle variations in functional ability after lower limb arthroplasty with particular regard 
to highly active individuals. The score covers the 4 domains of walking, running, stair 
climbing, and general activities (Talbot et al. 2010, Jenny et al. 2014). Possible scores range 
from 0 to 18 points. The MCID has not been defined for HAAS.
2.4.3.5 TKFQ
First described by Weiss et al. (Weiss et al. 2002a), the Total Knee Function Questionnaire 
(TKFQ) was developed to assess a wide spectrum of activities involving the knee. The 
questionnaire comprises 55 multiple-choice questions, 42 of which query the personal 
importance of as well as the frequency and difficulty of performing 3 types of functional 
activities: baseline activities, advanced activities, and 12 recreational activities and exercises 
(Conditt et al. 2004). The MCID has not been defined for TKFQ.
2.4.3.6 15-D
The 15D is a generic, comprehensive, 15-dimensional, self-administered instrument for 
measuring health-related quality of life (Sintonen. 2001). The questionnaire comprises 15 
dimensions with 5 ordinal levels on each dimension. From each dimension, the respondents 
choose the level that best describes their present health status. A set of population-based 
preference and utility weights is used to generate the 15D score on a 0 (being dead) to 1 
(full health) scale. Moreover, the 15D scores are generalizable and valid for deriving quality-
adjusted life years (QALYs). The generic MCID for the change of 15D scores is ±  0.15 
(Alanne et al. 2015).
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2.4.3.7 Visual Analog Scale
The 100 mm visual analog scale (VAS) is widely used to measure pain and satisfaction 
intensity pre- and post-surgery. Several studies have found that a pain scale PASS value of 
40 can be used as an outcome criterion for knee osteoarthritis (Tubach et al. 2012, Perrot 
and Bertin. 2013). It is generally accepted that a pain VAS score of 30, 70, and 100 indicates 
the upper boundaries of mild, moderate, and severe pain intensity. The MCID is defined as 
10 points for VAS (Myles et al. 2017). Satisfaction can be also scored on a VAS (Robinson 
et al. 1997, Dolan and Sutton. 1997). Moreover, the VAS can also be used to evaluate pain, 
satisfaction, and restrictions both before and after knee arthroplasty. The VAS satisfaction 
scale is divided into four sections: 0 to 25 dissatisfied, 26 to 50 unsure, 51 to 75 satisfied, and 
76 to 100 very satisfied (Scott et al. 2016).
2.4.4 Radiographical evaluation
The severity of knee OA is assessed from preoperative standing fixed flexion view (FFV) 
radiographs using the Kellgren-Lawrence (KL) (KELLGREN and LAWRENCE. 1957) 
classification system. The Kellgren and Lawrence grading system is used to classify the 
severity of OA (grade 0: no OA; grade 1: doubtful OA; grade 2: minimal OA; grade 3: 
moderate OA, and grade 4: severe OA). KL grade 2 requires definite osteophyte(s) and 
joint space narrowing. The KL grades 3 and 4 require multiple moderate osteophytes, 
definite joint space narrowing with deformity, and sclerosis is also present for KL grade 4. 
A mild preoperative radiographic grade of OA has been shown to be the reason for residual 
symptoms after knee arthroplasty, and therefore should be taken into account when 
analyzing the postoperative outcome of knee arthroplasty (Niinimaki et al. 2011, Scott et 
al. 2016).
Postoperative plain radiographs are used to identify radiolucency in the bone-cement 
interface or the implant-cement interface, and also implant subsidence. In younger 
patients, aseptic loosening has been reported to be the most common reason for revision 
when infections are excluded (Odland et al. 2011).
2.4.5 Implant survivorship
2.4.5.1 Arthroplasty registers
National registers collect information on a combination of different knee arthroplasty 
implants. These registers were originally designed to collect data on surgeon and implant 
performance and the main outcome collected was implant failure. Recently, patient-
reported outcome measures have been collected by some of the registers to measure patients’ 
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subjective outcomes related to knee arthroplasty. The most commonly cited national 
registers are listed in the table 2.
Table 2. Common national knee arthroplasty registers
Country Type Year started Abbreviation
UK National 2003 NJR
Australia National 1999 AOANJRR
Sweden National 1975 SKAR
Canada National 2003 CJRR
Holland National 2007 LROI
New Zealand National 1999 NZJR
Denmark National 1997 DKR
Norway National 1994 NAR
Finland National 1980 FAR
USA National 2010 AJRR
2.4.5.1.1 Nordic Arthroplasty Register Association
The Nordic Arthroplasty Register Association (NARA) was established in 2007 and 
the database includes all primary hip and knee replacement procedures performed in 
Norway, Denmark, Sweden, and Finland since 1995 for hip procedures and since 1997 for 
knee procedures. The overall aim of NARA is to improve the quality of research and the 
understanding of the clinical course of patients undergoing joint replacement surgery, and 
thereby to enhance the possibilities for improving the quality of the treatment associated 
with joint replacement surgery. The NARA database includes only variables which all 
countries can deliver, and 20 variables are included in the knee datasets. Based on NARA, 
for national registries to be successful as collaborating registers, the following key points 
must be met: 1. an adequate number of inhabitants in the countries, 2. a uniform health 
care system, 3. long traditions of nationwide registries, 4. high data quality due to regular 
validation processes, 5. uniform unique personal ID-systems, 6. possibility to follow up all 
patients registered in the National Arthroplasty register, 7. 100% unambiguous linkage of 
the index operation to all types of complications and outcomes, 8. possibility to link the 
database to all other national quality registries (NARA report 2016).
The NARA includes the following national registers: The Danish Hip Arthroplasty 
Register, The Danish Knee Arthroplasty Register, The Finnish Arthroplasty Register, 
The Norwegian Arthroplasty Register, The Swedish Hip Arthroplasty Register, and The 
Swedish Knee Arthroplasty Register (NARA report 2016).
47
2.4.5.1.2 Level of evidence
Good quality register-based studies have been commonly qualified as level II studies in 
the level of evidence. Originally the levels of evidence were described in a report by the 
Canadian Task Force on the Periodic Health Examination in 1979 (Spitzer et al 1979). 
The levels of evidence were further described and expanded by Sackett in an article on 
levels of evidence for antithrombotic agents (Sackett. 1989). Since the introduction of 
levels of evidence, several other organizations and journals have adopted variation of the 
classification system (Burns et al. 2011). The hierarchies rank studies according to the 
probability of bias. RCTs are typically given the highest level because they are designed 
to be unbiased and have less risk of systematic errors but due to low quality of RCT study 
it may not always to be considered as class I study and the same principle comprise with 
other levels of evidence (Burns et al. 2011). Examples of different modifications of level of 
evidence gradings are shown in the tables 3 and 4.
Table 3. Type of evidence by Sackett (Sackett. 1989)
I Large RCTs with clear cut results 
II Small RCTs with unclear results 
III Cohort and case-control studies 
IV Historical cohort or case-control studies 
V Case series, studies with no controls
Table 4. Type of evidence by the Centre for Evidence-Based Medicine
1A Systematic review (with homogeneity) of RCTs
1B ,QGLYLGXDO5&7ZLWKQDUURZFRQ¿GHQFHLQWHUYDOV
1C All or none study
2A Systematic review (with homogeneity) of cohort studies
2B Individual Cohort study (including low quality RCT, e.g. <80% follow-up)
2C “Outcomes” research; Ecological studies
3A Systematic review (with homogeneity) of case-control studies
3B Individual Case-control study
4 Case series (and poor quality cohort and case-control study
5 ([SHUWRSLQLRQZLWKRXWH[SOLFLWFULWLFDODSSUDLVDORUEDVHGRQSK\VLRORJ\EHQFKUHVHDUFKRU³¿UVW
principles”
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2.5 Reasons for failures in knee arthroplasty
2.5.1 Failures in registers
The most common reason for failures in the NJR and NZJR annual reports are listed in 
table 5. Failures may be divided into early and late failures where non-wear-related early 
failures are most commonly infections.
Table 5. Reasons for revisions in NJR and NZJR annual reports 2017
Reason of revision NJR (%) NZJR (%)
Aseptic loosening 25 30
Other indication 12 -
Patellar resurfacing - 20
Infection 11 22
Pain 11 25
Instability 10 -
Implant wear 9 -
Lysis 7 -
Malalignment 5 -
Stiffness 4 -
Subluxation / dislocation 3 -
Periprosthetic fracture 2 -
Implant fracture 1 3
2.5.2 Age-dependence
Charette et al. retrospectively reviewed 4 259 primary TKAs performed over a 4-year period 
in the USA. In their analysis, they divided patients into a less than 55 years of age group 
and a more than 55 years of age group. The reasons for revision were different between 
these groups with instability being a leading cause of revision in younger patients, while 
infection and loosening more commonly led to failure in older patients. Younger patients 
were more susceptible to the early risk for reoperation and non-wear-related complications 
(Charette et al. 2019). Aggarwal et al. retrospectively reviewed the reasons for and the 
results of revision TKA performed over a ten-year time period (1999–2009) in the USA. 
They divided 84 patients into a less than 50 years of age group and the 60 to 70 years of age 
group. The most common reasons for revision in the younger and older groups were the 
following: aseptic loosening 27% vs 27%, infection 23% vs 30%, arthrofibrosis (stiffness) 
14% vs 6%, polyethylene wear 11% vs 14%, and  instability of joint 10% vs 14%, respectively 
(Aggarwal et al. 2014).
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2.5.3 Aseptic loosening and osteolysis
Aseptic loosening may occur as the result of inadequate initial fixation, mechanical loss 
of fixation over time, or the biologic loss of fixation caused by particle-induced osteolysis 
around the implant. Biologic and mechanical factors have been associated with the early and 
late stages of the development of osteolysis following joint replacement (Abu-Amer et al. 
2007). The initial response is a localized inflammatory response that is characterized by the 
formation of fibrous tissue that encapsulates the implant. Aseptic loosening is characterized 
by poorly vascularized connective tissue dominated by fibroblasts and macrophages which 
form the interface tissue between the bone and implant or cement (Gallo et al. 2002). After 
TKA there have been reported changes in the periprosthetic BMD which may have effect 
in fixation of knee arthroplasty but this relation is controversial (Levitz et al. 1995, Li and 
Nilsson. 2000, Saari et al. 2007).
During the 1980s, biomechanical studies indicated that a metal reinforcement of 
the polyethylene tibial component would result in lower implant-derived stresses to the 
underlying bone, and thus better fixation (Bartel et al. 1982, Reilly et al. 1982, Lewis et 
al. 1982). At that time, the major cause of failure was the loosening of tibial components 
(Moreland. 1988) and the designs of TKAs were changed to metal-backed tibial components 
with less conformed implants to decrease shear forces between the interfaces. 
Despite the introduction of these new designs, revisions due to aseptic loosening were 
still reported (Knutson et al. 1994). The cement itself was assumed to cause problems due 
to heat injury or chemical toxicity inducing aseptic loosening (Mjoberg. 1986, Sturup 
et al. 1994). Uncemented designs were developed to achieve bone ingrowth (Blaha et al. 
1982, Hungerford et al. 1989, Rosenberg et al. 1990). Although good survival rates were 
reported with uncemented implants, they were still not better than those of cemented 
designs (McCaskie et al. 1998, Hofmann et al. 2001). In radiostereometric analysis (RSA), 
no differences in migration between cemented and uncemented implants were reported 
(Nilsson et al. 1991, Toksvig-Larsen et al. 1998), but uncemented components showed 
increased tilting (Nilsson and Karrholm. 1993). Moreover, higher revision rates were 
reported with uncemented prostheses (Robertsson et al. 1997, Duffy et al. 1998b, Berger 
et al. 2001b).
Kutzner et al. reported an increased number of aseptic loosening cases with cemented 
LCS implants in a Norwegian study population. They assumed that one of the reasons for 
aseptic loosening was a too thin cement mantle between the implant and the bone (Kutzner 
et al. 2018). Other reasons for aseptic loosening in TKA that been reported are as follows: 
wear particle exposure (Le et al. 2014, Lombardi et al. 2014); implant alignment (Ritter et 
al. 2011, Kim et al. 2014a); cement mantle thickness (Walker et al. 1984, Vanlommel et al. 
2011); resurfacing the patella (Lygre et al. 2011); and implant design (Namba et al. 2012, 
Gothesen et al. 2013, Namba et al. 2014). 
In the SKAR annual report 2018, aseptic loosening was one of the main reasons 
for revision during a 10-year period. Previously, aseptic loosening has been reported as 
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being the main reason for revision. However, in the latest annual report, it is equal with 
infections (SKAR annual report). In the New Zealand arthroplasty register annual report 
2017, aseptic loosening was the main reason for revision in TKAs when both femoral and 
tibia loosening were calculated. Loosening of the tibia component was more common than 
loosening of the femoral component. In the NJR, aseptic loosening was the most common 
reason for revision, accounting for approximately 38% of all single-stage revision operations 
(NJR annual report 2018).
A study by Vessely et al. reported survivorship of 1 000 patients treated consecutively 
with the same prosthesis, component combination, and fixation at a mean 15.7 years of 
follow-up. The survivorship of this cemented cruciate-retaining implant was excellent, with 
a survivorship free of revision for any reason of 95.9% at 15 years, and a survivorship free of 
revision for aseptic loosening of 98.8% at 15 years (Vessely et al. 2006). 
In a multicenter prospective observational cohort study with 318 patients, Mulhall 
et al. reported that aseptic loosening was one of the three main reasons for revision with 
instability and wear (Mulhall et al. 2006). In this study, the mean time from primary to 
revision TKA was 7.9 years. 
In another study, septic loosening and polyethylene wear were the most important 
indications after 8 years, whereas infections occurred in the earlier phase (Koh et al. 2017). 
A study concerning younger patients reported the risk for aseptic mechanical failure to 
be 4.7 times higher in patients less than 50 years of age compared with patients more than 
65 years of age (Meehan et al. 2014).
The mobile bearing concept, which was firstly introduced in unicompartmental knee 
arthroplasty, could theoretically decrease the forces on the implant-bone interface and 
improve fixation (Buechel and Pappas. 1986, Goodfellow and O’Connor. 1986). These 
designs have reported reasonable survival rates (Buechel. 2004, Callaghan et al. 2005, 
Tarkin et al. 2005), but an increased risk for aseptic loosening compared with fixed bearing 
TKAs have also been reported (Gothesen et al. 2017, Kutzner et al. 2018).
The coating of implants may also decrease the risk for aseptic loosening. Hydroxyapatite-
coated components have shown less migration and better or equal fixation with the bone 
compared with cemented implants (Onsten et al. 1998, Nelissen et al. 1998, Regner et 
al. 2000, Toksvig-Larsen et al. 2000). In a prospective study of 1 000 TKAs, Cross at al. 
reported a 10-year cumulative survival rate of 99.14% (CI 92.5–99.8) (Cross and Parish. 
2005). 
In another prospective study of 118 hydroxyapatite-coated and uncemented TKAs in 
patients less than 55 years of age, there were two revisions of the tibial components because 
of aseptic loosening. At 12 years, the overall rate of implant survival was 97.5% (Tai and 
Cross. 2006a). 
Voigt et al. concluded that in patients less than 65 years of age, an HA-coated tibial 
implant may provide better durability than other forms of tibial fixation (Voigt and Mosier. 
2011a).
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2.5.4 Infections
The incidence of periprosthetic joint infection (PJI) is between 1% and 4% (Peersman 
et al. 2001, Phillips et al. 2006). The risk factors for developing PJI following total joint 
arthroplasty include male gender, higher age, higher BMI, and the presence of comorbidities, 
especially cardiac conditions (Zmistowski et al. 2013). 
A study by Vessely et al. reported that more than 1 ⁄3 of implant failures are related to 
deep infections. In this series, the total rate of deep infection was 1.8% (Vessely et al. 2006). 
Another study reported that the annual incidence of PJI was highest during the first 4 
years after primary TKA. In this study, the cumulative incidence of PJI was 0.8% at 1 year, 
1% at 2 years, 1.5% at 5 years, and 2% at 15 years after the index operation (Koh et al. 2017). 
O’Toole et al. predicted that because diabetes and obesity will affect approximately 50% 
of the increasing total population of TKA patients, this will potentially have great financial 
implications given the increased rate of PJI within this patient population (O’Toole et al. 
2016). 
Younger age is also associated with higher infection rate in the early stages after primary 
TKA. In a risk-adjusted model reported by Meehan et al, the risk for PJI was 1.8 times 
higher in patients younger than 50 years of age compared with patients 65 years of age or 
older (Meehan et al. 2014).
In the NZJR annual report 2017, infections were the reason for revision in about 25% 
of cases, and this level has remained stable during the last 10 years of surveillance (NZJR 
annual report 2017). 
In the SKAR annual report 2018, infections were the reason for revision in about 30% 
of all revisions in TKAs and less than 5% in UKAs, if the indication for knee arthroplasty 
was OA (SKAR annual report 2018). 
In the NJR, infections accounted for 6% of one-stage revisions and 84% of two-stage 
revisions (NJR annual report 2018). 
In the AOANJRR, infection is the most common reason for revision with TKAs 
during the first 5 years following surgery. After that, loosening becomes more common 
(AOANJRR annual report 2018).
2.5.5 Pain
Chronic post-surgical pain (CPSP) is defined as moderate to severe pain that continues for 
at least three months post-operatively (Treede et al. 2019). Many studies have reported that 
15% to 20% of patients are not satisfied after knee arthroplasty, and pain is the main cause 
of this dissatisfaction (Parvizi et al. 2014, Lavand’homme and Thienpont. 2015, Scott et al. 
2016, Goh et al. 2016a). 
Intrinsic causes of pain include pathology within the knee joint: infection, 
implant failure, implant loosening, instability, subluxation/dislocation, arthrofibrosis, 
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impingement, or disorders of the extensor mechanism. Extrinsic causes of pain after knee 
arthroplasty include pathology derived outside of the knee: hip disease, spine pathology, 
vascular insufficiency, tendinitis, or bursitis (Dennis. 2004a, Flierl et al. 2019). 
Other reasons for CPSP can be absence of end-stage arthritis preoperatively, compression 
damage caused by a tourniquet during surgery, synovitis, recurring hemarthrosis, and 
fibromyalgia (Worland et al. 1997, Saksena et al. 2010, D’Apuzzo et al. 2012). Heterotopic 
ossification may cause pain and loss of motion after TKA (Roth et al. 2014). Moreover, 
preoperative financial worker’s compensation or psychiatric diagnoses may decrease 
satisfaction after TKA (Saleh et al. 2004a). In the NZJR annual report, pain is reported 
to be the reason for revision in 25 to 30% of cases during a 10-year period (NZJR annual 
report 2017). In the NJR, pain accounted for almost 17% of revision cases (NJR annual 
report 2018). In a study from New Zealand, the cumulative incidence for secondary patella 
resurfacing performed due to anterior knee pain was highest during the first 5 years after 
primary TKA (0.5%) (Koh et al. 2017). Patients with CPSP often continue the use of 
pain drugs even if the amounts of these are reduced compared to the period before TKA. 
Worryingly there have been papers reporting also continuous use of opiates even after 2 
years postoperatively (Goesling et al. 2016, Rajamaki et al. 2019). 
2.5.5.1 Mental health aspects
Depression is known to be a predictor of inferior outcomes in TKA in older patients (Faller 
et al. 2003, Brander et al. 2007, Lingard and Riddle. 2007). Klit et al. reported that patients 
with preoperative depression achieved less improvement and had statistically significant 
lower OKS, SF-36 PCS, and SF-36 MCS scores at 12-month follow-up compared with non-
depressed patients (Klit et al. 2014).   
Patients with preoperative neuropathic pain, long-term systematic opiate consumption 
and / or central sensitization might benefit from specific pre- or peri-operative management 
with antihyperalgesic drugs (Lavand'homme and Thienpont. 2015). 
Catastrophizing is a negative cognitive and affective response to pain. It is 
multidimensional, comprising elements of rumination, magnification, and helplessness 
(Burns et al. 2015). Typically, catastrophizing remains constant after the operation and 
is not affected by changes in the severity of pain. Depression may be one reflection of 
catastrophizing. A systematic review could not conclude which risk factors among those 
psychological processes, such as catastrophizing, anxiety, and depression, contribute to 
chronic pain after TKA (Burns et al. 2015). Catastrophizing can be a significant predictor 
of pain felt at night after TKA, because catastrophizing is associated with insomnia, which, 
in turn, may contribute to a generalized state of hyperalgesia (Edwards et al. 2009). 
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2.5.6 Instability
In the NJR, instability accounted for almost 18% of revisions (NJR annual report 2018). In 
the SKAR, instability as a reason for revision accounted for 15% of revisions with TKAs 
but for less than 10% with UKAs.
Instability is often associated with malalignment of either the femoral or tibial 
component or a combination of these (Berger et al. 1998, Nicoll and Rowley. 2010). 
Preoperative evaluation of the rotation of components using computed tomography 
(CT) has improved the accuracy of indication for revision, but a real connection between 
component rotations and clinical outcome may still be controversial (Babazadeh et al. 
2019).
Song et al. divided the reasons for TKA instability into six groups: flexion/extension 
gap mismatch, implant malposition, isolated ligament insufficiency, extensor mechanism 
insufficiency, implant loosening, and global instability (Song et al. 2014). 
Sometimes, patients present a painful TKA even if radiographs, CT scans, and 
other diagnostic methods appear normal. In these patients, the possibility of soft tissue 
imbalance has to be identified with clinical methods, but periodic repeated evaluations are 
recommended until the etiology of pain is determined (Dennis. 2004b). 
2.5.7 Other reasons
Today, the causes of pain after TKA can be better determined using evolved diagnostic 
methods than before, and it is assumed that fewer revisions are being performed due to 
unexplained or unspecified reasons. Pietrzak et al. reported the reason for revision to be 
an unknown reason in 0.4% of their French study population of 255 patients (Pietrzak et 
al. 2019). 
Among arthroplasty registers, the SKAR and NJR report the unspecified reason as 
a reason for revision, and the difficulty in defining the exact reason for revision in real 
life may be the variation between registers. In the SKAR, for example, unspecified reason 
included about 5% of all revisions (SKAR annual report 2018), whereas unspecified reasons 
accounted for 21% in the NJR (NJR annual report 2018).
2.5.8 Unicondylar Knee Arthroplasty
With unicondylar knee arthroplasty (UKA), the progression of the OA disease is the 
specific reason for revision, and it accounted for 32% of revisions with UKAs in the 
AOANJRR annual report 2018 and for approximately 40% in the SKAR annual report 
2018. 
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UKA may be performed on patients with isolated cartilage damage on the medial side of 
the knee, and who have no damage in the lateral and patellofemoral joints, which includes 
the risk for operating early arthritis of the knee. Knee arthroplasty, both UKA or TKA, 
has been reported to be an unreliable treatment method in early knee OA. Furthermore, 
patients tend to have poorer results than in end-stage arthritis and an increased risk for 
conversion to TKA (Murray et al. 2015).
A retrospective review reported the reasons for the revision of 559 Oxford medial UKAs 
performed between 2007 and 2013. The study included 19 revisions. Disease progression 
was the most common reason for revision (52.63%). Other reasons for revision included 
tibial component loosening (21.05%), oversized tibial component (10.52%), unexplained 
pain (10.52%), and femoral component loosening (5.26%) (Borrego Paredes et al. 2017).
A study from a USA population compared the MarketScan Commercial and Medicare 
Supplemental Databases to evaluate the risk for complications, hospital re-admission for 
any reason, and mortality within 90 days of surgery between UKA and TKA patients 
operated on from 2002 to 2012. They also divided the study populations as younger (<65 
years) and older (>65 years) patients to analyze the effect of age on the results. At 7 years, 
the risk for subsequent revision was significantly higher (34%) for UKA than for TKA in 
the younger population. This study concluded that patients who undergo UKA have fewer 
post-operative complications but have a higher rate of re-operation and revision at up to 10 
years of follow-up compared with patients who undergo TKA. In addition, patient age as 
well as surgeon and hospital volume were found to be significant factors effecting UKA 
survivorship (Hansen et al. 2019).
A study from the Finnish population compared short-term results with cemented and 
uncemented Oxford UKAs. In this study, the most common reason for revision was the 
unspecified reason registered in the FAR, which may reflect the difficulty in diagnostics in 
pre-revision evaluation. The reasons identified were insert dislocation, aseptic loosening of 
the tibia component, malposition, or pain only (Knifsund et al. 2019).
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arthroplasty in patients less than 65 years of age
2.6.1 Differences in survivorship of knee arthroplasty in different ages
In the registers, there is a strong association between age and survival of knee arthroplasty, 
an association that is reflected by the increasing risk for revision in younger primary OA 
patients. The risk for revision within different age-groups reported in the NZJR and 
AOANJRR annual reports are presented in figure 9.
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2.6.2 Cemented TKA
In a study cohort of 84 patients (108 knees) between 1977 and 1992, experiences with TKAs 
performed on patients who were less than 55 years of age (22–55) were reviewed. All but 
one of the TKAs were posterior stabilized designs. In total, 20 patients were operated with 
bilateral TKA. In this study, the average annual rate of failure was 0.3% and the over-all 
rate of survival of the prostheses was 94% at 18 years when revision of the femoral or tibial 
component alone was considered as a failure. The rate of survival was 90% at 18 years when 
3 isolated patellar revisions were included as failures. The rate of survival at 18 years was 
87% when any operative intervention that altered the knee component was included. Late 
infection developed in 2 patients, 1 patient was revised because of wear, and 3 patients had 
posterior dislocation of the tibial component. The average Hospitalized for Special Surgery 
(HSS) knee score for the 103 unrevised knees was 55 points (22–80) preoperatively and 92 
points (75-100 points) postoperatively. Of the 103 knees, 9% had tibial radiolucent lines of 
no more than two millimeters in width that were present immediately postoperatively but 
did not progress during the study period (Diduch et al. 1997a). 
A study by Duffy et al. included 52 cemented TKAs which were performed using 
the Press-Fit Condylar knee system that included both components cemented, patella 
resurfaced, and modular tibia implant. Patients were aged 55 years or younger and they 
were operated from1988 to 1994. The patients were followed for a minimum of 10 years 
with an average follow-up of 12 years (10–15). There were 8 total revisions (15%). These 
included 1 early revision due to sepsis at 1 year and 1 revision for instability at 8 years. Six 
revisions occurred between 10 and 15 years, and they were all associated with polyethylene 
wear combined with osteolysis. Implant survival rate was estimated to be 96% at 10 years 
and 85% at 15 years follow-up. The knee score improved from an average of 36 points 
Figure 9. Age-dependent risk for revision in knee arthroplasty the NZJR (left) and the AOANJRR 
(right) annual reports 2017, OA primary diagnosis)
56
preoperatively to 92 points, and the function score improved from 40 to 86 points. At an 
average of 8 years of radiographic follow-up (range, 2–15 years), there were 2 knees with 
radiographic evidence of loosening (Duffy et al. 2007a).
A study with non-modular tibial components was done by Ranawat et al. They reported 
results on 430 Press Fit Condylar (PFC) TKAs with an all-polyethylene, posterior-
stabilized cemented tibial component between 1992 and 2000. Average age was 57 years, 
and 13 TKAs were bilateral. With the exception of 1 posttraumatic failure, they did not 
find any radiographic evidence of component loosening, progressive radiolucent lines, 
osteolysis, or severe malalignment. In this study cohort, the overall failure rate was 1.8% 
with average follow-up of 5 years. KS clinical scores improved from an average of 43 to 95 
(72–100) and KS functional scores from 53 to 98 (90–100) (Ranawat et al. 2005a).
In a study by Lonner et al., the reported results of 32 TKAs performed for osteoarthritis 
on 32 patients who were 40 years of age or younger were reviewed. At a mean follow-up of 
7.9 years, KSS increased from an average of 47 to 88 points and the function scores increased 
from 45 to 70 points. Three revisions were performed for aseptic failures causing an aseptic 
failure rate of 12.5% at 8 years (Lonner et al. 2000b).
2.6.3 Uncemented TKA
In their register-based study, Gioe et al. prospectively followed 1 047 patients 55 years old 
or younger who underwent knee arthroplasty over a 14-year period. The mean age of the 
patients in this study was 49.8 years (range, 28–55 years) and the majority of the patients 
were female (62.8%). The preoperative diagnosis was OA in 93.3% of cases. The main designs 
of the implants (85%) were: DePuySynthes/Johnson&Johnson 47%, Stryker/Osteonics 
23.4%, and Wright Medical 14.1%. Compared with patients with cemented implants, 
patients with uncemented implants were 2.7 times more likely to be revised. The 14-year 
cumulative survival rate for uncemented implants was 65.9% (47.9–83.9%) compared to a 
survival rate for cemented implants of 84.5% (75.3–93.7%) (Gioe et al. 2007b).
Kim et al. compared the results of cemented vs uncemented TKAs in the same patient. 
They performed 170 bilateral, sequential, simultaneous TKAs in 85 patients aged 55 
years or less between 1995 and 1996. In total, 80 patients (160 knees) were available for 
clinical and radiographic evaluation at a mean of 16.6 (16–17) years follow-up. Patients 
were randomized into cemented or uncemented groups, and all patients were operated with 
Nexgen CR implants. No patient in either group had undergone previous knee surgery. 
Complication rates were low and similar in both groups. Pre- and postoperative KSS, 
ROM, WOMAC, and UCLA activity scores did not differ significantly between groups. 
Kaplan–Meier survivorship analysis revealed a femoral component survival rate of 100% 
(95%CI 0.93–1.0) in both groups at 17 years, with loosening or revision considered as the 
end point for failure. The tibial component survival rate was 100% (95% CI 0.93–1.0) in the 
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cemented group and 98.7% (95% CI 0.92–1.0) in the uncemented group at 17 years, with 
loosening or revision considered as the end point for failure. (Kim et al. 2014b.)
A total of 93 patients with OA aged 55 or younger were randomized to compare 
outcomes between cemented tibial fixation (48 patients) and uncemented fixation with 
screw augmentation (45 patients). The femoral component was uncemented in both groups. 
The Multigen (Lima, San Daniele, Italy) knee system was used in both groups. Clinical and 
radiological evaluations were made pre- and post-operatively at 3 and 6 months, 1 year, and 
then annually until 5 years, and biannually thereafter. There was no difference in revision 
rate, and the cumulative survival rate at 9 years for aseptic reasons was 93.7% (95% CI, 82–
100%) in the uncemented group and 90.0% (95% CI, 80–100%) in the cemented group. At 
the end of the follow-up, the uncemented group had significantly better ROM (p=0.042) 
and WOMAC scores (p = 0.036) (Lizaur-Utrilla et al. 2014).
2.6.4 Hybrid TKA
In a Norwegian register-based study, 7 174 primary TKAs operated on between 1994 and 
2000 were analyzed, and 10% of these had hybrid fixation. The mean age of all patients was 
70 years but a separate analysis of the less than 60 years age group was also conducted. A 
Cox multiple regression model was used to evaluate the differences in survival among the 
prosthesis brands, their types of fixation, and whether or not the patella was resurfaced. 
In patients less than 60 years of age, no statistically significant differences between the 
cemented, hybrid, and uncemented prostheses in bi-and tricompartmental prostheses were 
found. The 5-year KM estimated survival was 98.5 (96.8–100) in the tricompartmental 
hybrid TKA and 94.0 (90.7–97.3) in the bicompartmental hybrid TKA (Furnes et al. 
2002a).
Another register-based study from Norway compared 4 585 hybrid TKAs with 20 095 
cemented TKAs. The analysis included 3 brands of prostheses: the LCS classic, the LCS 
complete, and the Profix. Overall, the hybrid group had lower risk for revision than the 
cemented group. There was design dependence with the results: the Profix hybrid TKa had 
lower risk for revision than the cemented TKA, but the LCS classic and the LCS complete 
did not. In the analysis, they adjusted the patients in the three age groups (<60 years, 60–
70 years, and >70 years) and there was no statistically significant difference between the 
groups. At 11 years, the KM survivorship was 94.3% (CI: 93.9–94.7) in the cemented TKR 
group and 96.3% (CI: 95.3–97.3) in the hybrid TKR group (Petursson et al. 2015). 
Conversely, a prospective study of 1 046 patients by Gioe et al. reported that patients 
with hybrid implants were 1.8 times more likely to be revised compared with cemented 
implants. Other factors, such as age, gender, cruciate ligament status, or index surgery year, 
did not influence the risk for revision. Moreover, the cumulative 14-year survival rate for 
the hybrid implant was 66.5% (51.2–81.8%) (Gioe et al. 2007b).
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2.6.5 Inverse hybrid TKA
In a series of 2 studies, Wilson et al. reported the results of uncemented TM  compared 
with cemented tibias. In total, 70 subjects with severe osteoarthritis were randomized to 
receive either the Nexgen LPS monoblock trabecular metal tibial component (37 patients), 
or the cemented NexGen LPS tibial component (33 patients). Femoral components 
were cemented in both groups. Radiostereophotogrammetric (RSA) analysis was used 
to calculate the changes in placement and fixation of the components. In the first 2-year 
report, they expressed uncertainty concerning the long-term stability of the trabecular 
metal tibial implant due to the high early migration in some cases (Wilson et al. 2010b). 
In the second analysis, they found that the TM implants had stabilized at 5 years and 
migration had ended. At 5 years, there were 27 patients in the TM group and 18 in the 
cemented group left for analysis. The mean ages (SD) of the patients were 61(9) years in 
the cemented group and 60(8) years in the trabecular metal group. Based on the RSA 
measurements at 5 years, they concluded that TM implants appeared to achieve solid 
fixation despite high initial migration (Wilson et al. 2012b). 
2.6.5.1 Tantalum metal
Tantalum metal (TM) is a transition metal with an open cell tantalum structure composed 
of repeating dodecahedrons with an appearance similar to cancellous bone. Porous 
tantalum implants are fabricated through a multistage process involving the pyrolysis of 
polyurethane foam to create a vitreous carbon scaffold followed by the chemical deposition 
of tantalum metal. The tantalum coating is typically composed of 99% tantalum and 
1% vitreous carbon with a volume porosity of between 75 and 80% (Bobyn et al. 1999). 
Conventional porous coatings usually have a porosity of between 30 and 40%. The elasticity 
of tantalum (3 GPa) compares favorably with subchondral (2 Gpa) or cancellous bone 
(1.2 GPa) (Patil et al. 2009). Tantalum (Ta) has been in clinical use since before 1940. It 
has been used in diagnostic and implant applications, e.g., as a radiographic marker (Ta 
powder) (Black. 1994). When tantalum metal implants have been tested in bone or soft 
tissue surfaces, integration has occurred (Bobyn et al. 1999, Hacking et al. 2000, Matsuno 
et al. 2001).
Due to its interesting potential for osteointegration, trabecular metal has been used 
in tibial implants for uncemented use. In these implants, the polyethylene is attached to 
the metal using a direct compression molding process that infuses the polyethylene into 
the trabecular metal with a penetration depth of approximately 1.5 mm. It is expected 
that this component will produce less stress shielding of the proximal tibia compared with 
conventional tibial components owing to its lower stiffness. However, documentation on 
this mechanism is lacking in the literature (Patil et al. 2009). In theory, fixation with TM 
implants would be ideal for the stiff bone of younger patients, where cement penetration 
may be suboptimal (Figure 10).
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2.6.5.2 Fixation of the tibial component with tantalum metal
Behery at al. compared uncemented tibias (NexGen Trabecular Metal tibial trays vs 
Vanguard Regenerex tibial trays) with comparable cemented tibias (Vanguard Ascent/
Maxim tibial trays vs NexGen Precoat Stemmed tibia trays) in 2 different TKA 
designs. Clinical outcomes measured with UCLA, EQ-5D, SF-12, KSS, and ROM were 
comparable between the uncemented and cemented implants. Over the 5-year follow-up 
period, patients with uncemented tibial implants experienced a significantly higher rate of 
radiographic aseptic tibial loosening than those with cemented implants (10% uncemented, 
0% cemented (Behery et al. 2017)
De Martino et al. retrospectively evaluated the clinical and radiographical results of 
3 primary TKAs using uncemented porous tantalum monoblock tibial components. The 
average age of patients was 67 years (41–82 years). All patients were followed for a minimum 
of 10 years (10–13), and no patients were lost to follow-up. The 10-year survivorship was 
96.9% with revision for any reason as the end point and 100% with tibial component 
revision for aseptic loosening or osteolysis as the end point. The mean KSS scores improved 
from 56 points (28–71) preoperatively to 93 points (75–100) postoperatively. The mean 
KSS function scores improved from 54 points (10–65) preoperatively to 90 points (75–100) 
postoperatively (De Martino et al. 2016).
In a study from the USA, Kamath et al. compared 100 uncemented posterior stabilized 
tantalum metal tibias with 312 cemented posterior stabilized TKAs using the same design 
(NexGen). Patients were younger than 55 years with a diagnosis of osteoarthritis. All 
femoral components were uncemented cobalt-chromium components with a cemented all-
polyethylene patellar component. The average follow-up was more than 5 years for both 
cohorts (60–83 months). In the uncemented group, there was no radiographic loosening 
greater than 1 mm in any zone or that progressed over the study period. However, 2 
patients in the cemented group demonstrated evidence of radiographic aseptic loosening 
and clinical symptoms during follow-up. There were 3 revisions in the uncemented group 
Figure 10. TM monoblock implant
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and 5 revisions in the cemented group, but none of these were due to aseptic loosening 
(Kamath et al. 2011b).
Henricson et al. compared the subsidence of uncemented trabecular metal tibial 
components with that of cemented tibial components in patients younger than 60 years 
using RSA analysis for a 2-year period. A total of 22 patients (mean age 53 years) received 
an uncemented NexGen trabecular metal cruciate-retaining monobloc tibial component 
and 19 patients (mean age 53 years) a cemented NexGen cruciate-retaining modular tibial 
component. The clinical results were measured with Knee Society knee and pain scores. The 
improvements in the median knee score was 51 points in the trabecular metal group and 46 
points in the cemented group. All the trabecular metal components migrated during the 
initial three months and then stabilized. The exception was external rotation, which did 
not stabilize until 12 months. Subsidence was stable with no lift-off from the resected tibia 
which had been reported in other uncemented designs (Henricson et al. 2008)
The same authors (Henricson et al.) published the following results on the same patient 
population at 5 years (Henricson et al. 2013b) and at 10 years (Henricson and Nilsson. 
2016b). In the study with 10 years follow-up, 16 patients (19 knees) with TM tibial 
components and 17 patients (18 knees) with cemented tibial components remained for 
analysis. Excluding the initial migration over the first 3 months, the annual migration was 
very low in both implant groups. At 2 years, thin radiolucent lines (<1 mm) were found 
in 1 TM TKA and in 10 cemented TKAs on postoperative radiographs. At 10 years, no 
radiolucent lines could be detected in the TM TKAs and in 3 cemented TKAs. Moreover, 
there were no statistically significant differences in Knee Society knee score, pain score, or 
function score between the groups at 10 years. (Henricson and Nilsson. 2016b).
Comparable results on the early postoperative subsidence of the tibia component with 
the later stabilization of TM tibias has also been reported earlier in an RCT study (Dunbar 
et al. 2009).
Most of the studies reporting the results of TM tibial components have reported 
comparable and acceptable results compared with cemented components. However, a series 
of 106 uncemented TKAs in 93 patients reported contrary results. In this study, TKAs 
were performed without cement, with a PCL-substituting design, and tibial components 
composed of monoblock TM tibias. The mean age of the patients was 65 years (32–87). In 
total, 9 failures were reported at a mean 18 months (3–41 months) follow-up. All failures 
except one occurred in male patients with medial tibial collapse. The tibial components 
demonstrated a consistent radiographic failure mode characterized by medial subsidence of 
the tibial baseplate. They concluded that the failures were due to the tall height and weight 
of the male patients. Conversely, all TKAs were performed by a single surgeon, which may 
have affected the results (Meneghini and de Beaubien. 2013).
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2.6.6 Effect of age on revision rates in young patients
In patients younger than 65 years, the risk for revision differs between fixation methods 
and genders. The NJR annual report 2018 reported a higher risk for revision in males in 
both the less than 55 years and the 55 to 64 years age groups with cemented TKA and in 
patients less than 55 years of age with uncemented TKAs compared with females. Males 
with hybrid TKAs had a lower risk for revision in both age groups (Table 6).
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KM estimates of cumulative revision risk (CI95%) at 10 years. Fixation method and age groups  less 
than 55 years and 55 to 64 years in the National Joint Registry annual report 2018. Results of total 
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mobile bearings.
Fixation method Age < 55 years Age 55–64 years
All cemented males 8.10 (7.40–8.87) 4.53 (4.29–4.77)
All cemented females 6.67 (6.13–7.26) 3.91 (3.71–4.12)
All uncemented males 9.38 (7.10–12.34) 3.62 (2.87–4.56)
All uncemented females 7.48 (5.43–10.27) 5.28 (4.28–6.49)
All hybrid males 6.86 (4.03–11.51) 3.83 (2.51–5.81)
All hybrid females 7.54 (4.72–11.93) 4.71 (3.36–6.60)
In the NZJR 19th annual report, revision rates increased with uncemented TKA in patients 
less than 55 years of age and in UKA patients (Table 7). The report did not include separate 
revision rates for cemented and uncemented UKAs.
7DEOH&RPSDULVRQRIGLIIHUHQW¿[DWLRQPHWKRGVLQNQHHDUWKURSODVW\LQWKH1HZ=HDODQG-RLQW
Registry. Revision rate / 100 component-years (CI 95%) in the New Zealand Joint Registry annual 
report 2018.
Fixation method Age < 55 years Age 55–64 years
Cemented 0.90 (0.82–0.98) 0.61 (0.58–0.65)
Uncemented 1.32 (1.03–1.65) 0.78 (0.61–0.96)
Hybrid 0.97 (0.71–1.29) 0.62 (0.49–0.77)
Unicondylar 1.83 (1.57–2.12) 1.52 (1.38–1.67)
2.7 Outcome of knee arthroplasty in patients less than 65 years of age
2.7.1 Concept of working-age patients
An EU Health Program report defined the working-age population as a group of people 
aged between16 years and 64 years (Oortwijn W et al.)
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The International Classification of Functioning (ICF) model proposed by the 
World Health Organization (WHO) divides working-ability into six mutually related 
components: 1) disease and disorder, 2) functions and structures, 3) activities pertaining 
to the execution of a task or action by an individual, 4) participation pertaining to the 
involvement in a life situation, 5) environmental factors, and 6) personal factors. These 
components all contain different aspects that influence participation in work. 
The increasing need for knee arthroplasty in younger patients (Laskin. 2002, Kurtz et 
al. 2007, Leskinen et al. 2012) and the tendency for higher revision rates in these patients 
(Furnes et al. 2002b, Harrysson et al. 2004, Julin et al. 2010) constitutes a major challenge 
for the future to decide the best available concepts of knee replacement that will last the 
burden of time, considering the long life expectancy of patients.
2.7.2 Return to work
In a study by Jorn et al., shorter postoperative sick-leave was associated with a light workload 
and preoperative sick-leave shorter than 180 days. Preoperative sick-leave longer than 180 
days increased the risk for partial or complete disability pension. Moreover, the operation 
also fulfilled the expectations of the patients to a larger degree among those patients who 
went back to work (Jorn et al. 1999).
In a systematic review of 5 studies, the time of return to work after TKA ranged from 
8 to 12 weeks in the UK and the USA after TKA (Tilbury et al. 2014). This finding was 
comparable with another clinical series from the same authors, where the mean time to 
return to work was 12.9 weeks after TKA (Tilbury et al. 2015). The employment rate at 1 
year postoperatively was 83% after TKA. An interesting finding with respect to productivity 
was that 19% of TKA patients worked fewer hours postoperatively than preoperatively.
In a study population from the United Kingdom, 40% of patients aged 65 years or less 
who were working before TKA returned to work at a mean of 13.5 weeks postoperatively. 
As was reported in the study by Jorn et al (Jorn et al. 1999), the better functional outcomes 
of TKA, assessed by PROMs, reported in this study were significantly associated with a 
better return to work. However, TKA did not facilitate a return to work for those patient 
who were not working before the operation. The greatest predictor for a better return to 
work was younger age (Scott et al. 2017).
2.7.2.1 Effects of socio-economical features
A prospective cohort study of 120 patients from the USA reported those factors associated 
with return to work. The factors associated with a faster return to work included a sense of 
urgency about returning, working in a handicap accessible workplace, being female, being 
self-employed, a higher functional comorbidity index score, a higher WOMAC physical 
function score, and a higher mental composite summary score on the SF-12. These results 
indicated that patients who had a sense of urgency about returning to work do so in half 
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the time taken by those without a sense of urgency. Factors associated with a slower return 
to work included receiving workers’ compensation, having a more physically demanding 
job, and having less pain preoperatively (and higher WOMAC pain score). The physical 
demands of the patient’s job played a marginal role in the patients’ return to work after 
TKA. Indeed, the study showed that properly managed and highly motivated patients are 
capable of returning to work in physically demanding jobs (Styron et al. 2011). 
In another study by Saleh et al., receiving workers’ compensation also resulted in 
lower functional scores compared with a control group, and only 24% of patients from the 
compensation group returned to their previous job (Saleh et al. 2004b). 
The same effect was noticed in a study from a Canadian patient cohort. Patients 
who received workers’ compensation had significantly higher pain scores, poorer self-
perceived functional outcomes, and a lower range of knee flexion than the control group 
postoperatively. These patients also required more readmission visits and were more 
reluctant to answer questions about functional outcomes (de Beer et al. 2005).
2.7.3 Special aspects regarding knee arthroplasty in patients less than 65 years
A cross-sectional study from the Dutch population concluded that a majority of patients 
who were treated with TKA were overweight, had multiple comorbidities, performed a 
high amount of light-intensity physical activity, and a few patients were depressed. In a 
comparison of retired patients and the general population of the Netherlands, working-age 
patients scored better on preoperative characteristics than retired patients with quality of 
life and symptoms scores, except for physical activity level which scored worse than the 
general population (Hylkema et al. 2017). 
Noble et al. conducted a prospective study of 253 patients with at least 1-year follow-up 
where they reported patients’ satisfaction after unilateral TKA. According to this study, 
satisfaction was age dependent. For example, 96% of patients 60 years of age or younger, 
81% of patients aged 60 to 75 years, and 86% of patients older than 75 years reported 
satisfaction after TKA (Noble et al. 2006b).
2.7.4 Previous studies of working-age patients
Several previous studies have reported the outcomes of TKA in younger patients. However, 
a comparison with the existing literature is difficult because of the variations in the cohorts 
of patients with differences in time periods and demographic features (Goh et al. 2016a). 
Although patient-related scores had been used in earlier studies, Morgan et al. were the 
first to include the OKS in the population of younger patients, and thereafter PROMs have 
become routinely reported in studies (Morgan et al. 2007). Those previous studies that have 
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included a cohort of working-age patients and the outcome measurements applied in these 
studies are presented in Table 8.
Table 8. Previous studies reporting outcomes of working-age patients
Author Yeara Study design Ageb Follow-up KSS PROM 
-/+
(Stern et al. 1990) 1990 - 50 6.2 92 -
(Diduch et al. 1997b) 1997 Prospective 51 (22–55) - 94 -
(Gill et al. 1997) 1997 Prospective 50.7 (30–55) 9.9 (5.7–18.0) 97 -
(Duffy et al. 1998c) 1998 prospective 43 13 (10–17) 84 -
(Hofmann et al. 2002a) 2002 retrospective 42 (31–50) 9.2 - -
(Mont et al. 2002) 2002 retrospective 43 (31–50) 7.2 (5–8.9) 89 -
(Ranawat et al. 2005b) 2005 prospective 57 (47–60) 5 (2–11) 95 -
(Tai and Cross. 2006b) 2006 prospective 50.7 (32–55) 7.9 (5–12.5) - -
(Ritter et al. 2007a) 2007 retrospective 50 (18–55) 9.1 (4.9–20.5) 91 -
(Duffy et al. 2007a) 2007 retrospective 53 (29–55) 12 (10–15) 92 -
(Morgan et al. 2007) 2007 retrospective 50.7 (31–59) 7.3 (3–12) 98 +
(Price et al. 2010b) 2010 prospective 55.4 (32–60) 15.5 (12–19) 74.8 +
(Kim et al. 2012) 2012 prospective 45 (29–50) 16.8 (15–18) 94 -
(Klit et al. 2014) 2014 prospective 54 (49,57) 1.0 +
(Parvizi et al. 2014) 2014 prospective 54 (19–60) 2.6 (1–4.7) -
(Goh et al. 2016a) 2016 retrospective 47 (30–50) 6.7 (3–16) 83.1 +
a The year the study was published
b Mean age (range) or median (Q1, Q3)
2.7.4.1 Special features with outcome measures
Over time, evaluation methods have shifted from surgeon-reported scores to PROMs. 
Traditionally, the results of knee arthroplasty have been measured with surgeon-reported 
measures, implant survival rates, complications, ROM, and radiographic results. The focus 
of outcome measurement has shifted towards the use of PROMs and alternative end points, 
such as influence on socioeconomic status and sex life after TKA (Klit et al. 2014). 
Measuring outcomes pre- and postoperatively should meet the expectations that patients 
consider important (Bourne et al. 2010). Pain relief is the main target of knee arthroplasty, 
but functional and physical activities are emphasized in younger patients. Even in younger 
patients, physical activity is not necessarily shown in real-world functions but more in 
desirable expectations (Keeney et al. 2014). This may also present unrealistic expectations 
of the effects of knee arthroplasty, which is then reflected in dissatisfaction with outcomes.
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2.7.4.2 Expectations
Klit et al. evaluated outcomes of patients less than 60 years of age with 12 months follow-
up. PROMs increased from preoperative to 12 months postoperative (Q1, Q3): SF-36 PCS 
from 31.3 (26.7–36.6) to 46.8 (37.8–53.2), SF-36 MCS from 50.6 (39.0–61.5) to 58.5 (52.9–
61.6), and OKS from 21 (16–26) to 40 (30–45). At the 12-month follow-up, 68% of the 
patients reported that “all expectations” or “most expectations” were fulfilled, and 71% 
reported they were “very satisfied” or “satisfied” with the outcome (Klit et al. 2014).
Goh et al. conducted a retrospective study with 136 primary TKAs in 114 patients aged 
50 years or younger to evaluate functional outcomes with PROMs. At 2 years, the range of 
motion, KSS, OKS, and SF-36 physical and mental scores had increased significantly. At 
the same time, 88.8% of patients were satisfied with their surgeries, whereas 86.8% had their 
expectations fulfilled (Goh et al. 2016b).
Parvizi et al. retrospectively interviewed 661 patients aged less than 60 years at an 
average time of 2.6 years follow-up. They found that 90% of patients were satisfied with the 
overall functioning of their knees, 89% were satisfied with their ability to perform normal 
activities of daily living, and 91% were satisfied with the degree of pain relief (Parvizi et al. 
2014).
In a study from the Korean population, the top three expectations of 454 patients 
were evaluated. These three expectations were pain relief, restoration of walking ability, 
and psychological well-being. When the expectations were divided into 5 categories, pain 
relief was ranked the highest. The second highest was psychological well-being, the third 
restoration of baseline activity, the fourth the ability to perform high flexion activities, and 
the fifth the ability to participate in social activities. Moreover, age of less than 65 years, 
being employed, a high WOMAC osteoarthritis index function score, and a low SF-36 
social score were found to be significantly associated with higher overall expectations (Yoo 
et al. 2011).
2.7.4.3 Physical activity
In a prospective study of patients aged 65 years or less, activity levels improved significantly 
following TKA from mild to moderate activity measured with UCLA (Scott et al. 2017). 
The same improvement level with UCLA score has been reported in older, retired 
patients in two other studies with 36 months follow-up (Bauman et al. 2007) and 5.7 years 
follow-up (Dahm et al. 2008).
Keeney et al. compared the preoperative and postoperative physical activity levels of 
patients 55 years or less with patients 65 years or older with 33 months follow-up. Only 13% 
of patients 55 years or younger reported being moderately or highly active before their TKA 
compared with 23% of older patients. In total, 29% of younger and 23% of older patients did 
not increase their activity levels, and 14% of patients in both groups experienced a decline 
in activity (Keeney et al. 2014). 
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In a retrospective study, Parvizi et al. reported that after recovery 47% of patients had 
complete absence of a limp and 50% had participated in their most preferred sport or 
recreational activity in the past 30 days (Parvizi et al. 2014).
2.7.4.4 Unicondylar knee arthroplasty
Goh et al. compared the register-based results of 160 UKA patients and 360 TKA patients 
using patient-reported outcomes, health-related quality of life scores, patient satisfaction, 
and fulfilment of expectations in patients younger than 55 years. They did not find any 
significant difference in KSS, OKS, or Short-Form 36 at 2 years. In total, 89.4% of the TKA 
group and 88.8% of the UKA group were satisfied with the results. In addition, 86.9% of 
the TKA patients and 86.3% of the UKA patients had their expectations fulfilled, even 
though the UKA group had significantly greater flexion at 6 months and at 2 years (Goh 
et al. 2018). 
An analysis from the Norwegian Arthroplasty Register compared the outcomes of 972 
TKAs and 372 UKAs. They reported that patients younger than 65 years performed worse 
than older patients with the exception of the outcomes related to activities of daily living 
and improvement in health-related quality of life (Lygre et al. 2010a).
In a study by Schai et al., 28 patients less than 60 years of age were treated using the PFC 
UKA system with a mean follow-up time of 40 months. Pain relief was satisfactory in 25 
of the 28 knees (90%). Average knee flexion was 124° and no patient had an extension lag 
reported. The KSS improved postoperatively from 52 points to 93 points (Schai et al. 1998).
A retrospective study of 101 patients (118 knees) aged 60 years or younger treated with 
the Oxford UKA reported a return-to-activity rate of 93% with a minimum follow-up of 
2 years. This study reported that patients mostly took part in low- or mid-impact activities, 
whereas high-impact activities had mostly been given up. The reason for the decline in their 
activity level was mainly based on the patients’ decision to preserve the prosthesis rather 
than by the limited functional performance of the joint arthroplasty (Walker et al. 2015b).
A retrospective study compared HTO (2 wedge plates (Aescula; Medyssey, 
Dongducheon, Korea)) and medial unicompartmental arthroplasty (cemented Miller-
Galante fixed-bearing prosthesis (Zimmer, Warsaw, Indiana)) in patients less than 65 years 
of age with a minimum follow-up of 2 years. This study could not identify any significant 
differences between HTO and UKA in terms of return to recreational activity and short-
term clinical outcomes. (Yim et al. 2013.)
A systematic review was done to find answers to the following questions: was there 
an improvement in physical activity based on validated activity scores following UKA? 
What are the sport disciplines and the sport patterns of UKA patients? What are the 
pre- and post-operative sport participation rates and the return to activity rates of UKA 
patients? Analysis showed a significant increase in low-impact activities and a decrease in 
high-impact activities after UKA. The total number of different sport activities decreased, 
whereas the session length und frequency remained unchanged overall. Moreover, 2 studies 
in this review included patients 65 years or less (Waldstein et al. 2017) (Table 9). 
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Table 9. Summary of pre- and post-operative sport participation rates and the return to activity rate 
according to a systematic review. Studies including patients 65 years or less are highlighted in bold 
font (Waldstein et al. 2017).
Study Mean age Pre-operative sport
Post-operative 
sport
Return to 
activity rate
(Fisher et al. 2006) 64 (49–81) 64% 59% 93%
(Walton et al. 2006) 71.5 SD 9.85 79% 86% -
(Naal et al. 2009) 66.0 (46–84) 93% 88% 95%
(Hopper and Leach. 2008) 62.1 (35–75) 88% 85% 97%
(Yim et al. 2013) 58.3 (43–65) 84% 60% -
(Pietschmann et al. 2013) 65.3 (44–90) 60% 53% 80%
(Jahnke et al. 2015) 63.5 (36–86) 90% 93% -
(Walker et al. 2015a) 60.1 (36–81) 93% 91% 98%
(Walker et al. 2015b) 55 (36–60) 93% 91% 93%
Ho et al.(Ho et al. 2016) - 83% 72% 87%
 /RFDOLQ¿OWUDWLRQDQDOJHVLDLQNQHHDUWKURSODVW\
 'LIIHUHQWLQ¿OWUDWLRQWHFKQLTXHV
Local infiltration analgesia (LIA) is a multimodal wound infiltration method for treating 
postoperative pain after knee arthroplasty. This pain management method is based on the 
systematic infiltration of a mixture of drugs around all the structures subject to surgical 
trauma during knee arthroplasty. Before multimodal drug infiltration methods came into 
clinical use, a single local anesthetic was reported to be effective in pain control after knee 
arthroplasty (Bianconi et al. 2003). 
Kerr and Kohan developed a local infiltration analgesia technique which served as the 
basis for the wide-spread use of such techniques to improve pain relief in knee arthroplasty 
surgery. A long-acting local anesthetic (ropivacaine), a nonsteroidal anti-inflammatory 
drug (ketorolac), and epinephrine were infiltrated periarticularly during the operation and 
for 15 to 20 hours postoperatively by hand through the wound catheter (Kerr and Kohan. 
2008b). 
Different infiltration techniques, such as periarticular infiltration, intra-articular 
infiltration, peri- or intra-articular infiltration combined with secondary postoperative 
infiltration, and postoperative infiltration though wound catheter, have been introduced. 
However, there is no consensus on which local anesthetic agent or infiltration technique 
is the most effective and tolerated. A wide RCT review reported better pain control in the 
periarticular group than the intra-articular group, and the use of LIA provided better pain 
relief and improved range of motion after TKA (Seangleulur et al. 2016). 
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The demographic factors of patients may also affect the pain level after knee arthroplasty. 
In a LIA study, postoperative pain was found to be higher in females and younger patients, 
whereas BMI, race, or ethnicity did not affect postoperative pain (Barrington et al. 2016).
Pre- and postoperative complications which may be related to LIA are infections and 
systemic toxicity of drugs used but in a systematic review and meta-analysis increased 
incidence of these were not reported in the studies included (Seangleulur et al. 2016).  
 (IIHFWRIORFDOLQ¿OWUDWLRQDQDOJHVLDRQSDLQ
A review by Seangleulur et al. divided LIA into 4 different techniques and reported the 
efficacy of each technique (Seangleulur et al. 2016). Opiate consumption referred to the 
amount of intravenous morphine or morphine equivalents that were converted using an 
opioid analgesic conversion table.
 3HULDUWLFXODULQ¿OWUDWLRQ
Studies that reported the periarticular infiltration technique to be effective or ineffective 
compared with placebo or no injection measured with VAS rest pain at 24 hours (results 
reported as weighted mean difference (CI95)) are listed in the table 10.
7DEOH(IIHFWZLWKSHULDUWLFXODULQ¿OWUDWLRQ
LIA ineffective LIA effective
0.53 (-0.59, 1,65) (Busch et al. 2006) -0.50 (-0.84, -0,16) (Fu et al. 2009)
-0.21 (-0.54, 0.12) (Zhang et al. 2011) -0.63 (-0.92, -0.34) (Fu et al. 2010)
-1.13 (-1.70, -0.56) (Chen et al. 2012)
-3.50 (-4.12, -2.88) (Lamplot et al. 2014)
-0.37 (-0.78, -0.04) (Nakai et al. 2013)
-0.34 (-0.67, -0.01) (Milani et al. 2015)
 ,QWUDDUWLFXODULQ¿OWUDWLRQ
Studies that reported the intra-articular infiltration technique to be ineffective or effective 
compared with placebo or no injection measured with VAS rest pain at 24 hours (results 
reported as weighted mean difference (CI95)) are listed in the table 11.
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7DEOH(IIHFWZLWKLQWUDDUWLFXODULQ¿OWUDWLRQ
LIA ineffective LIA effective
1.03 (0.54, -1.52) (Nakai et al. 2013) -1.48 (-1.98, -0.98) (Tanaka et al. 2001)
0.40 (-0.90, -1.70) (Rosen et al. 2010) -1.60 (-2.12, -1.08) (Fajardo et al. 2011)
1.47 (-0.09, 3.03) (Klasen et al. 1999) -0.10 (-1.55, -1.35) (Guara Sobrinho et al. 2012)
-0.80 (-1.69, 0.09) (Browne et al. 2004) -3.10 (-4.40, -1.80) (Shen et al. 2015)
-0.66 (-1.79, 0,47) (Mauerhan et al. 1997)
 3HULDUWLFXODULQ¿OWUDWLRQFRPELQHGZLWKSRVWRSHUDWLYHLQ¿OWUDWLRQ
Studies that reported periarticular infiltration with postoperative additional bolus to be 
ineffective or effective compared with placebo or no injection measured with VAS rest pain 
at 24 hours (results reported as weighted mean difference (CI95)) are listed in the table 12:
7DEOH(IIHFWZLWKSHULDUWLFXODULQ¿OWUDWLRQFRPELQHGZLWKSRVWRSHUDWLYHEROXV
LIA ineffective LIA effective
-0.80 (-2.34, 0.74) (Vendittoli et al. 2006) -2.04 (-2.55, -1.53) (Essving et al. 2010b)
-0.64 (-1.96, 0.68) (Andersen et al. 2008) -1.119 (-2.34, -0.78) (Kazak Bengisun et al. 2010)
-1.70 (-2.00, -1.40) (Zhang et al. 2011)
 3RVWRSHUDWLYHLQ¿OWUDWLRQ
Studies that reported the postoperative infiltration technique to be effective compared 
with placebo or no injection measured with VAS rest pain at 24 hours (results reported as 
weighted mean difference (CI95)) are listed in the table 13.
7DEOH(IIHFWZLWKSRVWRSHUDWLYHLQ¿OWUDWLRQ
LIA ineffective LIA effective
- -1.90 (-2.39, -1.41) (Gomez-Cardero and Rodriguez-
Merchan. 2010)
-2.02 (-3.14, -0.90) (Ong et al. 2010)
-1.31 (-2.37, -0.25) (Ikeuchi et al. 2013)
This review concluded that pain control in the periarticular group was found to be better 
than in the intra-articular group. Periarticular injection reduced 24-h VAS for pain, 
whereas intra-articular injection did not. Both peri- and intra-articular injection reduced 
opioid consumptions in the first 24 h compared with no injection or placebo, even if a 
greater reduction was shown after periarticular injection. In addition, an improvement in 
24-h ROM was shown after periarticular injection but not after intra-articular injection. 
The analgesic effects can be extended up to 48 h with postoperative injection through a 
catheter, but the risk for catheter-related infection was uncertain. 
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Signicant pain relief in rest at 48 hours was reported in 1 study with periarticular 
infiltration (Lamplot et al. 2014), in 2 studies with periarticular infiltration with 
postoperative bolus (Kazak Bengisun et al. 2010, Zhang et al. 2011) and in 3 studies with 
postoperative bolus (Gomez-Cardero and Rodriguez-Merchan. 2010, Ong et al. 2010, 
Ikeuchi et al. 2013). Intra-articular infiltration was not reported effective at 48 hours 
measured with pain at rest (Seangleulur et al. 2016).
 (IIHFWRIORFDOLQ¿OWUDWLRQDQDOJHVLDRQSDWLHQWUHODWHGRXWFRPHPHDVXUHV
Most of the studies concerning the outcomes of the LIA report results 24 hours or 48 hours 
postoperatively. The long-term effectiveness of LIA has not, however, been reported using 
PROMs.
Tanikawa et al. conducted a randomized study which compared the effectiveness of 
sciatic nerve block (SNB) to LIA with 21-days follow-up. All patients underwent general 
anesthesia combined with femoral nerve block. The LIA solution contained ropivacaine, 
dexamethasone, and adrenaline, whereas SNB was done with ropivacaine. They reported 
that SNB was more effective than LIA in reducing pain immediately after surgery but 
that SNB was less effective than LIA at 24 h after the surgery. For between 3 and 21 
postoperative days, there was no difference in VAS score between the SNB and the LIA 
groups (Tanikawa et al. 2017).
In another randomized study, Carli et al. compared knee functions after total 
arthroplasty combined with periarticular LIA or with continuous femoral nerve block 
with 6-weeks follow-up. In this study, outcomes were significantly better in the FNB 
group measured with KSS and WOMAC at 6 weeks and the results also favored the use of 
continuous FNB in other measures (Carli et al. 2010).
71
3 Aims of the Present Study
The main purpose of this study was to evaluate the outcomes of contemporary knee 
arthroplasty in terms of survivorship and patient-reported outcome measures with special 
reference to patients less than 65 years of age.
The specific aims of the studies were to investigate the following:
Study I: The trends and differences of incidences of TKA and UKA based on NARA 
data from four Nordic countries.
Study II: The survivorship of different fixation methods in total knee arthroplasty 
based on the NARA register in patients less than 65 years of age.
Study III: The survivorship of TM tibia based on FAR data.
Study IV: The effectiveness of TKA and UKA in terms of PROMs and satisfaction.
Study V: The effectiveness of LIA with pain and PROMs.
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4 Patients and Methods
4.1 Patients
A summary of the study designs, type of data, patients, and follow-up are presented in table 
14.
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For study I, we included patients aged 30 years or older who had undergone a TKA or 
UKA surgical procedure due to primary osteoarthritis of the knees according to NARA 
data. This data comprised information on the TKAs and UKAs performed in Denmark, 
Norway and Sweden from 1997 to 2012 and in Finland from 2000 to 2012. Patients who 
were less than 30 years old were excluded because of the small number of these patients. 
In total, 385 310 primary knee arthroplasties were registered in the 4 countries during 
the study period. During the study period, we observed an increase in OA from 84% to 90% 
and simultaneously a decline in rheumatoid arthritis (RA) from 10% to 4% as indication 
for knee arthroplasty. Among these operations, 317 008 TKAs and 27 687 UKAs were 
performed for knee OA in patients aged 30 years or older. Female patients represented 
202 940 (64%) of the TKA cases and 15 778 (57%) of the UKA cases. The mean age of the 
patients was 70 years (9.0) in the TKA group and 65 years (9.4) in the UKA group. The 
characteristics of the patients in the different countries are presented in table 15.
Table 15. Patient characteristics for Study I
Denmark Norway Sweden Finland Total
Mean age (SD) 69.0 (9.5) 69.7 (9.2) 69.8 (9.0) 69.0 (9.0)
Females 63.2% 65.8% 60.0% 67.5%
For study II, we included patients from the NARA data aged less than 65 years who had 
undergone an unconstrained primary TKA for primary OA between 2000 and 2016 to 
assess the survivorship of cemented, uncemented, hybrid, and inverse hybrid TKAs in 
these patients. This sample comprised 115 177 TKAs, and the demographics of the patients 
are listed in table 16.
Table 16. Patient demographics for Study II
Fixation concept Uncemented Inverse hybrid Hybrid Cemented
No of TKAs (%) 6 132 (5.3) 546 (0.5) 6 329 (5.5) 102 170 (88.7)
Mean age, years (SD)  57.3 (5.6) 57.0 (5.4) 58.1 (5.2) 58.7 (4.9)
Men, % 44 42 41 40
For study III, we included 1 151 TKAs which were performed using an uncemented porous 
tantalum tibial component. Of these operations, 1 143 (99%) were primary TKAs and 8 
(1%) revision TKAs. Only the primary TKAs were included in the study. Of the 1 143 
primary TKRs using the TM Monoblock Tibia, 647 (57%) were performed on women and 
597 (52%) on the right knee. At the time of the surgery, the mean age of the patients was 
63.6 years (range: 30-91). The majority of these procedures were performed due to primary 
osteoarthritis (n=1,086; 95%). Other indications included posttraumatic osteoarthritis 
(n=32; 2.8%), rheumatoid or other chronic inflammatory arthritis (n=20; 1.7%), and other 
unclassified indications (n=5; 0.4%).
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For study IV, 250 patients were enrolled between March 1st, 2012 and October 30th, 
2014. PROM data and patient background questionnaires were collected via surface mail 
preoperatively at 2 to 3 months and at 1 and 2 years postoperatively. In total, 250 patients 
(272 knees) were recruited to the study, and all patients gave written informed consent to 
participate. As 5 (2%) patients cancelled surgery, 6 (2.4%) were revised, 5 (2%) were lost 
to follow-up, and 2 (0.8%) died during the follow-up, 232 patients (93%; 254 knees) were 
available for the 2-year follow-up visits, and the analysis of the final results was based on 
these patients. While simultaneous bilateral TKAs were performed for 22 patients, none 
of the patients received bilateral UKAs. The final patient population comprised 227 TKAs 
and 27 UKAs. 
Of the 232 patients (254 knees), 227 knees (89%) underwent cemented TKA using 
either PFC (182 knees; DePuy Synthes, Warsaw, IN) or Nexgen (45 knees; Zimmer Biomet, 
Warsaw, IN), which were selected based on the personal preference of the surgeon. In 12 
(5.3%) of the TKAs, the patella was resurfaced. Of the 227 TKAs, 218 (96%) were cruciate 
retaining (CR) and the remaining 9 were posterior stabilized (PS). UKA was performed 
for 27 patients using the uncemented Oxford phase 3 (Zimmer Biomet, Warsaw, IN) 
prosthesis. The patients’ preoperative ASA classifications, KL grade, and working status 
are presented in table 17.
7DEOH3DWLHQWSUHRSHUDWLYH./JUDGH$6$FODVVL¿FDWLRQDQGZRUNLQJVWDWXVIRU6WXG\,,,
TKA (n=227) UKA (n=27)
n % n %
Kellgren-Lawrence (knees)
KL 2
KL 3
KL 4
33
105
89
15
46
39
5
12
10
18
46
36
ASA
1
2
3
73
116
38
32
51
17
11
15
1
41
56
3
At work preoperatively 110 53 18 65
For study V, we enrolled 60 patients undergoing unilateral TKA in this randomized, 
double-blinded, placebo-controlled study. For the final analysis at 2 years follow-up, 56 
patients completed the study, including 27 patients in the LIA group and 29 patients in the 
Placebo group. All patients included in this study were operated at Coxa Hospital between 
March 2011 and March 2012. The characteristics of the patients are presented in table 14.
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4.2 Methods
4.2.1 Register-based studies (Study I, II, and III)
4.2.1.1 NARA
NARA compiles data on 4 Nordic countries that have similar health care organizations 
and comparable patient characteristics. The NARA data comprises information on the 
TKAs and UKAs performed in Denmark, Norway, and Sweden from 1997 onwards and 
in Finland from 2000 onwards.
The knee arthroplasty registers of Sweden (SKAR) and Denmark (DKR) and the 
arthroplasty registries of Norway (NAR) and Finland (FAR) participated in studies I 
and II. All 4 registers have used individual-based registration of operations and patients. 
A NARA minimal dataset was created to contain data that all 4 registers could deliver. 
However, for administrative reasons, the Finnish Arthroplasty Register has only been able 
to provide Finnish data according to the NARA data definitions from the beginning of 
2000. A pilot study from NARA data did not include FAR data and it did not have an 
age cut-off (Robertsson et al. 2010b). The NARA database includes data on patients that 
enables TKA and UKA incidence analyses, i.e., patient-level data on both demographics 
and implant types.
The selection and transformation of the respective datasets and the de-identification of 
the patients, which included the deletion of the unique personal identification numbers, 
were performed within each national register. The anonymous data were then merged into 
a common database.
Data were treated with full confidentiality, according to the rules of the respective 
countries. The quality of data in the Nordic registries is high, and the registries have 
both national coverage and a high degree of completeness (annual reports: Danish knee 
arthroplasty register, Norwegian Arthroplasty Register, Swedish Knee Arthroplasty 
Register, Finnish Arthroplasty Register) (Espehaug et al. 2006).
4.2.1.2 FAR (Study III)
Study III was based on information recorded in the FAR that was related to patients that 
underwent TKA with an uncemented porous tantalum tibial component (Trabecular 
Metal Monoblock Tibia; Zimmer, Warsaw) between January 1, 2003 and December 31, 
2010. At the time of the study period, coverage of the FAR was over 95%. Revisions are 
linked to the primary surgery using the unique personal identification number assigned 
to each resident of Finland. Three hospitals in Finland were involved in this study cohort. 
To assess the impact of age on implant survival, we analyzed age as a linear variable 
using age groups 1) age under 55 years (n=167; 15%), 2) age from 55 to 65 years (n=458; 
40%), and 3) age over 65 years (n=518; 45%). The impact of gender on survival was also 
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assessed. For the end points, we used all revisions and revisions for aseptic loosening of the 
TM Monoblock Tibia.
4.2.2 Prospective and RCT studies (study IV and V)
In study IV, the inclusion criteria were as follows: 1) age 65 or less and 2) scheduled for 
either TKA or UKA. UKA was considered if the patient was evaluated to be suitable 
for UKA both on a radiological and patient-derived basis. The exclusion criteria were as 
follows: 1) rheumatoid arthritis or other inflammatory diseases, 2) unwilling to provide 
informed consent, 3) physical, mental, or neurological conditions that could compromise 
the patient’s ability and compliance with postoperative rehabilitation and follow-up (e.g., 
drug or alcohol abuse, serious mental illness, general neurological conditions, such as 
Parkinson’s disease, multiple sclerosis, etc.), and 4) known sensitivity to materials in the 
devices. 
All operations were performed by senior orthopaedic surgeons, and all patients were 
treated with the same routine postoperative rehabilitation and pain management protocol. 
Four different PROMs were used to measure the effectiveness of knee arthroplasty in 
these patients: OKS, KOOS, HAAS, and the RAND 36 general quality of life (QoL) 
questionnaire. Primary outcome was defined as the effect of knee arthroplasty on pain 
and function as measured with OKS and KOOS. Secondary outcomes were the effect 
of knee arthroplasty on QoL (RAND 36), physical activity (HAAS), and satisfaction. A 
background questionnaire included information on working status, physical activities, and 
medical comorbidities. The Visual Analogue Scale (VAS) was measured using a scale from 
0 to 100 to evaluate pain and satisfaction caused by knee arthroplasty both before and after 
surgery. The VAS satisfaction scale was divided into four sections: 0 to 25 dissatisfied, 26 to 
50 unsure, 51 to 75 satisfied, and 76 to 100 very satisfied, as proposed previously by Scott et 
al. (Scott et al. 2016).
The severity of knee OA was assessed from preoperative standing fixed flexion view 
(FFV) radiographs using the Kellgren-Lawrence (KL) (KELLGREN and LAWRENCE. 
1957) classification.
In study V, inclusion criteria consisted of (1) patients requiring primary TKA for primary 
osteoarthritis and (2) aged 18 to 75 years. Exclusion criteria were (1) rheumatoid arthritis 
or other inflammatory diseases, (2) BMI >35, (3) American Society of Anesthesiologists’ 
physical score >3, (4) renal dysfunction, (5) allergy to any of the study drugs, (6) previous high 
tibial osteotomy or previous osteosynthesis, (7) >15 degrees varus or valgus malalignment, 
and (8) physical, emotional, or neurological conditions which could compromise the 
patient’s compliance with postoperative rehabilitation and follow-up.
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4.2.2.1 Randomization and blinding
On the morning of the surgery, an independent research nurse not involved in patient 
care performed the randomization sequence by drawing 1 opaque-sealed envelope from 
a mixture of 60 alternatives (allocation ratio: 1:1). The nurse prepared the study solution 
and delivered it to the operating room just before surgery. In the local infiltration analgesia 
(LIA) group, the study solution contained levobupivacaine (150 mg) mixed with ketorolac 
(30 mg) and adrenaline (0.5 mg). In the control (Placebo) group, the solution contained 
isotonic saline. Total volume of the solution was 100 mL in both groups. The allocation 
list was stored at the office of the research nurse until all patients had been included and 
all 1-year follow-up materials had been completed. Only the research nurse who opened 
the envelope and prepared the study solution was aware of the infiltration’s quality and all 
other personnel involved in the patient’s care remained blinded throughout the study.
4.2.2.2. Preparation and pain management
Oral paracetamol 1 g was given approximately 1 h before operation as premedication. 
Single shot spinal anesthesia was induced at the L4-5 or L3-4 level by using a 27 G spinal 
needle with a dose of 3 mL bupivacaine 5 mg/mL. A single 3.0 g bolus of cefuroxime was 
used as antibiotic prophylaxis and tranexamic acid 1g was given at the end of surgery. In 
the postanesthesia care unit, an ice pack was used for all patients. All patients were treated 
with oral paracetamol 1 g every 6 h and oral meloxicam 15 mg every 24 h, initiated 2 h after 
surgery. Patient-controlled analgesia (PCA) with oxycodone (dose 2 mg, lock-out time 8 
min) was used in all patients to ensure adequate pain relief. No other analgesic drugs were 
used. If the pain management was insufficient, a lumbar epidural catheter was inserted and 
levobupivacaine infusion was initiated as rescue analgesic causing the patient to drop out 
of the study. Nausea was treated with intravenous ondansetron 4 mg when needed. For 
thromboprophylaxis, subcutaneous enoxaparin 40 mg every 24 h was started 6 to 10 h after 
the end of operation.
 6XUJHU\DQGLQ¿OWUDWLRQWHFKQLTXH
All patients were operated using standard knee replacement techniques by 4 experienced 
orthopaedic surgeons. Both groups received a periarticular infiltration intra-operatively. 
All infiltrations were done using 50 mL syringes and 7 cm long 20 G needles. The solution 
was infiltrated in 2 stages: the first after the bone surfaces were prepared, but before the 
components were inserted, and the second after the components were inserted, but before 
both tourniquet´ s release and wound closure. The first 50 mL infiltration was aimed at both 
sides through the posterior capsule and in the areas of the resected menisci. The second 
was aimed periosteally next to the resected bone surfaces and parapatellar approach, but 
not in subcutaneous tissue. The tourniquet was released before closure and hemostasis was 
ensured. Drainage and compression bandage were applied in all patients.
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4.2.2.4 Recovery
In the recovery room, all patients were mobilized by a physiotherapist soon after recovery 
of motoric function. Patients were advised to use a PCA pump for oxycodone delivery and 
the consumption of oxycodone was calculated at 6, 12, 24, and 48 hours postoperatively. 
The Visual Analog Scale (VAS) was used to quantify the pain intensity, with a target level 
under 3. The VAS reading was recorded at 3, 9, 18, and 48 hours postoperatively by a nurse 
or physiotherapist. The range of motion (ROM) was measured at 6, 12, and 24 hours 
postoperatively by a physiotherapist.
4.2.2.5 Outcomes
The primary outcome was the oxycodone consumption during the first 48 hours 
postoperatively. A secondary outcome was functional outcome 1 year after surgery. All 
patients were evaluated by a physiotherapist blinded to the study solution at a routine 
follow-up visit 3 months postoperatively. Total Knee Function Questionnaire (TKFQ), 
Oxford Knee Score (OKS), High-Activity Arthroplasty Score (HAAS), and 15D quality 
of life instrument were collected preoperatively at 3 months and at 1 year postoperatively 
for prospective outcome analysis.
4.3 Statistical methods
4.3.1 Study I
In study I, we described patient characteristics, categorized into sex and age groups, 
using descriptive statistics presented as mean and standard deviation (SD). Incidences 
are presented as the number of operations performed per 104. Age was categorized into 3 
groups: <65 years, 65 to 74 years and 75+ years. We analyzed trends in the general incidence 
of TKAs and UKAs in Denmark, Norway, and Sweden from 1997 to 2012 and in Finland 
from 2000 to 2012. The incidence was calculated as incidence density, which is defined as 
the number of new cases in a population during a given time period relative to the sum 
of the person-time of the at-risk population. Negative binomial regression was used to 
estimate the incident rate ratios (IRR) and the 95% confidence intervals (CI) of UKAs 
and TKAs for each country due to evidence of overdispersion of the data. IRR reports 
the estimated average annual increase of incidence. Analyses were stratified by sex and age 
group. The statistical analyses were conducted using SPSS software (IBM SPSS Statistics 
for Windows, Version 22 Armonk, NY: IBM Corp.) and Stata 8.2 software (StataCorp 
4905 Lakeway Drive, College Station, Texas 77845 USA).
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4.3.2 Study II
In study II, we assessed the descriptive statistics of the included patients. The inclusion 
time period was 2000 to 2016. We used Kaplan-Meier survival analysis to assess implant 
survival probability (with respective 95% confidence interval (CI)) of the TKA fixation 
at 7, 10, and 15 years. The results in tables and figures were not shown when fewer than 
40 were at risk. Outcome was defined as the removal, addition, or exchange of at least one 
of the components. This included  polyethylene insert exchanges of the modular tibial 
components for any reason. Differences between groups were considered to be statistically 
significant if the p-values were less than 0.05 in a two-tailed test. 
Cox regression analysis was used to estimate the hazard ratios associated with implant 
survival. The covariates included in the analysis were fixation type, sex, country, and 
age. Age was included as a continuous variable, whereas the others were categorical. The 
correlation of scaled Schoenfeld residuals with time was examined to investigate violation 
of the proportional hazard (PH) assumption. Log-log survival curves were also inspected 
visually to see whether the PH assumption was met. Multiple violations of the PH 
assumption were detected. In order to deal with the PH violation, we used time-dependent 
coefficients using step function. Based on the log-log curves, cut-offs were set as 1, 3, and 6 
years. We did stratified analyses based on age and implant brand group and a similar time 
axis division was made according to the log-log curves and residual testing. For the time-
dependent coefficients, the data were broken down into time-dependent parts according 
to the time intervals used in the time axis division. For each final analysis, the PH test 
investigating Schoenfeld residuals was performed.
Statistical analyses were performed using SPSS Statistics version 23 (IBM Corporation, 
Armonk, NY, USA).
4.3.3. Study III
In study III, the endpoint for survival was defined as revision with either one component or 
the whole implant being removed or exchanged. All survival analyses were performed using 
all revisions and revisions for aseptic loosening of the tibial component as the end points. 
Kaplan-Meier survival data were used to construct the survival probabilities of implants at 
1, 5, and 7 years. The Cox multiple-regression model was used to study the differences in 
revision risk (RR) between revision indications and to adjust for potential confounding 
factors. The variables included in the Cox model were as follows: primary osteoarthritis 
(reference indication) vs other indications, cemented vs uncemented femur (reference 
implant), unresurfaced vs resurfaced patella (reference technique), gender, and age both as 
a continuous and as a categorized variable. The following age groups were analyzed: 1) age 
under 55 years and 2) age from 55 to 65 years with 3) age over 65 years as a reference age 
group. During the study period, the reasons for failures and revisions among the patients 
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were ascertained from the patients´  medical records and radiographs taken at the hospitals 
where the revisions had been performed. The Cox regression analyses provided estimates 
of survival probabilities and adjusted risk ratios (ARR) for the various factors. Estimates 
from the Cox analyses were used to construct adjusted survival curves at the mean values of 
the risk factors. The Wald test was used to calculate p-values for the data obtained from the 
Cox multiple regression analysis. Differences between groups were considered statistically 
significant if the p-values were less than 0.05 in a two-tailed test. We used SPSS version 20 
statistical software (IBM, Armonk, New York, U.S.A.) for statistical analyses.
4.3.4 Study IV
In study IV, data were presented as median with quartiles (Q1 to Q3) or as mean (SD) 
or (CI95%). The Wilcoxon signed rank test and paired t-test for paired data were used to 
compare preoperative and postoperative values. The differences in distributions in the 3 
measured time points were calculated with Friedman test. A P-value less than 0.05 was 
considered statistically significant. Data were analyzed using the SPSS version 23 statistical 
package (IBM, Armonk, NY, USA.)
To prevent potential bias with TKA and UKA, the results were analyzed for both TKA 
and UKA together, and also separately for TKA and UKA.
4.3.5 Study V
In study V, the calculation of sample size was based on an expectation of a 40% difference 
in opiate consumption between the groups. The study was designed to have a power of 80% 
to detect a 40% difference between the 2 groups (type-I error probability 0.05). Based on 
the power calculation, 17 patients per group would be needed. Demographics and results 
are shown as percentages, mean values (SD), or as median (range). Differences between the 
groups were analyzed using the Mann-Whitney U-test. The Bonferroni method was used 
to correct for multiple measures. IBM SPSS Statistics version 20 statistical software (IBM, 
Armonk, New York, U.S.A.) was used for the statistical analysis.
4.4 Ethical considerations
In the NARA-based studies I and II and FAR-based study III, the ethical approvals for the 
studies were attained through the ethical approval process of each national registry: the 
Ethics Board of Lund University (LU20-02) (Sweden), the National Institute of Health 
and Welfare (Dnro THL/1743/5.05.00/2014) (Finland), the Norwegian Data Inspectorate 
(ref 24.1.2017: 16/01622-3/CDG) (Norway) and the Danish Data protection agency (1-16-
02-54-17) (Denmark).
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In study IV, the study protocol (R11178) was approved by the Ethics Committee of 
the hospital district. The study was registered with ClinicalTrials.gov (NCT03233620). All 
patients gave written informed consent to participate in the study.
With study V, the study protocol was approved by the local Ethics Committee 
(R10108). The Finnish Medicines Agency (Fimea) approved the study protocol for the 
drugs to be used (EudraCT 2010-024315-14). The study was registered with ClinicalTrials.
gov (NCT01305733). All patients gave their informed consent before inclusion in the study.
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5 Results
5.1 Incidences of knee arthroplasty (Study I)
At the beginning of the study, incidences were 3.4 in Denmark, 3.6 in Norway, 9.0 in 
Sweden, and 13.1 in Finland (/104 inhabitants). At the end of study, incidences were 20.5 in 
Denmark, 14.1 in Norway, 20.9 in Sweden, and 27.5 in Finland (/104 inhabitants). During 
the study period, the total incidence of knee arthroplasties increased in all four national 
registers. The change in incidence was analyzed from the beginning to the end of the study 
period. The total increase was 6.0-fold in Denmark, 3.9-fold in Norway, 2.3-fold in Sweden, 
and 2.1-fold in Finland. In 2012, the total incidence of TKAs was highest in Finland 
and lowest in Norway. The total incidence in Finland was 2.0-fold higher compared 
with Norway, 1.3-fold higher compared with Sweden, and 1.3-fold higher compared with 
Denmark. The increase in incidence was steady over time except for Finland where it was 
especially high between 2004 and 2006 for both TKA and UKA (Figure 11). The incidence 
of UKAs varied between countries, whereas that of TKAs increased constantly in every 
Figure 11. Total incidence 
of TKA and UKA by year 
of operation in patients 30 
years or older. Incidences 
are shown per 104 
inhabitants
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register. In Sweden, the incidence of UKA decreased significantly during the study period. 
A similar trend was also seen in Finland after 2006.
The increase in the incidence of UKA was 10.0-fold in Denmark, 1.5-fold in Finland, 
and 7.1-fold in Norway. However, the incidence of UKA decreased 0.5-fold in Sweden. 
During the study period, the estimated average annual increase in the general incidence 
of TKAs between age and gender groups was statistically significant in all countries 
(p<0.001), with the exception of Finnish females aged 65 to 74 years (1.017 (Cl 1.00–1.04), 
p=0.129) (Table 18).
7DEOH1HJDWLYHELQRPLDOUHJUHVVLRQDQDO\VLV,QFLGHQWUDWHUDWLRV,55ZLWKFRQ¿GHQFH
intervals
Age (y)
Male Female
IRR 95% CI IRR 95% CI
Denmark
30–64 1.18 1.15–1.20 1.16 1.14–1.18
65–74 1.09 1.04–1.14 1.12 1.10–1.14
75– 1.12 1.10–1.14 1.10 1.08–1.12
Norway
30–64 1.16 1.13–1.19 1.13 1.11–1.16
65–74 1.12 1.10–1.13 1.08 1.06–1.09
75– 1.09 1.08–1.11 1.06 1.04–1.07
Sweden
30–64 1.12 1.11–1.14 1.11 1.09–1.12
65–74 1.06 1.05–1.07 1.04 1.03–1.05
75– 1.06 1.05–1.06 1.04 1.03–1.04
Finland
30–64 1.13 1.10–1.16 1.11 1.08–1.13
65–74 1.04 1.02–1.05 1.02 1.00–1.04
75– 1.04 1.02–1.06 1.03 1.01–1.05
5.2 Incidence by gender
5.2.1 TKA
The incidences of TKAs were higher in women than in men in all countries. The trend 
of increase was similar between countries. The increase in the incidence of TKA was 4.2-
fold in males and 5.2-fold in females in Denmark. Corresponding increases were 5.9-fold 
vs 3.1-fold in Norway, 2.8-fold vs 2.4-fold in Sweden, and 2.7-fold vs 1.9-fold in Finland, 
respectively (Figure 12 and 13). 
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5.2.2 UKA
The increase in UKA incidence was 6.6-fold in males and 9.2-fold in females in Denmark. 
Corresponding changes in UKA incidences were 10.6-fold vs 5.1-fold in Norway, 0.5-fold 
vs 0.4-fold in Sweden, and 2.0-fold vs 1.3-fold in Finland, respectively (Figures 14 and 15).
Figure 12. Incidence of TKA 
in males 30 years or older. 
Incidences are shown per 104 
inhabitants
Figure 13. Incidence of TKA 
in females 30 years or older. 
Incidences are shown per 104 
inhabitants
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5.3 Incidence by age group
5.3.1 TKA
The incidence of TKAs was highest in Finland in patients aged 65 years and older. The 
total incidence was lowest in the youngest age group in all countries. However, an increase 
in the incidence of TKA was detected in all age groups. Between the less than 65 years age 
group, the 65 to 74 years age group, and the 75+ years age group, the increase in incidence 
of TKAs was 7.4-fold vs 5.0-fold vs 4.3-fold in Denmark, 7.6-fold vs 3.7-fold vs 2.6-fold 
in Norway, 5.8-fold vs 2.2-fold vs 1.9-fold in Sweden, and 3.9-fold vs 1.3-fold vs 1.5-fold in 
Finland, respectively (Figure 16).
Figure 14. Incidence of UKA 
in males 30 years or older. 
Incidences are shown per 104 
inhabitants
Figure 15. Incidence of UKA 
in females 30 years or older. 
Incidences are shown per 104 
inhabitants
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5.3.2 UKA
Corresponding differences between the age-groups in the incidence of UKA were 13.4-fold 
vs 9.3-fold vs 4.6-fold in Denmark, 14.0-fold vs 6.8-fold vs 2.3-fold in Norway, 1.3-fold vs 
0.2-fold vs 0.2-fold in Sweden, and 2.0-fold vs 0.9-fold vs 1.0-fold in Finland. The incidence 
of UKAs decreased significantly in Sweden in patients aged 65 years or older, and a similar 
but minor trend was also detected in patients aged 65 years or older in Finland. During the 
study period, the incidence of UKA increased in Denmark and Norway in all age groups 
and in patients younger than 65 years of age in Finland (Figure 17).
5.4 Fixation methods and survivorship (Study II and III)
In the KM analysis, the inverse hybrid group had the lowest risk for revision at 10 years 
(Figure 18). The proportion of cemented TKAs of all TKAs was 88.7%, and that of 
uncemented was 5.3%, hybrid 5.5%, and inverse hybrid 0.5%, respectively.
Figure 16. Incidence of TKA 
by age group. Incidences are 
shown per 104 inhabitants
Figure 17. Incidence of UKA 
by age group. Incidences are 
shown per 104 inhabitants
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At 10 years, KM-based survival rates were in descending order: inverse hybrid 96.0% (CI 
94.1–98.1), cemented 93.6% (Cl 93.4–93.8), hybrid 93.0% (CI 92.2–93.8), and uncemented 
91.2% (CI 90.1–92.2) (Table 19). At 15 years, the uncemented group evinced a slightly worse 
survival rate than the hybrid and cemented fixation groups; in the inverse hybrid group 
there were not enough patients at risk to calculate the survival rate at 15 years.
7DEOH8QDGMXVWHG.DSODQ0HLHU.0DQG\HDUVXUYLYDOUDWHVZLWKFRQ¿GHQFH
intervals (CI) for uncemented, inverse hybrid, hybrid, and cemented TKA
Type of 
À[DWLRQ
N of 
knees
N of 
revisions
At risk at 
10 years
KM-survivorship 
(%) at 10 years
At risk at 
15 years
KM-survivorship 
(%) at 15 years
Uncemented 6 132 363 915 91.2 (90.1–92.2) 214 88.7 (87.0–90.4)
Inverse Hybrid 546 16 66 96.0 (94.1–98.1) - -
Hybrid 6 329 330 1 349 93.0 (92.2–93.8) 239 91.4 (90.2–92.6)
Cemented 102 170 5 040 24 954 93.6 (93.4–93.8) 4 259 91.3 (91.0–91.7)
In Cox regression analysis in patients aged less than 65 years, uncemented fixation evinced 
an increased risk of revision compared with the cemented group both during the first 
postoperative year and after 6 years of follow-up. Hybrid fixation, on the other hand, was 
associated with a significantly decreased risk for revision compared with cemented fixation 
after 6 years of follow-up. The inverse hybrid group had a comparable risk for revision 
compared with cemented TKAs (Table 20). Because the survival of TKAs is age-dependent, 
an additional Cox regression analysis was conducted for two different age groups: 55 to 64 
years of age and less than 55 years of age (Tables 21 and 22).
Figure 18. Unadjusted Kaplan-
Meier cumulative risk for revision 
E\¿[DWLRQW\SH
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7DEOH&R[UHJUHVVLRQZLWKWLPHGHSHQGHQWFRHI¿FLHQWVDOOSDWLHQWVDJHG\HDUVLQFOXGHG
cemented TKA as reference)
7\SHRIÀ[DWLRQ Follow-up HR 95% CI
Uncemented
<1 years
1–3 years
3–6 years
>6 years
1.38
1.14
0.95
1.32
1.13–1.70
0.97–1.35
0.72–1.25
1.00–1.73
Inv hybrid
<1 years
1–3 years
3–6 years
>6 years
0.29
0.67
0.91
0.54
0.07–1.16
0.34–1.35
0.38–2.19
0.13–2.15
Hybrid
<1 years
1–3 years
3–6 years
>6 years
1.11
0.94
1.07
0.54
0.88–1.39
0.78–1.12
0.82–1.40
0.38–0.78
Cemented (ref.) 1.0 -
In patients aged 55 to 64 years, the risk for revision with uncemented TKAs increased in 
comparison with the cemented reference group during the first 3 years of follow-up. After 
6 years of follow-up, Hybrid TKAs still showed a significantly decreased risk for revision; a 
finding that was seen in the whole study cohort (Table 21). 
7DEOH&R[UHJUHVVLRQZLWKWLPHGHSHQGHQWFRHI¿FLHQWVLQSDWLHQWVDJHGWR\HDUV
7\SHRIÀ[DWLRQ Follow-up HR 95% CI
Uncemented
<1.5 years
1.5–3 years
3–6 years
>6 years
1.37
1.31
0.86
1.32
1.13–1.67
1.01–1.69
0.59–1.24
0.96–1.83
Inv hybrid
<1.5 years
1.5–3 years
3–6 years
>6 years
0.44
0.65
0.88
0.49
0.14–1.37
0.21–2.02
0.28–2.75
0.07–3.48
Hybrid
<1.5 years
1.5–3 years
3–6 years
>6 years
1.15
0.90
1.14
0.55
0.94–1.41
0.68–1.20
0.85–1.53
0.37–0.83
Cemented 1.0
In patients aged less than 55 years, there were no differences in survival between fixations 
(Table 22).
90
7DEOH&R[UHJUHVVLRQZLWKWLPHGHSHQGHQWFRHI¿FLHQWVLQSDWLHQWVDJHG\HDUV
7\SHRIÀ[DWLRQ HR 95% CI
Uncemented 1.10 0.91–1.32
Inv hybrid 0.62 0.29–1.29
Hybrid 0.83 0.67–1.04
Cemented 1.0 -
Because of the lower total number of TKAs in the inverse hybrid group compared with 
other groups, we conducted an additional sensitivity analysis to diminish bias between the 
groups. For this analysis, we only included patients with Nexgen TKAs. 
In this sensitivity analysis, KM survival rates of different fixations at 7 years were in 
descending order: the inverse hybrid 96.6% (CI94.7–98.5), cemented 95.8% (CI 95.5–96.1), 
uncemented 93.2% (CI 91.9–94.6), and hybrid 92.0% (CI 90.4–93.7).
In the Cox analysis of the Nexgen subgroup, an increased risk for revision was seen 
in uncemented and hybrid TKAs compared with cemented TKA. With inverse hybrid 
TKAs, the risk for revision was comparable to cemented TKAs (Table 23).
7DEOH&R[UHJUHVVLRQZLWKWLPHGHSHQGHQWFRHI¿FLHQWVLQSDWLHQWVDJHG\HDUVLQWKH1H[JHQ
subgroup
7\SHRIÀ[DWLRQ HR 95% CI
Uncemented 1.37 1.12–1.67
Inv hybrid 0.59 0.34–1.03
Hybrid 1.47 1.16–1.87
Cemented 1 -
5.4.1 Survivorship of the TM tibial component
Survivorship of the whole study cohort was 100% (95% CI 99–100) at 1, 5, and 7 years 
postoperatively using revision for aseptic loosening of the tibial component as the end-point. 
When revision for any reason was used as the end-point, 1-, 5-, and 7-year survivorship 
was 99% (95% CI 98–100), 97% (95% CI 96–98), and 97% (95% CI 96–98), respectively. 
Kaplan-Meier survival curves with the end-point as revision of the tibia component for any 
reason are shown in figure 19.
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In the analysis of different age groups, the survivorship of TM tibias were comparable at 5 
years (Table 24).
Table 24. Kaplan-Meier survivorship with end-point as revision of the tibia component for any reason 
in different age groups
Cohort Na MF (range) AR1 yr
1-year 
survival %
(95% CI)
AR
5 yr
5-year
survival % 
(95% CI)
All 20/1143 2.7 (0–7.9) 866 99 (99–100) 175 97 (96–99)
Age <55 years 3/167 2.5 (0–7.9) 126 99 (97–100) 25 98 (95–100)
Age 55–65 years 10/457 2.6 (0–7.9) 353 100 (99–100) 53 97 (95–99)
Age >65 years 7/519 2.8 (0–7.9) 387 99 (99–100) 97 98 (96–100)
a Number of revisions / number of total operations. MF = mean follow-up (years). AR = at risk.
In the Cox multiple regression model, there was no difference in risk for revision between 
any of the variables studied (Table 25).
Figure 19. Kaplan-Meier survival 
curves for 1 143 primary total 
knee arthroplasties using the 
Trabecular Metal Monoblock Tibia 
(mean follow-up 2.7 years). The 
HQGSRLQWZDVGH¿QHGDVUHYLVLRQ
of the tibia component for any 
reason
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Table 25. Risk for revision between demographic variables
Cohort Na MF (range) Adjusted RR for revision (95% CI) p
All 20/1143 2.7 (0–7.9) - -
Women 14/647 2.7 (0–7.9) 1.8 (0.7–4.7) 0.22
Men 6/496 2.6 (0–6.9) 1.0 -
Primary osteoarthritis 19/1087 2.7 (0–6.9) 1.0 -
Other indications 1/56 2.7 (0–6.9) 1.1 (0.1–8.6) 0.94
Cemented femur 13/548 3.6 (0–7.8) 1.0 -
Uncemented femur 7/595 1.8 (0–7.9) 1.1 (0.4–3.1) 0.82
Patella not resurfaced 15/974 2.5 (0–7.9) 0.6 (0.2–1.9) 0.40
Patella resurfaced 5/168 3.5 (0–6.9) 1.0 -
Age <55 years 3/167 2.5 (0–7.9) 2.7 (0.6–13.5) 0.21
Age 55–65 years 10/457 2.6 (0–7.9) 3.3 (0.2–47.5) 0.37
Age >65 years 7/519 2.8 (0–7.9) 1.0 -
a Number of revisions / number of total operations. MF = mean follow-up (years). RR = risk ratio from the Cox regression 
analysis (adjustment was made for age and sex).
5.4.2 Revision operations
In total, 20 knee revisions including removal or replacement of the uncemented porous 
tantalum tibial component with or without revision of the femoral component were 
reported during the period 2003 to 2010. The indications for revisions were ascertained 
from the patients’ medical records from the hospital concerned. 
The most common reason for revision was tibiofemoral joint instability with or without 
malposition of the TKR components (n=12, 60%). This was followed by PJI (n=7, 35%). 
Aseptic loosening was the reason for revision in one patient (5%).
5.5 Patient-reported outcomes (Study IV)
5.5.1 OKS
Mean OKS increased both statistically (18 points (CI 17–19), p<0.001) (TKA and UKA 
together) and clinically (exceeding MCID) significantly from the preoperative situation to 
2-year follow-up (Figure 20). The mean increase did not differ between TKAs and UKAs 
(Table 26).
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Table 26. OKS scores preoperatively and at 2-years analyzed separately for TKA (n=227) and UKA 
(n=27). The scores are shown as mean and 95% CI
TKA UKA
Preoperative 2 years p Preoperative 2 years p
OKS 22 (21–23) 41 (40–42) <0.001 24 (21–28) 42 (40–43) <0.001
5.5.2 KOOS
In study IV, a significant increase (p<0.001) was observed in all KOOS subscales, all of 
which also exceeded MCID. The mean increase of score between preoperative and 2-year 
follow-up were (TKA and UKA together): KOOS pain 41 (CI 39–43), KOOS symptoms 
35 (CI 32–37), KOOS ADL 37 (CI 35–40), KOOS sport/rec 40 (CI 37–44), and KOOS 
QoL 48 (CI 45–51) (Figure 21, Table 27).
Figure 20. OKS with 2-year 
follow-up (TKA and UKA 
together)
Figure 21. Outcome measured with 
KOOS subscales. Values presented 
as median (Q¹ to Q³)
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Table 27. KOOS scores preoperatively and at 2-years analyzed separately for TKA (n=227) and UKA 
(n=27). The scores are shown as mean and 95% CI.
TKA UKA
Preoperative 2 years Preoperative 2 years
KOOS pain 45 (43–47) 86 (84–88) <0.001 46 (39–53) 86 (81–91) <0.001
KOOS symptoms 43 (41–46) 79 (76–81) <0.001 48 (40–55) 77 (70–84) <0.001
KOOS ADL 50 (48–52) 88 (86–90) <0.001 56 (50–62) 89 (84–94) <0.001
KOOS sport/rec 14 (12–17) 55 (51–59) <0.001 16 (10–23) 55 (44–67) <0.001
KOOS QoL 21 (19–23) 70 (67–73) <0.001 25 (18–31) 68 (58–77) <0.001
ADL=Activity of Daily Living, sport/rec= Function in sports and recreation, QoL=Quality of Life.
5.5.3 HAAS
In study IV, the preoperative baseline (mean) in physical activity according to HAAS was 
moderate: 6/18 in patients in the TKA group and 7/18 in the UKA group, respectively. 
The increase in mean HAAS (TKA and UKA together) was 5 points (CI 4.6–5.5) over 
the 2-year follow-up period and the improvement was significant (p<0.001) (Figure 22). 
Outcomes were comparable between UKA and TKA (Table 28).
Figure 22. Outcome measured with 
HAAS. Values presented as median 
(Q¹ to Q³)
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Table 28. Outcome measured with HAAS. TKA and UKA separately. The scores are shown as mean 
and 95% CI
TKA UKA
Preoperative 2 years p Preoperative 2 years p
HAAS 6 (5–6) 11 (10–11) <0.001 7 (6-9) 12 (11-13) <0.001
5.5.4 RAND-36
RAND-36 score was analyzed with mental (MCS) and physical (PCS) subscales. Over the 
2-year follow-up period, the mean MCS increased (TKA and UKA together) 18 points 
(CI 15–20) and the mean PCS 31 points (CI 28–34). The change seen in both subscales was 
both significant (p<0.001) and also exceeded MCID (Figure 23 and Table 29).
Table 29. Outcome measured with RAND-36. TKA and UKA separately. The scores are shown as 
mean and 95% CI
TKA UKA
Preoperative 2 years p Preoperative 2 years p
RAND-36 MCS 61 (58–64) 79 (77–81) <0.001 65 (56–73) 78 (69–87) 0.007
RAND-36 PCS 37 (34–39) 68 (65–71) <0.001 39 (34–45) 70 (61–79) <0.001
MCS= mental component score, PCS= physical component score.
Figure 23. Outcome measured with RAND-36. PCS (left) and MCS (right) separately. Values 
presented as median (Q¹ to Q³)
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5.5.5 VAS pain
Pain relief was measured with the VAS (exercise and rest). A significant positive change of 
median value (in exercise: 80 (72.90) vs 13 (4.32), p<0.001 and in rest: 49 (26.71) vs 3 (0.7), 
p<0.001) from the preoperative situation to the 2-year follow-up was detected (Figure 24). 
In 16 (7%) patients, all of whom had undergone TKA, severe knee pain (VAS>30) was still 
reported 2 years after knee arthroplasty.
5.5.6 VAS satisfaction
At the time of the 2-year follow-up visit, 85% of patients were either satisfied (9%) or very 
satisfied (76%) with the outcome of their knee arthroplasty. Between 1- and 2-year follow-
up evaluations, 16 patients (6.7%) who had been either unsure or satisfied with the outcome 
at the 1-year visit had become more satisfied by the 2-year follow-up evaluation. The number 
of patients who were dissatisfied with the outcome did not change between the 1- and 2-year 
follow-up evaluations (Figure 25). At the 2-year follow-up visit, 98% of all patients reported 
that they would choose to undergo knee arthroplasty again, and 96% reported that they 
would recommend this operation to their best friend. Regarding satisfaction, there was no 
difference between patients in the UKA and TKA groups.
Figure 24. VAS pain in rest and exercise. 
Values presented as median (Q¹ to Q³)
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5.5.6.1 Effect of preoperative KL grade
Preoperative KL grade significantly affected both satisfaction and PROM outcomes 
measured at 2 years. The median VAS satisfaction was significantly poorer in patients with 
preoperative KL grade 2 OA compared with both patients with KL 3 (85 (51,97) vs 94 
(80,100) points, p=0.006) as well as those with KL 4 OA (85 (51,97) vs 91 (81,99) points, 
p=0.015) at the time of the 2-year follow-up visit (Figure 26). Furthermore, there was also a 
significant difference in median OKS between the groups at the time of the 2-year follow-
up visit: median OKS was worse in the KL 2 group than in both the KL 3 group (41 (36,44) 
vs 44 (38,46) points, p=0.015) and the KL 4 group (41 (36,44) vs 43 (40,45) points, p=0.037). 
However, this difference fulfilled the MCID criteria only when the KL 2 and KL 3 groups 
were compared. Similarly, patients with preoperative KL 2 OA, ended up with significantly 
poorer median subscale scores than those patients with more advanced radiographic OA 
(KL 4) at the time of the 2-year follow-up visit: KOOS symptoms (75 (61,89) vs 86 (78,93), 
p=0.001), KOOS ADL (88 (76,96) vs 93 (85,97), p=0.041), and KOOS sport/rec (40 (25,75) 
vs 60 (38,75), p=0.028). The significant improvements between preoperative and 2-year 
follow-up were observed in all PROMs and also in KL 2 patients (p<0.001).
Figure 25. VAS satisfaction
Figure 26. VAS satisfaction in different KL 
groups. Scores presented as median (Q¹ to 
Q³)
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Dissatisfaction in patients with unilateral TKA was analyzed to diminish bias with UKA 
and bilateral knee concerning satisfaction with knee arthroplasty. Crosstabulation and 
the chi square test were used to analyse the effect of the severity of preoperative OA with 
dissatisfaction. The difference was even more significant compared to the analysis shown 
in Figure 25. In the KL 2 group, the dissatisfaction rate was significantly higher compared 
with the KL 3 and KL 4 groups (Table 30).
7DEOH3URSRUWLRQRIGLVVDWLV¿HGSDWLHQWVDQG0&,' ¨SRLQWVLQGLIIHUHQW./JURXSVPHDVXUHG
with satisfaction VAS (0–100). Unilateral TKAs are included and KL2 is compared to KL3 and KL4 in 
dissatisfaction analysis.
KL 2 KL3 KL4 p
'LVVDWLV¿HG 27.3 5.2 6.7 0.007
MCID (%) 94 99 97 0.64
5.5.7 Revisions (study IV)
Of the 254 knee replacements originally operated, 6 (2.4%; 4 TKAs and 2 UKAs) had to 
be revised during the 2-year follow-up period. Two patients in the TKA group underwent 
secondary patellar resurfacing because of persistent anterior knee pain, one TKA was 
revised for prosthetic joint infection, and one TKA for stiffness due to arthrofibrosis. 
Of the 2 UKAs that underwent revision surgery, one was revised for dislocation of the 
polyethylene insert and the other for impingement. Revised patients were excluded from 
the final outcome assessment.
5.6 Effect of LIA on immediate pain management and PROMs (study V)
5.6.1 Effect of LIA on oxycodone consumption and pain management
The cumulative consumption of oxycodone was smaller in the LIA group than in the 
Placebo group at all measured time-points until 48 hours (Figure 27). A trend for decreased 
consumption of oxycodone in the LIA group persisted up to 24 hours postoperatively. The 
differences of means in the cumulative consumption of oxycodone were 17 mg (95%CI 
11–22) at 6 hours, 20 mg (Cl 11–30) at 12 hours, 28 mg (Cl 11–45) at 24 hours, and 35 mg 
(Cl 5–64) at 48 hours.
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In comparison of the different time intervals, the LIA group used statistically less oxycodone 
than the Placebo group during the first 6-hour interval: 14 (2–34) mg vs 30 (6–57) mg, 
p<0.001 (Figure 28). The differences of means in the time intervals were 17 mg (Cl 11–22) 
in the 0–6 hours interval, 4 mg (Cl -1–10) in the 6–12 hours interval, 7 mg (CI -2–16) in the 
12–24 hours interval, and 5 mg (CI -11–21) in the 24–48 hours interval.
A median level of under 3 in VAS score was considered to be an adequate pain management 
level and was achieved in both groups until 48 hours postoperatively (Figure 29). The 
differences of means in VAS were 0.5 (CI -0.3–1.4) at 3 hours, 1.0 (CI -0.2–2.1) at 9 hours, 
0.5 (CI -0.6–1.5) at 18 hours, and 0.4 (CI -0.7–1.4) at 48 hours showing that the groups had 
no significant differences in pain management.
Figure 27. Median cumulative 
consumption of oxycodone during 
48-hour interval postoperatively
Figure 28. Consumption of oxycodone 
during the time intervals. Consumption is 
presented as median (Q¹, Q³)
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Postoperatively, 3 patients in the Placebo group discontinued participation in the study 
because of intense pain and were treated with epidural analgesia. In the LIA group, 
however, none of the patients discontinued the study because of pain.
5.6.2 Effect of LIA measured with OKS
The functional outcomes between the groups differed in mean values, but the difference was 
not statistically significant as measured with OKS (Table 31). There was, however, a trend 
for higher mean values in OKS for patients in the LIA group at 12 months postoperatively.
Table 31. Outcomes measured with OKS in LIA and Placebo groups
LIA n=27 Placebo n=29 Mean difference (95%Cl)
OKS
pre op
3 months
1 year
23 (7.74)
37 (6.87)
44 (4.43)
22 (6.04)
36 (5.38)
41 (5.50)
-1.365
-0.654
-2.706
(-5.099–2.369)
(-4.093–2.785)
(-5.480–0.069)
5.6.3 Effect of LIA measured with HAAS
The functional outcomes between the groups did not have a significant difference as 
measured with HAAS (Table 32).
Figure 29. Postoperative pain at rest. VAS 
scores are presented as median (Q¹, Q³). 
3 h p=0.4, 9 h p=0.2, 18 h p=0.4, 48 h 
p=0.5
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Table 32. Effect of LIA measured with HAAS at 1-year follow-up
LIA Placebo Mean difference (95%Cl)
HAAS
pre op
3 months
1 year
8 (3.11)
11 (2.36)
12 (2.44)
7 (2.67)
11 (2.78)
11 (3.45)
-0.447
-0.047
-1.111
(-2.010–1.116)
(-1.489–1.394)
(-2.744–0.521)
5.6.4 Effect of LIA measured with 15-D
The functional outcomes between the groups did not have a significant difference as 
measured with 15-D (Table 33).
Table 33. Effect of LIA measured with 15-D at 1-year follow-up
LIA Placebo Mean difference (95%Cl)
15D
preop
3 months
1 year
0.88 (0.08)
0.92 (0.05)
0.93 (0.07)
0.87 (0.07)
0.92 (0.05)
0.91 (0.07)
-0.017
0.001
-0.018
(-0.056–0.023)
(-0.028–0.030)
(-0.056–0.020)
5.6.5 Effect of LIA measured with TKFQ
There was a statistically significant difference between the groups in 1 subscale of the 
TKFQ questionnaire. At 12 months postoperatively, it was easier for patients in the LIA 
group to sit for a long period of time (Table 34).
Table 34. Effect of LIA measured with TKFQ (Sitting for a long period of time) at 1-year follow-up
LIA Placebo Mean 
difference
(95%Cl)
TKFQ
Sitting for a long period of time
pre op
3 months
1 year
2 (0.72)
2 (0.58)
1 (0.49)
2 (0.57)
2 (0.50)
1 (0.47)
-0.255
0.077
-0.299
(-0.607–0.096)
(-0.227–0.380)
(-0.558– -0.040)
5.6.6 Effect of LIA in ROM
The difference of means in ROM at 6 hours between LIA and the placebo group was -26 
(CI -39– -12). At 24 hours -10 (CI -21–1) and 48 hours -1.5 (CI -13–10), the differences were 
not significant between the groups (Figure 30).
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Figure 30. ROM at measured time point. 
ROMs are presented as median (Q¹, Q³). 
6 h p=0.001, 24 h p=0.08, 48 h p=0.6. 
Bonferroni adjusted p-value for 6 h time 
point, p=0.004
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6 Discussion
6.1 Incidences
Traditionally, knee arthroplasty surgery has been reserved for elderly patients, for those 
with severe disease (Robertsson et al. 2014), and for younger patients with rheumatoid 
arthritis. In recent years, it seems that the indications have widened to include younger 
patients. This has resulted in a proportionally higher increase in incidence in patients 
younger than 65 years, when compared with patients 65 years or more (Robertsson et al. 
2010b, Leskinen et al. 2012). In a study from the Finnish Arthroplasty Registry, the annual 
cumulative incidence of UKAs and TKAs increased rapidly between 1980 and 2006, 
especially in patients aged 50 to 59 years, the so-called baby-boomer generation (Leskinen 
et al. 2012).
6.1.1 TKA
The total increase in the number of arthroplasties in all countries was mainly caused by 
an increased incidence of TKAs. The reasons for the increasing incidence of younger 
TKA patients may be multifactorial. However, increasing obesity among young patients 
(Kautiainen. 2005, Lohmander et al. 2009), participation in contact sports (Driban et al. 
2015), and the introduction of fast track surgery which better suits working-age patients are 
probable reasons. Of the 3 age groups, patients younger than 65 years of age represented the 
lowest incidence of TKAs. The relative incidence increase was, however, higher in that age 
group than in the other age groups. In our study, the incidence of TKAs steadily increased 
in all the participating countries, which is in line with finding from other studies (Kurtz et 
al. 2007, W-Dahl et al. 2010a, Leskinen et al. 2012). The incidence of TKA in females was 
found to be greater than in males in our study, but the results of previous studies have also 
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shown that the proportion of female patients compared with males has decreased over time 
(Nemes et al. 2015a). Moreover, sex distribution may also vary between nations (Paxton et 
al. 2011, Nemes et al. 2015b).
6.1.2 UKA
Concerning UKA, there was a significant decrease in the incidence of UKAs in patients 
65 years or older in Sweden. In 3 other countries, the variations of incidences in UKAs 
between groups were more heterogeneous. The reasons for the changes between UKA 
incidences are also multifactorial. Previous studies from national registers have affected 
UKA incidences as most registries show a higher overall revision rate for UKAs compared 
with TKAs (Furnes et al. 2007, Koskinen et al. 2008, W-Dahl et al. 2010b). However, 
there are also studies that claim UKAs have a better clinical outcome and are more cost 
effectiveness (Slover et al. 2006, Lygre et al. 2010b). Different UKA implant models with 
a longer learning curve compared with TKA, indications for primary UKA surgery, and a 
higher revision risk compared with TKA may explain the differences in the incidence. The 
increase in the incidence of UKA in patients younger than 65 years may be explained by 
the increase in minimally invasive surgery (MIS) that enables a shorter postoperative stay 
in hospital.
6.1.3 Working-age patients
Concerns have been raised about the long-term outcome of TKAs and the possibility of an 
increasing revision burden because younger age has been associated with a higher risk for 
early periprosthetic joint infection and aseptic mechanical failure after TKA (Meehan et 
al. 2014). In another study, young age impaired the prognosis of TKA and was associated 
with increased revision rates for non-infectious reasons (Julin et al. 2010). A comparison 
study undertaken by the Norwegian Knee Arthroplasty Register and a United States 
Arthroplasty Registry showed an increased risk for revision in patients younger than 65 
years compared with patients 65 years or older (Paxton et al. 2011). 
In our study, the proportional growth of TKAs during the study period was highest 
in patients younger than 65 years. Despite this, the incidence of knee arthroplasty in the 
youngest age group was lower than in patients aged 65 years or older. Based on this finding, 
the majority of knee arthroplasties will probably be performed on elderly patients also in 
future. Even though patients less than 65 years old represented a lower incidence level than 
patients 65 or older in our study, these working-age patients should be considered as an 
important subgroup because of their higher physical activity, their demands for surgery, 
and the multi-factorial reasons behind the success of TKA (Keeney et al. 2014, Klit et al. 
2014, Parvizi et al. 2014).
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6.1.4 Future projections
Even if incidences showed an increasing trend during the study period, some plateauing in 
the trends was seen during the last few years in our study. One study delivered projections 
for primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 
(Kurtz et al. 2007). In that study, the authors predicted that if the number of total knee 
arthroplasties performed continues at the current rate, the demand for primary total knee 
arthroplasty is projected to grow 7-fold by 2030. Another projection of the same but newer 
data from the USA reported that significant increases in the use of total hip arthroplasty 
(THA) and TKA are expected in the United States in both females and males in future 
(Singh et al. 2019).
Obesity is also a growing burden in many countries and, as this has been shown to 
be a certain risk factor for knee osteoarthritis, especially in young patients, it may also 
contribute to the increasing demand for TKAs in future (Apold et al. 2014a, Apold et al. 
2014b, Silverwood et al. 2015b).
6.1.5 Strengths and limitations of the study (study I)
The major strength is the unique collaboration of 4 national registers in the creation of a 
multinational database comprising a large number of patients that enables international 
comparison to reveal possible differences and may help to estimate future demands. 
Further, completeness and data validity were high in the Nordic countries at the end of 
study period: NAR 95%, SKAR 97%, DKR 97%, FAR 96% (annual reports 2015: Danish 
knee arthroplasty register, Norwegian Arthroplasty Register, Swedish Knee Arthroplasty 
Register, Finnish Arthroplasty Register). Previously, the completeness in the DKR was 
reported to be 89% in 2007 (Robertsson et al. 2010b). This may have caused a 10 to 15% 
underestimation of incidence in Denmark over the period 1997 to 2007. Indeed, the total 
relative change of incidence was highest in Denmark and that may have been due to the 
influence of the lower completeness of the DKR in the early years of study period. A lack of 
data on BMI and other subgroups could also be considered a limitation of our study.
 6XUYLYDOVRIGLIIHUHQW¿[DWLRQVVWXGLHV,,DQG,,,
We found that both cemented and hybrid TKAs evinced excellent 15-year survival rates in 
patients aged <65 years. Even though hybrid/inverse hybrid versions of the well performing 
contemporary TKA designs provided younger patients with a good mid-term outcome in 
our study, they were still used in a limited number of patients.  Especially in the inverse 
hybrid group, one single TKA design, with a very good track record comprised the vast 
majority of the whole group. Bone density tends to be higher in younger patients than in 
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older patients, and this may cause suboptimal integration of bone cement even when using a 
good cementing technique. In theory, younger patients might benefit from biologic fixation, 
i.e., bone ingrowth into uncemented implants. A meta-analysis (Gandhi et al. 2009) based 
on five RCTs and 10 observational studies with different mean ages of patients and with a 
minimum follow-up of two years, found improved survival for cemented compared with 
uncemented implants when revision for aseptic loosening was used as an endpoint. Another 
systematic review and meta-analysis (Voigt and Mosier. 2011b) compared hydroxyapatite-
coated, porous coated, and cemented tibial components. Evidence of more stable fixation 
after two years with hydroxyapatite-coated components compared with porous-coated and 
cemented implants was found, but there was no difference between revision rates at 10-
year follow-up. In an RCT, no difference was shown in revision rates and survival between 
cemented and uncemented TKAs with a mean follow-up of 15 years (Baker et al. 2007a). 
Arnold et al. conducted a systematic review of 11 RCTs to identify whether there was an 
association between fixation method and clinical outcome. They found that short- and 
long-term outcomes were not influenced by fixation type but, especially with uncemented 
TKAs, outcomes are implant- dependent (Arnold et al. 2013).
 7UHQGVEHWZHHQ¿[DWLRQV
In our study, the majority of TKAs performed for younger patients in the four participating 
Nordic countries were still cemented. The same trend in general has also been reported 
from other national registers. For example, the annual report 2017 of the National Joint 
Registry for England, Wales and Northern Ireland (NJR) reported that the proportion 
of all cemented TKA implants increased from 81.5% in 2003 to 87.3% in 2016. During the 
same time period, uncemented implants decreased from 6.7% to 2.0% and hybrid implants 
from 2.8% to 0.4%. The same increasing trend of using cemented implants was seen in 
the Australian Joint Registry (AOANJRR annual report 2017) which reported a change 
from 44.8% in 2003 to 66.4% in 2016. The use of uncemented implants decreased from a 
peak of 23.4% in 2003 to 11.8% in 2016. In our study, the proportional number per year 
of cemented TKAs decreased from 95.8% in 2000 to 90.8% in 2016 and an increase in 
uncemented TKAs was observed from 2.5% to 6.5%, respectively.
6.2.2 Risk for revision
In our study, hybrid TKAs, showed a decreased risk for revision after 6 years of follow-up, 
which may predict good long-term survival. Inverse hybrid TKAs showed a comparable 
risk with cemented TKAs, whereas uncemented TKAs had the most probable risk for 
revision. These findings are in line with some previous reports, even if the risk for revision 
with inverse hybrid TKAs has not been reported before. In a Finnish register-based study, 
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uncemented TKAs had a 1.4 times elevated adjusted risk for revision compared to that of 
cemented TKAs (Julin et al. 2010). In the AOANJRR annual report in 2017, the cumulative 
10-year revision percent of minimally stabilized TKA was 4.5 (4.3, 4.6) with cemented 
TKA, 6.1 (5.9, 6.3) with uncemented TKA and 4.6 (4.4, 4.7) with hybrid TKA. In the New 
Zealand Joint Register annual report in 2017, the revision rate for patient 55 to 64 years of 
age was the highest with uncemented implant: 0.84 (CI 0.67–1.05)/100 component-years) 
compared with 0.62 (CI 0.58–0.66)/100 component-years) with cemented implants and 
0.61 (CI 0.47–0.77)/100 component-years) with hybrid implants.
Based on our results, it seems that fixation methods other than cemented TKA may 
also result in good mid-term survivorship in working-age patients. Only uncemented 
fixation showed an increased risk for revision in comparison with the cemented reference 
group. In previous studies, early failures of uncemented TKAs were mainly caused by 
aseptic loosening of the patellar button and the tibial component (Collins et al. 1991, 
Bassett. 1998, Duffy et al. 1998a, Berger et al. 2001c, Barrack et al. 2004, Goldberg and 
Kraay. 2004, Carlsson et al. 2005). Uncemented fixation has been associated with a high 
failure rate due to inadequate bone ingrowth in TKAs (Lombardi et al. 2007). The same 
finding of inferior early results were also found in this study, especially in patients 55 to 
65 years of age. Survivorship of certain uncemented TKA designs has subsequently been 
reported to be comparable to that of cemented designs, but these reports have originated 
from single centers and may, at least in part, be explained by patient selection and also the 
fact that these are the results of high-volume surgeons (Whiteside. 1994, Hofmann et al. 
2002b, Beaupre et al. 2007, Baker et al. 2007b).
6.2.3 Tantalum metal tibias
The first TM monoblock tibial components were cemented ones. In 2010, O’Keefe, Winter 
et al. published a series of 125 TKRs in which a cemented TM monoblock tibial component 
was combined with cemented femoral and patellar components (O’Keefe et al. 2010). In 
that study, only two tibial components were revised during follow-up (a minimum of 5 
years). Another prospective study that compared 100 uncemented TM monoblock tibias 
to 312 cemented controls reported excellent survivorship of the TM monoblock tibial 
components at a minimum follow-up of 5 years. In that study, none of the uncemented 
tibial components loosened, neither were there any signs of osteolysis among these patients 
(Kamath et al. 2011a). 
A TM tibia has a highly porous tantalum tray with a fixed polyethylene insert and 
the reduced stiffness of the tantalum implant may cause less stress shielding than in 
conventional metal-backed components (Patil et al. 2009). Further, inducible displacement 
of uncemented TM tibia have reported less stiffness than cemented ones (Wilson et al. 
2010a). The uncemented TM tibial component has been shown to yield good results both 
in randomized clinical trials (RCT) series (Pulido et al. 2015, Henricson and Nilsson. 
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2016a) as well as in our study. Moreover, functional results have been comparable with 
cemented TKA (Fernandez-Fairen et al. 2013). The higher costs of TM tibial components 
may, however, have restricted its more general use in the Nordic countries. 
In study II, TM tibial components were used both in a group of uncemented TKAs 
as well as in inverse hybrid TKAs. In our study, the Nexgen TKA comprised the majority 
of the TKAs in the inverse hybrid group. Moreover, 87% of the Nexgen TKAs used TM 
tibial components. At 10 years, inverse hybrid TKAs showed a comparable survival rate 
with cemented TKA and also exceeded that of cemented TKAs in KM analysis. In an 
additional subgroup analysis of Nexgen TKAs, it appeared that there was no difference 
in mid-term survival rates between inverse hybrid and cemented Nexgen TKAs. Thus, it 
seems to be a safe option for selected younger patients undergoing TKA, but its superiority 
to cemented fixation remains unproven.
In study III, the majority of revisions were performed due to either instability alone or 
a combination of instability and component malalignment. One disadvantage of using a 
monoblock tibial component is the risk for instability or excessive tightness due to the lack 
of modularity after the tibial and femoral components are in place. With a monoblock type 
of implant, there is no potential for isolated polyethylene insert exchange if instability is 
observed after the primary operation, necessitating revision surgery. In this cohort, there 
were two patients with instability without malalignment of components and who could 
have been candidates for polyethylene insert exchange alone.
In theory, the lack of antibiotics-loaded bone cement and the huge surface area of the 
trabecular tibial component might predispose to PJI. However, the incidence of revisions 
due to PJI was only 0.7% in study III. In another paper based on Finnish Arthroplasty 
Registry data, the incidence of revisions due to PJI was 0.6% among 32 019 TKRs (Julin 
et al. 2010). Thus, this evidence from the population-based setting does not support this 
theory.
In study III, only one revision was performed due to aseptic loosening of this tibial 
component. Neither age nor any of the other variables showed any effect on the risk for 
revision in multivariate regression analyses.
6.2.4 Strengths and limitations of the study (study II and III)
In study II, the major strength was the unique collaboration of four national registers 
in the creation of a multinational database comprising a high number of patients. This 
NARA database enables international comparisons to reveal possible differences in trends 
and outcomes of TKA. Further, completeness and data validity were high in the Nordic 
countries at the end of study period: SKAR 97%, DKR 97%, NAR 95%, and FAR 96% 
(annual reports: Danish knee arthroplasty register, Norwegian Arthroplasty Register, 
Swedish Knee Arthroplasty Register, Finnish Arthroplasty Register). To the best of our 
knowledge, this is the first multi-national, register-based study analyzing the effect of all 
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four fixation method together on TKA survivorship. There are also a few limitations in 
study II. First, there were clearly fewer patients in the alternative fixation groups compared 
with the cemented reference group. This may have caused some selection bias as most of 
these operations were performed in only a few hospitals. Second, we did not have exact 
information on whether some of the uncemented implants were hydroxy-apatite coated or 
not.
In study III, one of the limitations was the lack of clinical data, including patient-
reported outcome measurements. Further, the register-based study setting with a large 
number of patients did not allow us to conduct radiographic analyses apart from those 
in revision surgery. Thus, radiographic signs of component loosening or osteolysis could 
not be analyzed in the total study cohort. Selection bias in the study cohort is a possibility 
because most of the patients (55%) were younger than 65 years. The mean age of the study 
cohort was only 64 years, whereas the mean age of all patients undergoing TKR in Finland 
during the study period was 69 years.
6.3 Outcomes of knee arthroplasty
6.3.1 PROMs
The functional outcomes of knee arthroplasty have traditionally been measured using 
surgeon-driven clinical scores, such as the Knee Society Score (Ranawat et al. 2005c, Duffy 
et al. 2007b, Ritter et al. 2007b). Nevertheless, there has been an increasing demand for 
the subjective, patient-originated evaluation of the outcomes (Goh et al. 2016a). There have 
been earlier studies on functional gain following TKA in young patients, but these have 
lacked a true prospective follow-up. These studies have used the upper age limit of 50 (Goh 
et al. 2016b) or 55 (Scott et al. 2016). In everyday clinical practice, however, these subgroups 
are marginal. Instead, the rising incidence of TKA has occurred in patients aged 50 to 
59 years (Leskinen et al. 2012), which is among the target group of our study. In practice, 
however, only a few such studies have been published so far that report PROM outcomes in 
working-age patients (Klit et al. 2014, Parvizi et al. 2014, Goh et al. 2016b). The increasing 
incidence of TKA also raises the question as to whether the financial resources invested in 
this treatment provide sufficient beneficial results in the face of the intensifying need for 
cost containment (NiemelaInen et al. 2017). 
In studies IV and V, we utilized a wide set of PROMs to assess the real-world effectiveness 
of knee arthroplasty in a prospective non-selected cohort and in a randomized clinical trial 
of patients undergoing TKA or UKA. In study IV, we found that patients aged 65 years or 
less benefited significantly from knee arthroplasty in terms of pain relief as well as in terms 
of improved physical activity and quality of life measured with PROMs. However, the total 
disappearance of symptoms was rare.
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6.3.2 Satisfaction
Scott el al. divided the satisfaction scale into four categories: very satisfied, satisfied, 
dissatisfied, and as the fourth group they included those patients who were unsure about 
their satisfaction (Scott et al. 2016). In study IV, we found that a small proportion of patients 
who were “unsure” at the time of the 1-year follow-up reported being satisfied at the time 
of the 2-year follow-up (7 patients, 2.9%). Thus, in some patients, complete recovery after 
knee arthroplasty may take up to 2 years. Dissatisfied patients, on the other hand, still held 
the same view at the time of the 2-year follow-up. Satisfaction is clearly a multidimensional 
experience because 98% of patients reported being willing to undergo knee arthroplasty 
again despite the fact that 15% of patients were dissatisfied with or unsure about the 
outcome of their surgery. The patient’s own perspective of the preoperative symptoms and 
functional disability may partly explain this difference; i.e., they may still have considered 
the outcome of knee arthroplasty to be better than the preoperative situation despite their 
residual knee symptoms.
In study IV, 85% of patients were satisfied or very satisfied with the outcome at 2 years 
postoperatively. Furthermore, an even higher proportion of patients (98%) reported a 
willingness to undergo knee arthroplasty again. In other recent studies, the subgroups who 
are dissatisfied with their surgery have been reported to range from 10% to 20% (Parvizi 
et al. 2014, Scott et al. 2016, Goh et al. 2016b). In this respect, knee arthroplasty is clearly 
inferior to total hip arthroplasty, and the problem of dissatisfied knee arthroplasty patients 
clearly needs further research.
Scott et al. reported a high (59%) dissatisfaction rate with TKA in patients with KL1–2 
grade OA preoperatively (Scott et al. 2016). In our study, satisfaction at 2 years was also 
significantly lower in the KL 2 group, both when compared with the KL 3 group and to 
the KL 4 group. The same effect of preoperative KL grade was highlighted even more in the 
analysis of unilateral TKAs (Figure 23 and Table 24). A significant improvement, however, 
was achieved in all KL subgroups when compared with the preoperative situation. As 
there was no difference in the KOOS pain subscale between the KL subgroups at 2 years, 
it seems that despite their higher dissatisfaction rate, patients with milder OA (KL 2) also 
achieved good pain relief. In patients with mild radiographic knee OA, there may be other 
factors than pain, such as depression or catastrophizing behavior, that could explain higher 
dissatisfaction rates despite the good pain relief achieved with surgery (Lavand'homme and 
Thienpont. 2015).
6.3.3 Pain
In study IV, knee arthroplasty resulted in significant pain relief, and most of this effect 
was seen already during the first postoperative year. Moreover, between 1 and 2 years 
postoperative, the number of patients with persistent knee pain continued to decrease. 
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Thus, some patients experienced a clearly delayed recovery, but the small subgroup (7%) 
of patients who reported severe knee pain still had persistent pain at the time of the 2-year 
follow-up. Previous studies have shown that persistent pain after knee arthroplasty is 
strongly associated with psychological aspects and young age (Singh and Lewallen. 2013, 
Lewis et al. 2015).
6.3.3.1 Effect of LIA on immediate pain
In study V, we found that single periarticular infiltration decreased total consumption of 
oxycodone for 48 hours, although most of this effect was achieved during the first 6 hours. 
Sufficient pain relief immediately after surgery also aids in controlling pain at a later stage. 
In a recent review, the benefits of delayed administration have been questioned, and the 
authors suggested the use of a single intraoperative administration of an anesthetic cocktail 
(Gibbs et al. 2012). On the other hand, the use of intra-articular catheter for additional drug 
administration may reduce the total consumption of opiates up to 48 hours postoperatively 
compared with the situation where additional bolus is not given. This is supported by a 
recent randomized study with 48 hours follow-up and intra-articular catheter (Essving et al. 
2010), that reported the total median consumption of opiate in the drug infiltration group 
to be 54 (4–114) mg compared with 86 (28–190) mg in our study. Whether the additional 
postoperative intra-articular bolus is given or not, supplementary oral medications, such as 
NSAIDs, are still needed as an adjunct to infiltration analgesia.
In our study, a compression bandage was used in all patients in both groups until the 
second postoperative day. The use of a compression bandage has been shown to improve pain 
control at rest at 8 hours and at 90 degrees knee flexion at 5, 6, and 8 hours postoperatively 
after TKA in a previous randomized study (Andersen et al. 2008a).
6.3.4 Physical activity
The clinically significant improvement in physical activity in younger knee arthroplasty 
patients is an important finding. Young patients may be self-evidently considered physically 
active. This may therefore restrict their access to knee arthroplasty because of the fear of 
compromised implant survival. A recent study by Keeney et al. showed that preoperatively 
there was no difference in physical activity levels between younger (55 years or less) and 
older patients (65 to 75 years), and that physical activity increased in both groups after knee 
arthroplasty (Keeney et al. 2014). In study IV, only 42 (17%) patients reported a preoperative 
activity level of over 50% according to the HAAS scale. Respectively, the preoperative 
physical activity level points were less than 50% when also measured with the KOOS (93% 
of patients) and SF-36 (76% of patients) subscales. However, significant improvement was 
seen in physical activity postoperatively in the HAAS as well as in the KOOS and SF-
36 physical activity subscales. Thus, in younger patients, the ability to exercise can also be 
improved with knee arthroplasty.
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Weiss et al. reported that patients undergoing TKA consider climbing stairs, the ability 
to walk, and kneeling to be especially important activities in their daily living (Scott et 
al. 2012). Because the preoperative physical activity of patients undergoing TKA has been 
shown to be low, more demanding activities, such as cycling or carrying heavy objects, have 
not been so important for them (Weiss et al. 2002b). 
In the working-age population, functions related to daily living are associated with 
working capability. In our study, 104 (45%) patients had retired or were about to retire 
preoperatively. Of the 128 (55%) patients who were working preoperatively, a high 
proportion (89%) returned to work during the 2-year follow-up period, and significant 
improvements in scores related to daily living supported this finding.
6.3.5 Quality of life
Changes in quality of life are based on both physical and mental improvements and are 
also related to pain relief. Even if physical scores improved more distinctly, it is notable that 
mental scores also improved significantly after knee arthroplasty. The Mental Component 
Score (MCS) of RAND 36 showed comparable improvement with the Physical Component 
Score (PCS) of RAND 36, emphasizing a comprehensive improvement in outcomes. 
Previously, Goh et al. also reported significant, albeit slightly smaller, improvements in 
these scores than the scores we found in the present study (PCS 16.9 vs 31.5 and MCS 4.4 
vs 17.5) (Goh et al. 2016b).
6.3.6 UKA
In study IV, UKA and TKA yielded similar results. Thus, the theoretical advantages of 
UKA over TKA (Mohammad et al. 2017) did not result in better clinical outcome in any of 
the PROMs used or higher satisfaction. This finding warrants further research, and future 
work should compare the outcome and effectiveness of UKAs and TKAs in randomized 
controlled trials.
6.3.7 Strengths and limitations of the study (study IV)
The obvious strength of the current study was the evaluation of the outcomes using multiple 
PROM data that have not been included in previous studies and a non-selected real-world 
cohort of patients. In addition, only a very small proportion (7%) of patients was lost to 
follow-up during the 2-year study period. Our study is also the first to evaluate the real-
world effectiveness of TKA and UKA in younger patients utilizing a wide set of PROMs. 
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This approach showed that satisfaction is clearly a multidimensional issue that may not be 
adequately assessed with a single question about satisfaction. 
A limitation is that study IV did not include a specific control group of patients above 
the age of 65 that would have enabled the comparison of our results with those of the older 
patient population. The UKA group was also markedly smaller than the TKA group.
6.3.8 Effect of LIA on PROMs
There have not been any studies that analyze the influence of infiltration analgesia on 
the functional outcome in at least 1-year follow-up. One previous study with 3- months 
follow-up found no difference in functional outcomes between placebo and drug 
infiltration groups measured with TUG test, OKS, or EQ5D (Essving et al. 2010). We 
found minor differences in functional outcomes as measured with the 15D, HAAS, and 
OKS instruments, but the clinical relevance of these findings is questionable, and the only 
significant finding was in 1 TKFQ subscale. The TKFQ scoring system has many subscales 
indicating different functional capabilities. The only statistically significant difference was 
observed at 12 months (sitting for a long period of time) but this was not evident earlier. 
Any statistical difference between groups in this TKFQ subscale probably occurred by 
chance, without any relation to LIA. Murray et al. concluded that the minimal clinically 
important difference (MCID) in OKS is expected to be between 3 and 5 points (Murray et 
al. 2007b). In our data, the difference in mean values in OKS at 1-year between the groups 
was 3 points, but this difference was not statistically significant.
6.3.9 Strengths and limitations of the study (study V)
The strength of study V was the 1-year follow-up and randomized set-up with study cohort. 
The limitation was that the length of hospital stay between groups was not measured. 
Effective postoperative pain relief might have allowed a shorter length of hospital stay. 
Moreover, the plasma concentrations of the infiltration drugs were also not measured. 
However, none of the patients suffered any identified side effects during the 1-year follow-
up period. 
6.4 Future considerations
Even if mechanisms in the etiology of OA have studied more thoroughly and new treatments 
are tested, the knee arthroplasty will be significant option for end stage symptomatic knee 
OA in the future. As knee OA and also knee pain in general are multidimensional issues, the 
treatment of these should be based on the healthy lifestyle and moderate physical activities, 
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which may help to control the associated problems e.g. increasing obesity. The lower grade 
knee OA is associated with lower outcomes and dissatisfaction after knee arthroplasty. This 
may be associated with both multifactorial reasons causing knee pain and insufficient effect 
of operative treatment to manage the whole spectrum of symptoms which may derive e.g. 
from the phase of the inflammatory cascade of knee arthritis or from degenerative meniscal 
tear which is commonly related to low grade OA. The correct timing of knee arthroplasty 
seems to be critical for desirable outcome and information on realistic effect and increase 
of outcomes may help for correct timing of knee arthroplasty. As the survivorship of 
TKAs has shown to be acceptable, this has led to broaden the indication towards younger 
patients. The age do not seems to be a limitation for acceptable outcome of TKA when OA 
is at end-stage. The risk of revision is associated with younger age in registers and this will 
probably be shown as increasing number of re-operations in the future both for increasing 
number of primary TKAs, longer time of living and desire to continue physical activities 
in younger TKA patients. Early reasons for revision are commonly related to comorbidities 
and treatment of diseases like diabetes and related obesity may decrease early revisions. 
Wear-related late reasons for revision are commonly shown as aseptic loosening and for this 
reason the surface between bone and implant should resist both the shearing forces from 
the movement of joint and depris burden from the polyethylene insert. All fixation methods 
have shown comparable and acceptable survivals and the use of uncemented TKAs may 
increase in some extend in younger patients with good bone quality in the future, especially 
if costs of uncemented implants will decrease near the cemented implants. Concerning 
UKAs, survivorships between cemented and uncemented have reported to be equal, which 
may guide the use towards uncemented implants because of lower time of operation and 
more convenient operative technic. Still obvious advantage of UKA compared to TKA 
remains controversial because of increased risk of revision of UKA compared to TKA and 
comparable functional outcomes with both systems.
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7 Conclusions
Study I
The incidence of knee arthroplasties continuously increased in the 4 Nordic countries over 
the study period. This increase was caused by an increase in the incidence of TKAs, whereas 
the incidence of UKAs varied between countries. The proportional increase in incidence 
was highest in patients aged younger than 65 years. Patients aged 65 years or older still 
comprise the majority of patients undergoing knee arthroplasty and are therefore the main 
contributor to the increase in the total number of TKA operations. Because of the trend 
of increasing incidences in younger age groups, the impact of this trend may be reflected in 
the revision burden in the future.
Study II
All four TKA fixation methods used in working-age patients showed reliable mid-term 
outcomes in terms of good implant survivorship. Cemented TKA still deserves the status 
of gold standard in TKA irrespective of the patients’ age: it works very reliably in the hands 
of many. Hybrid and inverse hybrid fixations are promising alternatives, but more research 
with larger patient numbers and longer follow-up are needed to see whether they really 
endure the test of time as well as cemented fixation.
Study III
Uncemented porous tantalum monoblock tibial components achieved excellent mid-
term survivorship in this Finnish Arthroplasty Register-based study. Early loosening of 
the uncemented tibial component was rare, and PJIs were as rare as with contemporary 
cemented TKAs.
Study IV
We found that knee arthroplasty provided patients aged 65 years or less with clinically 
significant pain relief as well improvements in ADL and quality of life. TKA and UKA had 
comparable outcomes. The patients´  physical activity was low or moderate preoperatively but 
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improved significantly during the 2-year follow-up. Some pain and functional deficiencies 
remained after knee arthroplasty, and this should be emphasized in the preoperative 
guidance given to patients who are considering or who are scheduled for such surgery. Mild 
radiographic OA preoperatively is a clear risk factor for patient dissatisfaction with the 
outcome of knee arthroplasty.
Study V
This study showed that a single perioperative infiltration of levobupivacaine, ketorolac, 
and adrenaline reduced opiate consumption until 48 hours after TKA. The effect was the 
most emphasized during the first 6 hours but persisted to some extend up to 24 hours. LIA 
also improved the early knee ROM, but no long-term functional benefits were observed in 
PROMs during 1-year follow-up.
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Background and purpose — The annual number of total knee 
arthroplasties (TKAs) has increased worldwide in recent years. 
To make projections regarding future needs for primaries and 
revisions, additional knowledge is important. We analyzed and 
compared the incidences among 4 Nordic countries
Patients and methods — Using Nordic Arthroplasty Register 
Association (NARA) data from 4 countries, we analyzed differ-
ences between age and sex groups. We included patients over 30 
years of age who were operated with TKA or unicompartmental 
knee arthroplasty (UKA) during the period 1997–2012. The nega-
tive binomial regression model was used to analyze changes in 
general trends and in sex and age groups.
Results — The average annual increase in the incidence of TKA 
was statistically signiﬁ cant in all countries. The incidence of TKA 
was higher in women than in men in all 4 countries. It was high-
est in Finland in patients aged 65 years or more. At the end of the 
study period in 2012, Finland’s total incidence was double that 
of Norway, 1.3 times that of Sweden and 1.4 times that of Den-
mark. The incidence was lowest in the youngest age groups (< 65 
years) in all 4 countries. The proportional increase in incidence 
was highest in patients who were younger than 65 years.
Interpretation — The incidence of knee arthroplasty steadily 
increased in the 4 countries over the study period. The differences 
between the countries were considerable, with the highest inci-
dence in Finland. Patients aged 65 years or more contributed to 
most of the total incidence of knee arthroplasty.
■
Total knee arthroplasty (TKA) for severe osteoarthritis (OA) 
has good long-term outcomes, and gives greater pain relief 
and better functional improvement than non-surgical treat-
ment (Carr et al. 2012, Skou et al. 2015). Good long-term 
implant survivorship has resulted in TKA also becoming a 
treatment for severe knee OA in younger patients, although 
outcomes and implant survivorship have been reported to be 
worse than in elderly patients (Lonner et al. 2000, Rand et al. 
2003, Price et al. 2010, Julin et al. 2010).
Reported increases in the rate of TKA and estimates of 
future demand predict a substantial increase in the incidence 
of TKA in many countries (Jain et al. 2005, Kurtz et al. 2007, 
Kim et al. 2008, Culliford et al. 2010, W-Dahl et al. 2010a, 
Nemes et al. 2015). Both the broadening of indications for 
younger patients and the increase in total incidence of TKA 
have raised concerns of a possible increase in revision burden 
in the long term (Kurtz et al. 2007, Gioe et al. 2007). Dif-
ferences between geographic locations and age groups have 
been noted in the incidences of TKA (Katz et al. 1996, Wells 
et al. 2002). The major increase in the incidence of TKA has 
been found in people born in the period 1946–1964 (the baby-
boomer generation) (Leskinen et al. 2012).
The aim of this study was to analyze trends in the incidence 
of TKA and unicompartmental knee arthroplasty (UKA) using 
Nordic Arthroplasty Register Association (NARA) data from 
between 1997 and 2012, to identify any changes or differences 
in (or between) age groups, the sexes, and countries.
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Patients and methods
The NARA compiles data on 4 Nordic countries that have sim-
ilar organization of healthcare and comparable patient charac-
teristics (Table 1). The NARA has information on the TKAs 
and UKAs performed in Denmark, Norway, and Sweden from 
1997 through 2012 and in Finland from 2000 through 2012.
The knee arthroplasty registries of Sweden (SKAR) and 
Denmark (DKR) and the arthroplasty registries of Norway 
(NAR) and Finland (FAR) participated in the present study. 
All 4 registries have used individual-based registration of 
operations and patients. A minimal NARA dataset was cre-
ated to contain data that all 4 registries could deliver, but for 
administrative reasons the Finnish Arthroplasty Register has 
been able to provide Finnish data according to the NARA data 
deﬁ nitions from the beginning of 2000. A pilot study carried 
out from NARA data did not include FAR data and it did not 
have an age cutoff (Robertsson et al. 2010). The NARA data-
base includes data on the patients that enable TKA and UKA 
incidence analyses, i.e. patient-level data on both demograph-
ics and implant types.
Selection and transformation of the respective datasets and 
de-identiﬁ cation of the patients, which included deletion of 
the national civil registration numbers, were performed within 
each national register. The anonymous data were then merged 
into a common database. Because of the small number of 
patients aged 30 years or less who were operated, in the pres-
ent study we only included patients aged 30 years or more 
who had undergone a TKA or UKA surgical procedure due to 
primary osteoarthritis of the knee.
The data were treated with full conﬁ dentiality, according 
to the regulations of the respective countries. This included 
restricted access to the common database, which was limited 
to the authors of the present paper. The quality of data in the 
Nordic registries is high, and the registries have both national 
coverage and a high degree of completeness (annual reports 
2015: Danish Knee Arthroplasty Register, Norwegian Arthro-
plasty Register, Swedish Knee Arthroplasty Register, Finnish 
Arthroplasty Register) (Arthursson et al. 2005, Espehaug et 
al. 2006).
of TKAs and UKAs in Denmark, Norway, and Sweden from 
1997 to 2012 and in Finland from 2000 to 2012. The inci-
dence was calculated as incidence density, which is deﬁ ned 
as the number of new cases in a population during a given 
time period relative to the sum of the person-time values of 
the at-risk population. Negative binomial regression was used 
to estimate the incidence rate ratios (IRRs) and the 95% con-
ﬁ dence intervals (CIs) of UKAs and TKAs for each country 
because of evidence of overdispersion of data. IRR reports 
the estimated average annual increase of incidence. Analyses 
were stratiﬁ ed by sex and age group. The statistical analyses 
were conducted with SPSS 22.0 and Stata 8.2 software.
Results
Patient characteristics
385,310 primary knee arthroplasties were registered in the 
4 countries during the study period. During this period, we 
observed an increase in OA from 84% to 90% and simultane-
ously a decline in rheumatoid arthritis from 10% to 4% as 
indication for knee arthroplasty. Of these operations, 317,008 
TKAs and 27,687 UKAs were performed for knee OA in 
patients aged 30 years or more. Female patients represented 
202,940 (64%) of the TKA cases and 15,778 (57%) of the 
UKA cases. The mean age of the patients was 70 years (SD 
9.0) in the TKA group and 65 years (SD 9.4) in the UKA 
group (Table 1). 
Incidence of knee arthroplasty (TKA and UKA)
In all 4 countries, the incidences of knee arthroplasty increased 
during the study period (Figure 1). At the beginning of the 
study, the incidences were 3.4 in Denmark, 3.6 in Norway, 9.0 
in Sweden, and 13 in Finland per 10,000 population. At the 
end of the study, the incidences were 21 in Denmark, 14 in 
Norway, 21 in Sweden, and 28 in Finland per 10,000 popula-
tion. The relative change in incidence of knee arthroplasty was 
6.0-fold in Denmark, 3.9-fold in Norway, 2.3-fold in Sweden, 
and 2.1-fold in Finland from the start of the study to the end. 
Table 1. Patient characteristics. Mean age applies to both TKA and UKA. The number of 
operations has been divided into age groups. Study period 1997–2012, except for Finland 
(2000–2012)
    Denmark Norway Sweden Finland Total
Mean age (SD) 69.0 (9.5) 69.7 (9.2)   69.8 (9.0) 69.0 (9.0) 
Females, % 63 66   60 68 
UKA (n)   5,395   5,054   12,956   4,282 
Age groups, n (%)     
 30–64 21,624 (33) 12,872 (31)   42,084 (30) 30,264 (31) 106,844
 65–74 24,577 (38) 15,751 (37)   53,492 (39) 38,305 (39) 132,125
 75+ 18,587 (29) 13,412 (32)   43,403 (31) 30,324 (31) 105,726
Total 64,788 42,035 138,979 98,893 344,695
Ethics
Ethical approval for the study was 
obtained through the ethical approval 
process of each national registry.
Statistics
We described patient characteristics, cat-
egorized into sex and age groups, using 
descriptive statistics presented as mean 
and standard deviation (SD). Incidences 
are presented as the number of opera-
tions performed per 104 of population. 
Age was categorized into 3 groups: < 65 
years, 65–74 years and ≥ 75 years. We 
analyzed trends in the general incidence 
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The relative change in incidence of UKA was 10-fold in 
Denmark, 1.5-fold in Finland, 7.1-fold in Norway, and 0.5-
fold in Sweden from the start of the study to the end.
During the study period, the estimated average annual 
increase in the incidence of TKA by age groups and sex was 
statistically signiﬁ cant in all countries, with the exception 
of Finnish females aged 65–74 years (IRR = 1.02, 95% CI: 
1.00–1.03) (Table 2). IRR was highest in the youngest age 
group in both sexes and a decreasing trend was detected as 
age increased. Females had lower IRRs, except in Denmark in 
patients aged 65–74 years. A statistically signiﬁ cant decrease 
in UKAs was detected in Sweden in patients who were 65 
years or more, whereas in Denmark and in Norway there was 
a signiﬁ cantly higher annual incidence of  UKA in all age 
groups—except for UKAs in women aged 75 years or more in 
Norway. There was no signiﬁ cant change in the annual inci-
dence of UKA over the study period in Finland, in men or 
women of any age group (Table 2).
Incidence by sex
The incidences of TKA according to sex are shown in Fig-
ures 2 and 3. The incidence was higher in women than in men 
in all 4 countries. At the end of the study period, the inci-
dences of TKA were 9.1 in Denmark, 11.0 in Norway, 18.2 
in Sweden, and 20.9 in Finland per 10,000 men—giving a 
relative change of 4.2-fold in Denmark, 5.9-fold in Norway, 
2.8-fold in Sweden, and 2.7-fold in Finland from the start of 
the study to the end. In women, the incidences of TKA were 
22.6 in Denmark, 15.7 in Norway, 22.5 in Sweden, and 32.8 
in Finland per 10,000 women at the end of the study, and the 
relative change was 5.2-fold in Denmark, 3.1-fold in Norway, 
2.4-fold in Sweden, and 1.9-fold in Finland from the start of 
the study to the end.
The incidence of UKA was higher in Sweden in both men 
and women at the start of the study than at the end of the study, 
whereas in the other 3 countries the incidence of UKA was 
higher at the end of the study than at the start of the study 
(Figures 4 and 5).
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Figure 1. Total incidence of TKA and UKA by 
year of operation in patients aged 30 years or 
more. Incidences are shown per 10,000 inhab-
itants. The incidence in Denmark is estimated 
to include 10–15% underestimation between 
1997 and 2007 due to lower completeness.
Figure 2. Incidence of TKA in males aged 
30 years or more. Incidences are shown per 
10,000 inhabitants.
Figure 3. Incidence of TKA in females aged 
30 years or more. Incidences are shown per 
10,000 inhabitants.
Table 2. Negative binomial regression analysis. Incidence rate ratios 
(IRRs) with 95% conﬁ dence intervals
 Arthroplasty Male Female 
         Age, years IRR 95% CI IRR 95% CI
Denmark
 TKA 30–64 1.17 1.14–1.19 1.15 1.13–1.17
 UKA 30–64 1.26 1.20–1.32 1.24 1.17–1.30
 TKA 65–74 1.08 1.04–1.13 1.12 1.10–1.13
 UKA 65–74 1.25 1.18–1.31 1.20 1.16–1.24
 TKA 75+ 1.12 1.10–1.13 1.10 1.08–1.12
 UKA 75+ 1.20 1.14–1.26 1.14 1.11–1.17
Norway 
 TKA 30–64 1.16 1.14–1.18 1.13 1.12–1.15
 UKA 30–64 1.13 1.07–1.19 1.11 1.05–1.18
 TKA 65–74 1.11 1.10–1.13 1.08 1.07–1.09
 UKA 65–74 1.12 1.08–1.16 1.07 1.01–1.13
 TKA 75+ 1.09 1.08–1.10 1.06 1.04–1.07
 UKA 75+ 1.09 1.05–1.14 1.02 0.96–1.06
Sweden 
 TKA 30–64 1.15 1.13–1.16 1.13 1.11–1.14
 UKA 30–64 1.02 0.99–1.05 1.00 0.98–1.02
 TKA 65–74 1.07 1.06–1.09 1.05 1.04–1.07
 UKA 65–74 0.93 0.92–0.94 0.91 0.90–0.92
 TKA 75+ 1.07 1.06–1.08 1.05 1.04–1.05
 UKA 75+ 0.90 0.89–0.91 0.88 0.87–0.89
Finland 
 TKA 30–64 1.13 1.11–1.16 1.11 1.09–1.14
 UKA 30–64 10.5 0.99–1.11 1.02 0.95–1.09
 TKA 65–74 1.04 1.02–1.06 1.02 1.00–1.04
 UKA 65–74 0.99 0.91–1.06 0.96 0.92–1.00
 TKA 75+ 1.04 1.03–1.06 1.03 1.01–1.05
 UKA 75+ 0.99 0.92–1.06 0.95 0.90–1.00
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Incidence by age group
The incidence of TKA was highest in Finland in patients aged 
65 years or more. The total incidence was lowest in the young-
est age group in all countries. The incidence was higher at the 
start of the study than at the end in all age groups (Figure 6).
Discussion
We found that the total incidence, comprising both TKAs and 
UKAs, increased in all countries and the trends of increase 
were comparable between countries. The increase in surgical 
procedures in Finland from 2004 to 2006 may be explained by 
the coming into force of a new social and healthcare regulation 
that instructed hospitals to shorten patient waiting times for 
surgery. Despite having comparable socioeconomic situations 
and healthcare systems, differences in the incidence of knee 
arthroplasty between countries were notable. A pilot study 
from the NARA data tested a common dataset and reported 
results from the period 1997–2007 (Robertsson et al. 2010). 
The present study continued to analyze changes in the inci-
dence of arthroplasty until 2012, based on experience gained 
from the pilot study.
The total increase in the number of arthroplasties in all 
countries was mainly caused by an increased incidence of 
TKA. In Sweden, there was a signiﬁ cant decrease in the inci-
dence of UKA in patients aged 65 years or more. In 3 other 
countries, variations in incidences of UKA between groups 
were more heterogeneous (Table 2, Figures 4 and 5). The rea-
sons for the changes in incidence of UKA are multifactorial. 
Previous studies from national registries have affected UKA 
incidences, as most registries show higher overall revision 
rates of UKAs than of TKAs (Furnes et al. 2007, Koskinen et 
al. 2008, W-Dahl et al. 2010b). However, there have also been 
studies claiming better clinical outcome from UKA and also 
more cost-effectiveness (Slover et al. 2006, Lygre et al. 2010). 
Different UKA implant models with a longer learning curve 
compared to TKA, indications for primary UKA surgery, and 
a higher revision risk than with TKA may explain the differ-
ences in the incidence compared to TKA. The increase in the 
incidence of UKA in patients less than 65 years of age may 
be explained by the increase in minimally invasive surgery 
(MIS), which enables a shorter postoperative stay in hospital.
The 4 countries had comparable populations with regard to 
age and sex, and therefore instead of age-standardized data we 
analyzed incidence between age groups. Of the 3 age groups, 
patients less than 65 years of age had the lowest incidence of 
TKA. However, the relative increase in incidence was higher 
in that age group than in the other age groups. In recent years, 
it appears that the indications have widened to include younger 
patients, which has resulted in a proportionally higher increase 
in incidence in patients less than 65 years of age, compared to 
patients aged 65 years or less (Robertsson et al. 2010, Leski-
nen et al. 2012). Before this, knee arthroplasty surgery was 
initially reserved for elderly patients and those with severe 
disease (Robertsson et al. 2014), and younger patients with 
rheumatoid arthritis. The reasons for increasing incidence 
in younger TKA patients may be multifactorial. Increasing 
obesity in young people (Kautiainen 2005, Lohmander et al. 
2009), participation in contact sports (Driban et al. 2015), and 
the introduction of fast-track surgery (which suits younger 
patients well) are probable reasons.
The present study had some strengths and limitations. The 
major strength was the unique collaboration of 4 national reg-
istries in the creation of a multinational database covering a 
large number of patients, which enabled international com-
parisons to reveal possible differences and which might help 
to estimate future demands. Furthermore, the completeness 
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Figure 4. Incidence of UKA in males aged 
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and validity of data were high in the Nordic countries at the 
end of the study period (completeness, NAR: 95%; SKAR: 
97%; DKR: 97%; FAR: 96%) (annual reports 2015: Danish 
Knee Arthroplasty Register, Norwegian Arthroplasty Regis-
ter, Swedish Knee Arthroplasty Register, Finnish Arthroplasty 
Register). Completeness in the DKR was reported to be 89% 
in 2007 (Robertsson et al. 2010), which may have caused 
10–15% underestimation of incidence in Denmark over the 
period 1997–2007. Total relative change in incidence was 
highest in Denmark, and that may have been due to the inﬂ u-
ence of a lower completeness for the DKR in the early years 
of the study period (Table 3). The lack of data on BMI and 
other subgroups could also be considered a limitation of the 
present study.
The incidence of TKA steadily increased in all participat-
ing countries in this study, which is in line with ﬁ ndings from 
other studies (Kurtz et al. 2007, W-Dahl et al. 2010a, Leskinen 
et al. 2012). The incidence of knee arthroplasty in females was 
found to be greater than that in males in our study, but the 
results of previous studies have also shown that the propor-
tion of female patients has decreased with time (Nemes et al. 
2015). Moreover, the sex distribution may also vary between 
nations (Paxton et al. 2011, Nemes et al. 2015). One study 
delivered projections for primary and revision hip and knee 
arthroplasty in the United States from 2005 to 2030 (Kurtz 
et al. 2007). In that study, the authors predicted that if the 
number of total knee arthroplasties performed continues at the 
current rate, the demand for primary TKA would be projected 
to grow by a factor of 7 by 2030. In another previous study 
from the Finnish Arthroplasty Registry, the annual cumulative 
incidence of UKA and TKA increased rapidly between 1980 
and 2006, especially in patients aged 50–59 years, the so-
called baby-boomer generation (Leskinen et al. 2012). In our 
study, the increase in incidence was mainly due to the increase 
in incidence of TKAs. This ﬁ nding is consistent with a study 
by W-Dahl et al. (2010a) from the Swedish Knee Arthroplasty 
Register, which showed that although the incidence of TKA 
has increased in patients under 55 years of age, the incidence 
of UKA and high tibial osteotomy (HTO) has decreased. Obe-
sity is also a growing burden in many countries and, as this has 
been shown to be a certain risk factor for knee osteoarthritis, 
especially in young patients, it may contribute to the increas-
ing demand for TKAs in future (Apold et al. 2014a, b, Silver-
wood et al. 2015).
A previous study has raised concerns about the long-term 
outcome of TKAs and the possibility of an increasing revision 
burden, because younger age has been associated with a higher 
risk of early periprosthetic joint infection and aseptic mechan-
ical failure after TKA (Meehan et al. 2014). In another study, 
young age was found to impair the prognosis of TKA and was 
associated with increased revision rates for non-infectious rea-
sons (Julin et al. 2010). A comparison study undertaken by the 
Norwegian Knee Arthroplasty Register and a United States 
arthroplasty registry showed an increased risk of revision in 
patients less than 65 years of age compared to patients aged 
65 years or older (Paxton et al. 2011). In our study, the pro-
portional growth of TKAs during the study period was highest 
in patients who were younger than 65 years. Despite this, the 
incidence of knee arthroplasty in the youngest age group was 
lower than in patients aged 65 years or more. Based on this 
ﬁ nding, the majority of knee arthroplasties will probably be 
performed on elderly patients in the future also. Even though 
patients less than 65 years old represented a lower incidence 
level than patients who were 65 or older in our study, these 
working-age patients should be considered to be an important 
subgroup because of their higher physical activity and higher 
demands for surgery, and the multifactorial reasons behind the 
success of TKA (Keeney et al. 2014, Klit et al. 2014, Parvizi 
et al. 2014). An effect on the revision burden can therefore be 
anticipated in future.
In summary, the incidence of knee arthroplasty has steadily 
increased in the 4 Nordic countries. This increase was caused 
by an increase in the incidence of TKA, whereas the incidence 
of UKA varied between countries. The proportional increase 
in incidence was highest in patients aged less than 65 years. 
However, patients who are 65 years or more still comprise the 
majority of those who undergo knee arthroplasty, and they are 
the main contributory factor to the increase in the total number 
of TKA operations.
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Abstract 25 
Background Cemented fixation is regarded as gold standard in total knee arthroplasty (TKA). 26 
Among working age patients, there has been controversy regarding the optimal fixation method in 27 
TKA. To address this issue, we conducted a register-based study to assess the survivorship of 28 
cemented, uncemented, hybrid and inverse hybrid TKAs in patients aged < 65 years.  29 
Methods We used the Nordic Arthroplasty Register Association data of 115 177 unconstrained 30 
TKAs performed for patients aged < 65 years with primary knee osteoarthritis over 2000-2016. 31 
Kaplan-Meier (KM) survival analysis with 95% confidence intervals (CI) and Cox multiple-32 
regression model with adjustment for age, sex, and nation were used to compare fixation methods in 33 
relation to revision for any reason. 34 
Results The 10-year KM survivorship of cemented TKAs was 93.6% (CI 93.4-93.8), uncemented 35 
91.2% (CI 90.1-92.2), hybrid 93.0% (Cl 92.2-93.8) and inverse hybrid 96.0% (CI 94.1-98.1). In the 36 
Cox model, hybrid TKA showed decreased risk of revision after 6 years’ follow-up compared to the 37 
reference group (cemented) (hazard ratio (HR) 0.5 (CI 0.4-0.8)), while uncemented TKAs showed 38 
increased risk of revision both <1 year (HR 1.4 (1.1-1.7)) and > 6 years’ (HR 1.3 (1.0-1.7)) follow-39 
up compared to the reference. 40 
Interpretation Both cemented and hybrid TKAs had 10-year survival rates exceeding 92% in 41 
patients aged < 65 years. Cemented TKA, however, was used in vast majority (89%) of the 42 
operations in the current study. As it performs reliably in the hands of many, it still deserves the 43 
status of gold standard in TKA in working age patients. 44 
 45 
 46 
47 
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Introduction 48 
Previous studies reported both highest increase in incidence of TKAs and also highest risk for 49 
revision in patients younger than 65 years of age (Julin et al. 2010, Carr et al. 2012, Leskinen et al. 50 
2012, Meehan et al. 2014, Nemes et al. 2015, Niemelainen et al. 2017). This has increased the 51 
interest to find a more durable fixation method for TKA. A previous systematic review did not 52 
report any differences in survival or functional outcome between cemented and uncemented TKAs 53 
in patients aged 60 years or less (Franceschetti et al. 2017). A meta-analysis without age limit 54 
showed better survival rates with cemented TKAs when all studies were combined, but in 55 
randomized studies survivals were equivocal (Gandhi et al. 2009). Uncemented fixation in TKA has 56 
offered comparable outcomes with cemented TKA in a few studies, but higher costs of uncemented 57 
components have favored cemented TKA still as gold standard (Dalury. 2016, Miller et al. 2018, 58 
Zhou et al. 2018).  59 
A previous study applying radiostereometric analysis (RSA) showed that early migration seen with 60 
uncemented tibial components settled until 2 years whereas cemented ones continued to migrate 61 
(Wilson et al. 2012, Henricson and Nilsson 2016). So far, the use of uncemented TKAs has been 62 
limited. Previous studies have reported an increased risk for aseptic loosening of the tibial 63 
component in patients treated with uncemented TKA (Bassett. 1998, Duffy et al. 1998, Berger, 64 
Lyon et al. 2001, Goldberg and Kraay. 2004, Carlsson et al. 2005), but due to evolvement of 65 
designs and materials uncemented fixation has become an interesting choice especially for younger 66 
patients with good bone quality (Hu et al. 2017). Trabecular metal (TM) has showed promising 67 
results in both register and clinical studies (Niemelainen et al. 2013, Henricson et al. 2013, Pulido et 68 
al. 2015). Although differences have been observed between different fixation concepts in terms of 69 
revision rates, functional outcomes have been equivalent irrespective of the fixation method 70 
(Gandhi et al. 2009, Gao et al. 2009, Demey et al. 2011, Arnold et al. 2013). The most optimal 71 
fixation method in TKA still remains controversial for these younger patients.  72 
 4 
 
We assessed survivorships of 4 different fixation methods (cemented, uncemented, hybrid, and 73 
inverse hybrid) in patients younger than 65 years of age based on the Nordic Arthroplasty Register 74 
Association (NARA) database. 75 
Materials and methods 76 
We included all uni- or bilateral unconstrained primary TKAs that had been implanted in patients 77 
aged less than 65 years for primary OA over 2000-2016 (Figure 1). Previous reports have shown 78 
that the effect of including bilateral cases in studies of hip and knee joint prosthesis survival is 79 
negligible (Robertsson and Ranstam. 2003, Lie et al. 2004). The Swedish Knee Arthroplasty 80 
Register (SKAR), The Danish Knee Arthroplasty Register (DKR), The Norwegian Arthroplasty 81 
Register (NAR) and The Finnish Arthroplasty Register (FAR) participated in the study. The Nordic 82 
Arthroplasty Register Association (NARA) compiles data on 4 Nordic countries that have similar 83 
health care organizations and comparable patient characteristics (Robertsson et al. 2010). A NARA 84 
minimal dataset was created to contain data that all 4 registers could deliver (NARA report 2016). 85 
The NARA dataset includes 20 different main variables and in total 90 variables. All registers use 86 
individual-based registration of operations. Selection and transformation of the respective data sets 87 
and de-identification of the patients, which included the deletion of the personal identity numbers, 88 
were performed within each national register. The anonymous data were then merged into a 89 
common database. Data were treated with full confidentiality, according to the rules of the 90 
respective countries. The quality of data in the Nordic registers is high, including both 100% 91 
coverage and following completeness: SKAR 97%, DKR 97%, NAR 97%, FAR 96% (NARA 92 
report 2016) (Espehaug et al. 2006). The fixation of TKAs was divided into 4 groups: 1) cemented, 93 
2) uncemented, 3) hybrid (uncemented femur with cemented tibia), and 4) inverse hybrid (cemented 94 
femur with uncemented tibia). 95 
Statistics 96 
 5 
 
We assessed the descriptive statistics of the patients included. The inclusion time period was 2000-97 
2016. We used Kaplan-Meier (KM) survival analysis to assess implant survival probability (with 98 
respective 95% confidence interval (CI)) of the TKA fixation at 10 and 15 years. The results in 99 
Tables and Figures were not shown when less than 40 knees were at risk. Outcome was defined as 100 
removal, addition or exchange of at least one of the components, including polyethylene insert 101 
exchanges of modular tibial components, for any reason. 102 
We used Cox regression analysis to estimate hazard ratios associated to implant survival. Covariates 103 
included in the analysis were fixation type, sex, country and age. Age was included as a continuous 104 
variable whereas the others were categorical. Correlation of scaled Schoenfeld residuals with time 105 
was examined to investigate violation of proportional hazard (PH) assumption. Log-log survival 106 
curves were also inspected visually to see if assumption was met. We detected multiple violations 107 
of PH assumption. In order to deal with PH violation, we used time dependent coefficients (fixation, 108 
age, sex and nation) using step function. Based on the log-log curves cut-offs were set as follows: 1, 109 
3 and 6 years. We did stratified analyses based on age and implant brand group and similar time 110 
axis division was made according to log-log curves and residual testing. For the time dependent 111 
coefficients the data was broken into time dependent parts according to the time intervals used in 112 
the time axis division. For each final analysis the PH test investigating Schoenfeld residuals was 113 
performed. 114 
Statistical analyses were performed using R 3.5.2, survival package (R Foundation, Vienna). 115 
Ethics 116 
Ethical approval for the study was attained through the ethical approval process of each national 117 
registry: the Ethics Board of Lund University (LU20-02) (Sweden), the National Institute of Health 118 
and Welfare (Dnro THL/1743/5.05.00/2014) (Finland), the Norwegian Data Inspectorate (ref 119 
24.1.2017: 16/01622-3/CDG) (Norway) and the Danish Data protection agency (1-16-02-54-17) 120 
(Denmark). 121 
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Results 122 
The mean follow-up time standard deviation (SD) was 6.4 (4.3) years for cemented TKA, 4.7 (3.4) 123 
years for uncemented TKA, 6.0 (4.3) years for hybrid TKA and 6.1 (3.2) years for inverse hybrid 124 
TKA. There were slight differences in the proportion of men between the fixation groups, ranging 125 
from 40% in cemented to 44% in uncemented group (Table 1). TKA models varied between 126 
countries without a common trend and the most commonly used TKA models in the participating 127 
countries are showed in the Appendix 1. Nexgen®, PFC® and Triathlon® were the most commonly 128 
used models within the fixation concepts (Appendix 2). The number of TKAs performed annually 129 
grew substantially over 2000-2009, and remained rather stable after that; cemented fixation was 130 
used in vast majority of TKAs over the whole study period (Figure 2). Altogether, cemented 131 
fixation was used in 89 % of all TKAs, and uncemented in 5.3%, hybrid in 5.5% and inverse hybrid 132 
in 0.5%, respectively. Patella was resurfaced in 24 487 TKAs (21%) and uncemented patellar 133 
buttons were used in only 151 (0.1%) TKAs. In the subgroup of Nexgen® TKAs, patella was 134 
resurfaced in 5821 (22%) TKAs, and an uncemented patellar button was only used in 2 knees (both 135 
of them in cemented Nexgen group). 136 
At 15 years, KM-based survival rates were: cemented 91.3% (Cl 91.0-91.7), hybrid 91.4% (CI 90.2-137 
92.6), uncemented 88.7% (CI 87.0-90.4). For inverse hybrid only 10-year survival was available 138 
(96.0% (CI 94.1-98.1)) (Table 2, Figure 3). 139 
In the Cox regression analysis, uncemented fixation showed an increased risk of revision compared 140 
to the reference group (cemented TKA) both during the first postoperative year and also after 6 141 
years of follow-up. Hybrid fixation was associated with a decreased risk of revision compared to the 142 
cemented fixation after 6 years of follow-up. The risk of revision was similar between the inverse 143 
hybrid and the reference group (Table 4). Because of the age dependence of TKA survivorship, the 144 
additional Cox regression analyses were conducted for 2 different age groups: 55-64 years of age 145 
(Table 5) and less than 55 years of age (Table 6). In patients aged 55-64 years, risk of revision with 146 
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uncemented TKAs was increased in comparison with the cemented reference group during the first 147 
3 years of follow-up and after that similar compared to reference. Hybrid TKAs still showed a 148 
decreased risk of revision after 6 years of follow-up; a finding that was already seen in the whole 149 
study cohort (Table 5). In patients aged less than 55 years, revision risks were similar between 150 
fixation methods (Table 6). Differences between age, sex, and country were the other covariates in 151 
the Cox regression analysis and their results are listed in Appendix 4. 152 
The inverse hybrid group mainly comprised Nexgen TKAs (95% of the knees) (Appendix 2), and 153 
approximately more than 80% of the inverse hybrid Nexgen TKAs used TM monoblock tibial 154 
components (an estimate from national registers’ data). Because of the obvious risk for selection 155 
bias, we conducted an additional sensitivity analysis to diminish bias between groups. For this 156 
analysis, we only included patients operated on with Nexgen TKAs (Appendix 3). In this sensitivity 157 
analysis, survival rates of different fixations were in descending order: the inverse hybrid 96.6% 158 
(CI94.7-98.5), cemented 95.8% (CI 95.5-96.1), uncemented 93.2% (CI 91.9-94.6) and hybrid 159 
92.0% (CI 90.4-93.7) at 7 years (Table 3). In the Cox analysis of the Nexgen subgroup, increased 160 
risk of revision was found for uncemented and hybrid TKAs compared to cemented TKAs, and for 161 
inverse hybrid TKAs the risk of revision was comparable to cemented TKAs (Table 7).  162 
Discussion 163 
We found that both cemented and hybrid TKAs showed 10-year survival rates exceeding 92% in 164 
patients aged < 65 years. Even though hybrid / inverse hybrid versions of the well performing 165 
contemporary TKA designs provided younger patients with a good mid-term outcome in our study, 166 
they were still used in a limited number of patients. And especially in the inverse hybrid group, one 167 
single TKA design, with a very good track record comprised the vast majority of the whole group. 168 
It is thus safe to conclude, that cemented TKA still fulfils the most important task of a TKA: it 169 
works very reliably in the hands of many. Also, cemented TKA should still be considered as the 170 
gold standard in TKA of all OA patients irrespective of their age. 171 
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We acknowledge certain strengths and limitations in our study. The major strength of our study is 172 
the unique collaboration of 4 national registers in the creation of a multinational database 173 
comprising a high number of patients. This NARA database enables international comparisons to 174 
reveal possible differences in trends and outcomes of TKA. To our knowledge, this is the first 175 
multi-national, register-based study comparing the outcomes of all 4 fixation methods in TKA. 176 
There are also a few obvious limitations in our study. First, there were clearly less patients in the 177 
alternative fixation groups as compared to the cemented reference group (Figure 2). There are 178 
potential sources of selection bias in our data. Other concepts than cemented TKAs may have been 179 
done in higher volume units, and there may have been less preoperative bone loss or less severe 180 
deformity. On the other hand, uncemented components may have been used in patients with higher 181 
demands and also there may have been concerns about cemented fixation during operation. If the 182 
choice of fixation had been constant at hospital level in our study population, this might lower this 183 
risk of bias. Further, especially inverse hybrid fixation, but also hybrid fixation into some extent, 184 
had another obvious advantage over cemented fixation in our study setting. That is the monoblock 185 
uncemented tibial component, since wash-out procedures for infection in such knees (without 186 
exchange of any component) have not been regarded as revisions in the NARA data. Thus, due to a 187 
small number of patients and also possibility of some missing infection revisions, the results of 188 
inverse hybrids should be interpreted with caution. Further, Nexgen TKAs comprised 91% of the 189 
inverse hybrid group. This implant has been reported to have 97-99% 10-year survival rate in 190 
previous studies (Kim et al. 2012, Niemelainen et al. 2013, Robertsson et al. 2019). Further, in 191 
Finland Nexgen inverse hybrid TKAs (with TM tibial component) have been performed only in 3 192 
hospitals, 1 of which is a high-volume specialized center (Niemelainen et al. 2013). In the hybrid 193 
group, 3 TKA designs with a very good track record (PFC, Nexgen, Profix) comprised 76% of all 194 
TKAs. Second limitation is that due to the nature of the NARA dataset, we had limited number of 195 
covariates for analysis and also, we didn’t have exact information on whether some of the 196 
 9 
 
uncemented implants were hydroxide apatite coated or not. On the hip side, HA-coating does not 197 
seem to provide any added value in terms of improved survival rates (Hailer et al. 2015, Lazarinis et 198 
al. 2017), thus it most probably does not cause any bias to these TKA results. 199 
In our study, vast majority of TKAs performed for younger patients in the attending 4 Nordic 200 
countries were still cemented, and very small changes, if any, were observed in the fixation methods 201 
used over the study period (Figure 2). The same trend in general has also been reported from other 202 
national registers: Annual report 2017 of the National Joint Registry for England, Wales and 203 
Northern Ireland (NJR) reported that the proportion of all cemented TKA implants increased from 204 
82 % in 2003 to 87 % in 2016. During the same time period uncemented implants decreased from 205 
6.7% to 2.0% and hybrid implants from 2.8% to 0.4%. The same increasing trend of using 206 
cemented implants was seen in the Australian Joint Registry (AOANJRR annual report 2017). In 207 
our study, the proportion of cemented TKAs only slightly decreased from 96 % in 2000 to 91 % in 208 
2016, and a simultaneous small increase in usage of uncemented TKAs was seen (from 2.5% to 6.5 209 
%), respectively. 210 
In our study, both cemented and hybrid TKAs had up to 15-year survival rates exceeding 91% in 211 
patients aged < 65 years. Hybrid TKAs showed decreased risk of revision in comparison to 212 
cemented TKA after 6 years of follow-up. Inverse hybrid TKAs showed 96% survivorship at 10 213 
years. Uncemented TKAs had the worst 10-year survival rate (91%). These findings are in line with 214 
previous literature. In a Finnish register-based study, uncemented TKAs had 1.4 times elevated 215 
adjusted hazard ratios (HR) for revision for any reason compared to cemented TKAs (Julin et al. 216 
2010). In the AOANJRR annual report in 2017, the cumulative 10-year revision probability of 217 
minimally stabilized TKA was 4.5 (4.3, 4.6) with cemented TKA, 6.1 (5.9, 6.3) with uncemented 218 
TKA and 4.6 (4.4, 4.7) with hybrid TKAs. In The New Zealand Joint Register annual report in 219 
2017, the revision rate with patient 55-64-years old was the highest with uncemented implant: 0.84 220 
(CI 0.67-1.05) / 100 component-years compared to 0.62 (CI 0.58-0.66) / 100 component-years with 221 
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cemented implants and 0.61 (CI 0.47-0.77) / 100 component-years with hybrid implants. To our 222 
knowledge, this study is the first to compare the survivorships of all 4 different fixation concepts in 223 
TKA. 224 
In theory, younger patients might benefit from biologic fixation, i.e. bone ingrowth into uncemented 225 
implants. A meta-analysis (Gandhi et al. 2009) based on 5 RCTs and 10 observational studies with 226 
different mean ages of patients and with a minimum follow-up of 2 years, found improved survival 227 
for cemented compared to uncemented implants when revision for aseptic loosening was used as an 228 
endpoint. Another systematic review and meta-analysis (Voigt and Mosier 2011) compared 229 
hydroxyapatite-coated, porous coated and cemented tibial components. Evidence of more stable 230 
fixation after 2 years with hydroxyapatite-coated components compared to porous-coated and 231 
cemented implants was found, but revision rates at 10 year follow-up were similar. In a RCT no 232 
revision rates and survival were similar between the cemented and uncemented TKAs with mean 233 
follow-up of 15 years (Baker et al. 2007). In a systematic review of 11 RCTs to identify if there was 234 
an association between fixation method and clinical outcome, and they found that short- and long-235 
term outcomes were not influenced by fixation type (Arnold et al. 2013). In previous studies, early 236 
failures of uncemented TKAs were mainly caused by aseptic loosening of the patellar button and 237 
the tibial component (Collins et al. 1991, Bassett et al. 1998, Duffy et al. 1998, Berger et al. 2001, 238 
Barrack et al. 2004, Goldberg and Kraay. 2004, Carlsson et al. 2005). Uncemented fixation has 239 
been associated with a high failure rate due to inadequate bone ingrowth in TKAs (Lombardi et al. 240 
2007).  241 
As stated earlier, Nexgen comprised 95% of the TKAs in the inverse hybrid group, and 87% of 242 
these Nexgen TKAs had been used with TM tibial components, which are known to have good 243 
results (Niemelainen et al. 2013). We tried to tackle the obvious possibility of selection bias by 244 
conducting a sensitivity analysis including only patients with Nexgen TKAs (Tables 3 and 7). In 245 
that analysis, it appeared that there was no statistically significant difference in mid-term survival 246 
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rates or Cox-adjusted revision risks between inverse hybrid and cemented Nexgen TKAs. Further, 247 
hybrid and uncemented fixation showed an increased risk for revision in this Nexgen subgroup. 248 
Thus, the more expensive uncemented / hybrid / inverse hybrid versions did not provide these 249 
younger patients with any advantage over cemented fixation in the 10-year follow-up of Nexgen 250 
TKAs. 251 
To conclude, cemented TKA still deserves the status of gold standard in TKA irrespective of the 252 
patients’ age. In addition to age, the optimal fixation method in younger patients may be also 253 
influenced by patient´s other characteristics such as level of activity, anatomy or bone quality. Even 254 
though hybrid / inverse hybrid versions of the well performing contemporary TKA designs 255 
provided younger patients with a good mid-term outcome in our study, these results do not support 256 
systematic use of these more expensive components in TKA of younger patients. 257 
 258 
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Figure 1.  Flow chart. 266 
 267 
 268 
 269 
 270 
Figure 2. Number of operations. 271 
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 272 
 273 
Figure 3. Unadjusted Kaplan-Meier cumulative risk of revision by fixation type in patients <65 274 
years of age. 275 
 276 
 277 
 278 
 279 
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 280 
Table 1. Demographic data. 281 
 282 
Fixation concept 
  Uncemented Inverse hybrid Hybrid Cemented 
No of TKAs (%) 6 132 (5.3) 546 (0.5) 6 329 (5.5) 102 170 (88.7) 
Mean age, years (SD)  57 (5.6) 57 (5.4) 58 (5.2) 59 (4.9) 
Men, % 44 42 41 40 
Country, n of TKAs (%) 
Finland 900  (2.5) 350 (1.0) 146 (0.4) 34 406 (96) 
Norway 1 191 (8.7) 10 (0.1) 1 981 (14) 10 565 (77) 
Sweden 2 284 (5.0) 128 (0.3) 74 (0.2) 43 268 (95) 
Denmark 1 757 (8.8) 58 (0.3) 4 128 (21) 13 931 (70) 
 283 
 284 
 285 
 286 
 287 
 288 
Table 2. Unadjusted Kaplan-Meier (KM) 10- and 15-year survival rates with 95% confidence 289 
intervals (CI) are presented for uncemented, inverse hybrid, hybrid, and cemented TKA. 290 
 291 
     
Type of 
fixation 
N of 
knees 
N of 
revisions 
At risk at 
10 years 
KM-
survivorship 
(%) at 10 years 
At risk 
at 15 
years 
KM-
survivorship (%) 
at 15 years 
Uncemented 6 132 363 915 91.2 (90.1 – 92.2) 214 88.7 (87.0 – 90.4) 
Inverse Hybrid 546 16 66 96.0 (94.1 – 98.1) - - 
Hybrid 6 329 330 1 349 93.0 (92.2 – 93.8) 239 91.4 (90.2 – 92.6) 
Cemented 102 170 5 040 24 954 93.6 (93.4 – 93.8) 4 259 91.3 (91.0 – 91.7) 
 292 
 293 
 294 
 295 
 296 
 297 
 298 
 299 
 300 
 301 
 302 
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Table 3. Unadjusted Kaplan-Meier 7- and 10-year survival rates with 95% confidence intervals are 303 
presented for uncemented, inverse hybrid, hybrid, and cemented TKA in the Nexgen subgroup. 304 
 305 
     
Type of 
fixation N of knees 
N of 
revisions 
At risk 
at 7 
years 
KM-survivorship 
(%) at 7 years 
At risk 
at 10 
years 
KM-survivorship 
(%) at 10 years 
Uncemented 2 311 114 238 93.2 (91.9 – 94.6) - - 
Inverse Hybrid 497 13 185 96.6 (94.7 – 98.5) 55 96.6 (94.7 – 98.5) 
Hybrid 1 629 91 155 92.0 (90.4 – 93.7) - - 
Cemented 27 934 901 8 477 95.8 (95.5 – 96.1) 3 691 94.9 (94.6 – 95.3) 
 306 
 307 
 308 
 309 
 310 
 311 
Table 4. Cox regression with time-dependent coefficients (all patients aged <65 years included, 312 
cemented TKA as reference). 313 
 314 
  Follow-
up (yr) 
Hazard 
ration (HR) 
95% CI 
Type of fixation Uncemented < 1 1.38      1.13-1.70 
  1-3 1.14      0.97-1.35 
  3-6 0.95      0.72-1.25 
  > 6 1.32      1.00-1.73 
 Inv hybrid < 1 0.29 0.07-1.16 
  1-3 0.67 0.34-1.35 
  3-6 0.91 0.38-2.19 
  > 6 0.54 0.13-2.15 
 Hybrid < 1 1.11 0.88-1.39 
  1-3 0.94 0.78-1.12 
  3-6 1.07 0.82-1.40 
 
 
 
 
Cemented 
> 6 
 
0.54 
1.0 
0.38-0.78 
Reference 
 315 
 316 
 317 
 318 
 319 
 320 
 321 
 322 
 323 
 324 
 325 
 326 
 327 
 16 
 
Table 5. Cox regression with time-dependent coefficients in patients aged 55- 65 years. 328 
 329 
  Follow-up 
(yr) 
HR 95% CI 
Type of fixation Uncemented < 1.5 1.37 1.13-1.67 
  1.5-3 1.31 1.01-1.69 
  3-6 0.86 0.59-1.24 
  > 6 1.32 0.96-1.83 
 Inv hybrid < 1.5 0.44 0.14-1.37 
  1.5-3 0.65 0.21-2.02 
  3-6 0.88 0.28-2.75 
  > 6 0.49 0.07-3.48 
 Hybrid < 1.5 1.15 0.94-1.41 
  1.5-3 0.90 0.68-1.20 
  3-6 1.14 0.85-1.53 
 
 
 
Cemented 
> 6 
 
0.55 
1.0 
0.37-0.83 
Reference 
 330 
 331 
 332 
Table 6. Cox regression with time-dependent coefficients in patients aged < 55 years. 333 
 334 
   HR 95% CI 
     
Type of fixation Uncemented  1.10 0.91-1.32 
 Inv hybrid  0.62 0.29-1.29 
 
 
Hybrid 
Cemented 
 0.83 
1.0 
0.67-1.04 
Reference 
 335 
 336 
Table 7. Cox regression with time-dependent coefficients in patients aged < 65 years in the Nexgen 337 
subgroup. 338 
 339 
   HR 95% CI 
     
Type of fixation Uncemented  1.37 1.12-1.67 
 Inv hybrid  0.59 0.34-1.03 
 
 
Hybrid 
Cemented 
 1.47 
1 
1.16-1.87 
Reference 
 340 
 341 
Appendix 1. 342 
The 5 most commonly used TKA designs in each country 2000-2016. 343 
Norway   Sweden   Finland   Denmark  
LCS Complete 3 436  NexGen 16 734  Triathlon 12 834  PFC 6 967 
Profix 3 319  PFC 12 984  Nexgen 7 515  Nexgen 4 407 
Nexgen 3 034  AGC 3 635  PFC 5 168  AGC 3 426 
LCS 816  Triathlon 3 393  Duracon 3 995  Vanguard 2 354 
Triathlon 757  Vanguard  3 074  Vanguard 2 878  Advance 751 
 344 
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 345 
Appendix 2 346 
The 5 most commonly used TKA designs in the fixation concepts over 2000-2016. 347 
 348 
Cemented   Uncemented   Hybrid   Inverse hybrid  
Nexgen 27 948  Nexgen 2 204  PFC 2 248  Nexgen 497 
PFC 22 360  Triathlon 1 375  Nexgen 1 629  PFC 10 
Triathlon 15 664  PFC 1 221  Profix 906  Triathlon 7 
AGC 8 575  Duracon 310  Legion 363  Duracon 5 
Vanguard 8 297  Profix 235  AGC 194  Profix 5 
 349 
 350 
Appendix 3. 351 
Proportions of different fixation methods in the Nexgen subgroup during 2000-2016. 352 
 353 
 Norway  Sweden Finland  Denmark Total    % 
Cemented 2  669   15 839 6 471  2969 25 279 85 
Uncemented 187     751 698     676 2312 8 
Hybrid 177     34 5     1413 1629 5 
Inverse hybrid 1        123 341     32 497 2 
 354 
 355 
 356 
Appendix 4. Additional Cox regression covariates with time-dependent coefficients (in different 357 
age groups and the Nexgen subgroup). 358 
 359 
  Follow-
up (yr) 
HR 95% CI 
All patients aged <65 years 
Gender Women < 1 0.73 0.66-0.82 
  1-3 1.15 1.06-1.26 
  3-6 1.35 1.19-1.52 
  > 6 0.98 0.86-1.11 
Age Per year < 1 0.96 0.95-0.97 
  1-3 0.95      0.94-0.96 
  3-6 0.95      0.94-0.96 
  > 6 0.95      0.94-0.96 
Nation     
 Norway < 1 1.51 1.27-1.79 
  1-3 1.64 1.44-1.87 
  3-6 1.67 1.39-2.00 
  > 6 0.98 0.76-1.25 
 Denmark < 1 1.36 1.16-1.59 
  1-3 1.53 1.36-1.73 
  3-6 1.08 0.90-1.29 
  > 6 1.52 1.27-1.81 
 Finland < 1 1.32 1.16-1.51 
  1-3 1.18 1.06-1.31 
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  3-6 1.05 0.91-1.22 
 
 
 
Sweden 
> 6 
 
1.35 
1.0 
1.17-1.56 
- 
Patients aged 55- 65 years 360 
Gender Women < 1.5 0.81 0.74-0.90 
  1.5-3 1.24 1.09-1.41 
  3-6 1.33 1.14-1.54 
  > 6 0.99 0.85-1.15 
Age   0.96 0.95-0.97 
Nation Denmark  1.40 1.28-1.53 
 Finland  1.23 1.14-1.33 
 
 
Norway 
Sweden (ref.) 
 
 
1.50 
1.0 
1.36-1.66 
- 
Patients aged < 55 years 
Gender Women  1.07 0.96-1.18 
Age   0.96 0.95-0.97 
Nation Denmark < 1 1.37 1.01-1.85 
  1-3 1.86 1.51-2.28 
  3-6 0.83 0.60-1.16 
  > 6 1.22 0.90-1.66 
 Finland < 1 1.55 1.19-2.01 
  1-3 1.30 1.06-1.58 
  3-6 1.01 0.77-1.32 
  > 6 0.98 0.75-1.28 
 Norway < 1 1.52 1.08-2.13 
  1-3 1.91 1.51-2.4 
  3-6 1.59 1.15-2.2 
  > 6 0.81 0.52-1.3 
 Sweden < 1 1.0 - 
 (ref.) 1-3 1.0 - 
  3-6 1.0 - 
  > 6 1.0 - 
     
Patients aged < 65 years in the Nexgen subgroup 
Gender Women < 1 0.61 0.49-0.76 
  1-3 1.43 1.18-1.72 
  3-6 1.34 1.01-1.79 
  > 6 1.73 1.15-2.61 
Age   0.95 0.94-0.96 
Nation Denmark  1.84 1.57-2.16 
 Finland  1.39 1.20-1.62 
 Norway  1.62 1.29-2.02 
 Sweden  1 - 
 361 
 362 
 363 
 364 
 365 
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Previous poor results have kept the appeal of uncemented total knee arthroplasties (TKAs) minimal. We
analyzed the mid-term survivorship and reasons for failures of a contemporary uncemented porous tantalum
monoblock tibial component nation-wide. During the study period (2003–2010), such tibial components
were used in 1143 primary TKAs recorded in the Finnish Arthroplasty Registry. Seven-year survivorship of
these TKAs was 100% (95% CI 99–100) with revision for aseptic loosening of the tibial component, and 97%
(95% CI 96–98) with revision for any reason as the respective end points. The most common reasons for
revisions were instability and prosthetic joint infections. In conclusion, TKAs using an uncemented
porous tantalum monoblock tibial component showed excellent mid-term survivorship in a population-
based setting.
© 2014 Elsevier Inc. All rights reserved.
Cemented total knee arthroplasty (TKA) is a reliable and cost-
effective procedure for treating symptomatic end-stage osteoarthritis
(OA) of the knee [1,2]. Cemented TKA is also regarded as the gold
standard for patients undergoing TKA for knee OA [3]. The appeal of
uncemented TKAs has been minimal due to poor results so far [4–10].
These failures were mostly due to uncemented metal-back patellar
resurfacing, but also to aseptic loosening of the tibia component
[11,12]. However, as the incidence of TKAs has increased dramatically
among younger and more active patients in the last decade [13],
increasing concern has arisen about the durability of contemporary
cemented TKA designs for these patients. As aseptic loosening occurs
as a reactive process to wear debris from the polyethylene insert,
ways of reducing the volumetric wear have been sought [14]. Possible
interventions include making the PE insert more resistant to wear,
eliminating backside wear of the tibial tray and improving implant to
bone integration.
An uncemented porous tantalum tibial component has a highly
porous tantalum tray with a ﬁxed polyethylene insert which
eliminates backside wear and may thus reduce the long-term PE
particle burden. The PE insert is moulded into the trabecular metal
cells to a depth about 1.5 mm. The components are gamma irradiated
to 3.5 Mrad. The biological incorporation of trabecular metal implants
is well documented [15–18], and the elastic properties of this implant
are comparable to those of normal bone structure [19]. The lower
stiffness of the tantalum implant may cause less stress shielding than
in conventional metal-backed components. On the other hand, an
increased surface area of the extremely porous tantalum metal and
also a lack of antibiotic-loaded bone cement may in theory increase
the risk of periprosthetic joint infections (PJIs).
The aim of the present study was to analyze epidemiological trends,
survivorship and the reasons for failures of this implant nation-wide
based on data recorded on the Finnish Arthroplasty Registry.
Materials and Methods
Our study was based on information recorded on the Finnish
Arthroplasty Registry relating to patients undergoing TKA with an
uncemented porous tantalum tibial component (Trabecular Metal
Monoblock Tibia; Zimmer, Warsaw) between January 1, 2003, and
December 31, 2010. The coverage of the Finnish Arthroplasty Registry
was analyzed in 1994–1995 by comparing its data with those of the
discharge registers of the participating hospitals; it was found to cover
90% of implantations and implant removals. Since 1995, the data of
the Registry have been compared with those of the hospital discharge
registers every few years. Currently, over 95% of implantations are
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recorded. Revisions are linked to the primary surgery using the unique
personal identiﬁcation number assigned to each resident of Finland.
Patient Characteristics
Over the study period, 1151 TKAs were performed using an
uncemented porous tantalum tibial component. Of these operations
1143 (99%) were primary TKAs and 8 (1%) revision TKAs. Only the
primary TKAs were included. Of the 1143 primary TKAs using the TM
Monoblock Tibia, 647 (57%) were performed on women and 597
(52%) on the right knee. At the time of the surgery, the mean age of
the patients was 63.6 years (range: 30–91). The majority of
these procedures were performed due to primary osteoarthritis
(n = 1,086; 95%). Other indications included posttraumatic osteoar-
thritis (n = 32; 2.8%), rheumatoid or other chronic inﬂammatory
arthritis (n = 20; 1.7%), and other unclassiﬁed indications (n = 5;
0.4%). Three hospitals in Finland were involved in this study cohort.
The annual use of the TM Monoblock Tibia is shown in Fig. 1.
Implant-Dependent Trends
The femoral components among the 1,143 primary TKAs using an
uncemented porous tantalum tibial component were cemented in
48% (n = 549), and uncemented in 52% (n = 594) of the cases.
Furthermore, the patella was left unresurfaced in 85% (n = 974) and
resurfaced with a cemented button in the remaining 15% (n = 169)
of cases.
Other Confounders
To assess the impact of age on implant survival, we analyzed age as
a linear variable, and also using age groups 1) age under 55 years
(n = 167; 15%), 2) age from 55 to 65 years (n = 458; 40%), and 3)
age over 65 years (n = 518; 45%). The impact of gender on survival
was also assessed. As the end points we used all revisions and
revisions for aseptic loosening of the TM Monoblock Tibia.
Statistics
The endpoint for survival was deﬁned as revision with either one
component or the whole implant removed or exchanged. All survival
analyses were performed using all revisions and revisions for aseptic
loosening of the tibial component as the end points. Kaplan–Meier
survival data were used to construct the survival probabilities of
implants at 1, 5, and 7 years. The Cox multiple-regression model was
used to study differences in revision risk (RR) between revision
indications and to adjust for potential confounding factors. The
variables included in the Cox model were as follows: primary
osteoarthritis (reference indication) vs. other indications, cemented
vs. uncemented femur (reference implant), unresurfaced vs. resur-
faced patella (reference technique), gender, and age both as a
continuous and as a categorized variable. Age groups analyzed
were: 1) age under 55 years and 2) age from 55 to 65 years with 3)
age over 65 years (reference age group). The reasons for failures and
revisions among these patients during the study period were
ascertained from patients' medical records and radiographs from
those hospitals where the revisions had been performed. The Cox
regression analyses provided estimates of survival probabilities and
adjusted risk ratios (ARR) for the various factors. Estimates from the
Cox analyses were used to construct adjusted survival curves at mean
values of the risk factors. TheWald test was used to calculate P-values
for data obtained from the Cox multiple regression analysis.
Differences between groups were considered statistically signiﬁcant
if the P-values were less than 0.05 in a two-tailed test. We used
SPSS 20.0 statistical software (IBM, Armonk, New York, USA) for
statistical analyses.
Results
Survivorship of the TM Tibia Component
Survivorship of the whole study cohort was 100% (95% CI 99–100)
at 1, 5, and 7 years postoperatively using revision for aseptic loosening
of the tibial component as the end-point. When revision for any
reason was used as the end-point, 1-, 5-, and 7-year survivorships
were 99% (95% CI 98–100), 97% (95% CI 96–98) and 97% (95% CI 96–
98) respectively (Fig. 2, Table 1).
Multivariate Analysis
In the Cox multiple regression model, there was no difference in
risk of revision between any of the variables studied (Table 1).
Revision Operations
Twenty knee revisions including removal or replacement of the
uncemented porous tantalum tibial component with or without
revision of the femoral component were reported during the period
2003–2010. The indications for revisions were ascertained from the
patients' medical records from the hospital concerned. The most
common reason for revision was tibiofemoral (TF) joint instability
with or without malposition of the TKA components (n = 12, 60%).
This was followed by PJI (n = 7, 35%) and aseptic loosening (n = 1,
5%). Five of the seven PJIs were treated with two-stage revisions, one
Fig 1. Number of trabecular metal monoblock tibias implanted in primary total knee
arthroplasties in Finland per year, 2003–2010.
Fig 2. Kaplan-Meier survival curves for 1143 primary total knee arthroplasties using the
Trabecular Metal Monoblock Tibia (mean follow-up 2.7 years). The end-point was
deﬁned as revision of the tibia component for any reason.
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with one-stage revision, and one patient was treated by conservative
means (antibiotic treatment) due to her severe medical co-morbid-
ities. Six (0.5%) knees were revised due to instability alone, and
another six (0.5%) due to instability combined with malalignment of
the tibia component. All these unstable knees were reconstructed
with a constrained TKA (LCCK, Zimmer, Warsaw, In). One knee (84-
year-old male) was revised because of aseptic loosening of the tibia
component ﬁve months after the primary surgery. In addition to these
20 revisions included in the survival analyses, four patients (four
knees) underwent secondary patellar resurfacing because of anterior
knee pain.
Discussion
We found that an uncemented porous tantalum monoblock tibial
component had excellent mid-term survivorship in a population-
based setting. Themost common reasons for revisions were instability
and PJIs. During the study period only one revisionwas performed due
to aseptic loosening of this tibial component. Neither age nor any of
the other variables showed any effect on the risk of revision in the
multivariate regression analyses.
We concede that this register-based study has certain limitations.
One of these is the lack of clinical data, including patient-reported
outcome measurements. Further, the register-based study setting
with a large number of patients did not allow us to conduct
radiographic analyses apart from those in revision surgery. Thus
radiographic signs of component loosening or osteolysis could not be
analyzed. Selection bias in the study cohort is a possibility, as most of
the patients (55%) were younger than 65 years. The mean age of the
study cohort was only 64 years, whereas the mean age of all patients
undergoing TKA in Finland during the study period was 69 years
(Table 2). As young age increases the risk of revision after TKA [20],
one might have expected increased failure rates in this study cohort
compared to earlier reports with uncemented TKA components.
However, despite this possible selection bias towards younger (and
more active) patients, overall mid-term survivorship of the porous
tantalum monoblock tibial component was excellent.
In the present study, the proportion of female patients was lower
than in the general TKA population, as 70% of patients undergoing TKA
in Finland during the study period were women (Table 2). The higher
than anticipated proportion of males may suggest that uncemented
tibial components have been more commonly used in physically
active men with good bone quality.
Early failures of uncemented knee arthroplasties were mainly
caused by aseptic loosening of the patellar resurfacing and the tibial
component [4–10]. Cementless ﬁxation has been associated with high
failure rate due to inadequate bone ingrowth [21]. The reason for this
has been the excessively stiff construction of the tibial implant leading
to stress shielding and micro-motion at the prosthesis-bone interface.
Survivorship of certain uncemented TKA designs has subsequently
been reported comparable to that of cemented designs but these
papers have originated from single centers and may, at least in part,
be explained by good patient selection and high-volume surgeons
[22–25]. In the Finnish register-based study uncemented TKA had a
1.4 times elevated adjusted hazard ratio compared to that of
cemented TKA when revision was evaluated for any reason [20]. In
the Australian National Joint Replacement Registry's annual report for
2012 the cumulative 10-year revision ratewas 5.4 with cemented TKA
and 6.1 with uncemented TKA.
The majority of revisions were performed due to either instability
alone, or a combination of instability and component malalignment.
One disadvantage of using a monoblock tibial component is the risk of
instability or excessive tightness due to the lack of modularity after
the tibial and femoral components are in place. With a monoblock
type of implant there is no potential for isolated polyethylene insert
exchange if instability is observed after the primary operation
necessitating revision surgery. In this study cohort there were two
patients with instability without malalignment of components and
who thus could have been candidates for polyethylene insert
exchange alone. Uncemented, porous metal tibial trays with modular
polyethylene inserts are available in themarket, but due to the greater
stiffness of metal-backed components the stress-shielding effect on
the bone-implant surface may be emphasized. In the present study
the incidence of revisions due to instability (1.0%) was similar to that
of the general TKA population in Finland (1.3%) [20]. The Finnish
Arthroplasty Registry data, however, do not include information on
the type of knee revisions. Thus, the incidence of isolated polyethyl-
ene insert exchange procedures cannot be analyzed from that data.
The early TM monoblock tibial components were cemented ones.
In 2010, O'Keefe, Winter et al published a series of 125 TKAs in which
a cemented TM monoblock tibial component was combined with
cemented femoral and patellar components [16]. In that study, only
two tibial components were revised during follow-up (minimum of
5 years). Another prospective study comparing 100 uncemented TM
Table 1
Overall and Confounder-Based Survival and Cox-Adjusted Risk Ratio for Revision of TM Monoblock Tibia over 2003–2010 in Finland.
Cohort Na MF yr (Range) AR 1 yr
% 1-Year Survival
(95% CI) AR 5 yr
% 5-Year Survival
(95 % CI) AR 7 yr
% 7-Year Survival
(95% CI)
Adjusted RR for
Revision (95% CI) p
All 20/1143 2.7 (0–7.9) 866 99 (99–100) 175 97 (96–99) 29 97 (96–99) - -
Women 14/647 2.7 (0–7.9) 499 100 (99–100) 103 97 (95–98) 17 - 1.8 (0.7–4.7) 0.22
Men 6/496 2.6 (0–6.9) 367 99 (98–100) 72 98 (97–100) 12 - 1.0 -
Primary osteoarthritis 19/1087 2.7 (0–6.9) 825 99 (99–100) 164 97 (96–99) 28 97 (96–99) 1.0 -
Other indications 1/56 2.7 (0–6.9) 41 98 (95–100) 11 - 1 - 1.1 (0.1–8.6) 0.94
Cemented femur 13/548 3.6 (0–7.8) 486 99 (98–100) 164 97 (96–99) 20 97 (96–99) 1.0 -
Uncemented femur 7/595 1.8 (0–7.9) 380 100 (99–100) 11 - 8 - 1.1 (0.4–3.1) 0.82
Patella not resurfaced 15/974 2.5 (0–7.9) 733 99 (99–100) 126 98 (96–99) 29 98 (96–99) 0.6 (0.2–1.9) 0.40
Patella resurfaced 5/168 3.5 (0–6.9) 133 99 (98–100) 49 96 (93–99) 0 - 1.0 -
Age b 55 years 3/167 2.5 (0–7.9) 126 99 (97–100) 25 98 (95–100) 3 - 2.7 (0.6–13.5) 0.21
Age 55–65 years 10/457 2.6 (0–7.9) 353 100 (99–100) 53 97 (95–99) 9 - 3.3 (0.2–47.5) 0.37
Age N 65 years 7/519 2.8 (0–7.9) 387 99 (99–100) 97 98 (96–100) 17 - 1.0 -
The end-point was deﬁned as revision for any reason of the tibia component.
a Number of revisions/number of total operations. MF = mean follow-up (years). AR = at risk. RR = risk ratio from the Cox regression analysis (adjustment was made for age
and sex).
Table 2
Patient Demographics From the Finnish Arthroplasty Registry Between 2003 and 2010.
TKAs With a TM Tibial Component All TKAs
Women 647 (57%) 83414 (70%)
Men 496 (43%) 35024 (30%)
Mean age (range) 63.6 (30–91) 69.1 (9–106)
Indication: Primary OA 95% 93%
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monoblock tibias to 312 cemented controls reported excellent
survivorship of the TM Monoblock tibial components at a minimum
follow-up of 5 years. In that study, none of the uncemented tibial
components loosened, neither were there any signs of osteolysis
among these patients [18].Wilson, Astephen and co-workers reported
early migration of TM tibial components which were analyzed by RSA
[15]. However, when the authors analyzed the same patient cohort
(45 patients out of an original 70 patients) at ﬁve years postopera-
tively, all uncemented tibial components had achieved solid ﬁxation
[26]. In another series, Unger, Duggan and colleagues reported an
excellent outcome for 108 TKAs using TM monoblock tibial compo-
nents at a mean follow-up of 4.5 years [17]. In that study, none of the
tibial components were revised, although onemigration was reported
without need for revision. Our results, with only one out of 1143 TKAs
revised due to tibial component loosening, are in accordance with
these earlier reports.
In theory, lack of antibiotic-loaded bone cement and the huge
surface area of the trabecular tibial component might predispose to
PJI. However, the incidence of revisions due to PJI was only 0.7% in the
present study. In another paper based on Finnish Arthroplasty
Registry data, the incidence of revisions due to PJI was 0.6% among
32,019 TKAs [20]. Thus this evidence from the population-based
setting does not support this theory.
In conclusion, an uncemented porous tantalum monoblock tibial
component achieved excellent mid-term survivorship in a popula-
tion-based study setting. Early loosening of this uncemented tibial
component is very rare, even nation-wide, and PJIs are as rare as with
contemporary cemented TKAs. Longer follow-up is required to see
whether these results, especially in a cohort of fairly young TKA
patients, stand the test of time.
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ABSTRACT
Background and Aims: Previous studies have reported lower implant survival rates, residual 
pain, and higher patient dissatisfaction rates following knee arthroplasty in younger knee 
arthroplasty patients. We aimed to assess the real-world effectiveness of knee arthroplasty 
in a prospective non-selected cohort of patients aged 65 years or less with 2-year follow-up.
Material and Methods: In total, 250 patients (272 knees) aged 65 years or less were 
enrolled into this prospective cohort study. Patient-reported outcome measures were used 
to assess the outcome.
Results: The mean Oxford Knee Score and all Knee Injury and Osteoarthritis Outcome 
Score subscales increased significantly (p < 0.001) from preoperative situation to the 
2-year follow-up. Significant increase (p < 0.001) in physical activity was detected in 
High-Activity Arthroplasty Score and RAND-36 Physical Component Score (PCS). Pain 
was also significantly (p < 0.001) relieved during the follow-up. Total disappearance of 
pain was rare at 2 years. Patients with milder (Kellgren–Lawrence grade 2) osteoarthritis 
were less satisfied and reported poorer patient-reported outcome measure than those with 
advanced osteoarthritis (Kellgren–Lawrence grade 3–4). There was no difference in the 
outcome (any patient-reported outcome measure) between patients who underwent total 
knee arthroplasty and those who received unicondylar knee arthroplasty.
Conclusion: We found that measured with a wide set of patient-reported outcome 
measures, both total knee arthroplasty and unicondylar knee arthroplasty resulted in 
significant pain relief, as well as improvement in physical performance and quality of 
life in patients aged 65 years or less. Real-world effectiveness of these procedures seems 
to be excellent. 15% of patients still had residual symptoms and were dissatisfied with the 
outcome at 2 years after the operation.
Key words: Knee arthroplasty; patient-related outcome measures; outcome; 65 years or less; young patients; 
satisfaction; pain
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INTRODUCTION
Younger patients have high expectations for the out-
come of total knee arthroplasty (TKA), and this may 
predispose them to dissatisfaction after the operation 
(1–3). Furthermore, younger age is associated with 
higher rates of complications and an increased risk 
for revision surgery (4, 5). Arthroscopic surgery of the 
degenerative knee has been shown to be ineffective 
(6), and the incidence of high tibial osteotomy has 
also steadily decreased (7, 8). Hence, increasing num-
ber of younger patients with mild knee osteoarthritis 
(OA) are being offered knee arthroplasty. In the 
Nordic countries, the incidence of TKA has grown 
especially rapidly among patients younger than 
65 years of age (9). As both young age (4, 5) and mild 
knee OA (10) are known to be risk factors for revision 
surgery, it is of critical importance to assess the out-
come of knee arthroplasty within this demanding 
patient group.
Only a few recent studies have reported the out-
come of TKA measured with patient-reported out-
come measures (PROMs) in younger patients (1, 11, 
12). Only one (12) of these previous trials was a true 
prospective observational study. Furthermore, patient 
activity was not assessed with a specific activity score 
in any of these studies. All of them reported an overall 
positive effect of TKA on symptoms, activities of daily 
living (ADL), and quality of life (QoL). However, a 
variable proportion of patients (11%–25%) were dis-
satisfied with the outcome of their surgery. Scott et al. 
(1) reported that dissatisfaction was also related to a 
low grade of radiographic OA, previous surgery, and 
obesity.
Randomized controlled trials (RCTs) provide the 
least biased information of the efficacy of surgical 
interventions (13). However, RCTs mostly assess effec-
tiveness of interventions in ideal settings. Their ability 
to assess effectiveness of the whole clinical pathways 
is limited. Thus, there is an obvious need for valid 
observational (real-world) data on actual performance 
in routine settings (14).
The aim of our study was to assess the real-world 
effectiveness contemporary knee arthroplasty in 
patients aged 65 years or less. To achieve this goal, we 
conducted a prospective observational study with 
2-year follow up. This study report outcomes meas-
ured comprehensively using various PROMs to pro-
vide information on the effect of knee arthroplasty on 
physical activity, ADL, QoL, pain, and satisfaction.
MATERIALS AND METHODS
For this 2-year prospective cohort study, 250 patients 
were enrolled between 1 March 2012 and 30 October 
2014 at our high-volume academic tertiary referral 
center. PROM data and other study questionnaires 
were collected preoperatively, at 2 to 3 months and at 
1 year (10 to 14 months) and at 2 years (22 to 26 months) 
postoperatively.
All patients were treated in their local health cent-
ers by general practitioners before they referred the 
patients for consultation to our institution. The inclu-
sion criteria were as follows: (1) age 65 years or less 
and (2) scheduled for either TKA or unicondylar knee 
arthroplasty (UKA). The exclusion criteria were as fol-
lows: (1) rheumatoid arthritis or other inflammatory 
diseases; (2) unwilling to provide informed consent; 
(3) physical, mental, or neurological conditions that 
could compromise the patient’s ability and compli-
ance with postoperative rehabilitation and follow-up 
(e.g. drug or alcohol abuse, serious mental illness, and 
general neurological conditions such as Parkinson’s 
disease and multiple sclerosis); and (4) known sensi-
tivity to materials in the devices.
A total of 373 recruitment letters were sent consecu-
tively to patients of 65 years or less who were sent for 
consultation for knee arthroplasty, and the first 250 
patients (272 knees) who returned written informed 
consent to participate were recruited on the study. As 
5 (2%) patients canceled surgery, 6 (2.4%) were revised, 
5 (2%) were lost to follow-up, and 2 (0.8%) died during 
the follow-up; 232 patients (93%; 254 knees) were 
available for the 2-year follow-up visits, and the anal-
ysis of the final results was based on these patients. If 
the patient had isolated antero-medial OA in the plain 
radiographs, then demiarthroplasty was considered. 
While simultaneous bilateral TKAs were performed 
for 22 patients, none of the patients received bilateral 
UKAs. The final patient population comprised 227 
TKAs and 27 UKAs. Patient demographics are shown 
in Table 1.
All operations were performed by senior orthope-
dic surgeons, and all patients were treated with the 
same routine postoperative rehabilitation and pain 
management protocol.
Of the 232 patients (254 knees), 227 knees (89%) under-
went cemented TKA using either press-fit condylar 
TABLE 1
Patient demographics.
TKA UKA
 n = 227 n = 27
Age, year, mean (SD) 58 (5.1) 56 (5.4)
BMI, mean (SD) 31 (5.3) 29 (4.0)
n % n %
Females 125 61 14 52
OA (knees)
 Primary 204 90 26 96
 Secondary 23 10 1 4
KL (knees)
 KL 2 33 15 5 18
 KL 3 105 46 12 46
 KL 4 89 39 10 36
ASA
 1 73 32 11 41
 2 116 51 15 56
 3 38 17 1 3
At work preoperatively 110 53 18 65
TKA: total knee arthroplasty; UKA: unicondylar knee arthroplasty; 
SD: standard deviation; BMI: body mass index; OA: osteoarthritis; 
KL: Kellgren–Lawrence score; ASA: American Society of 
Anesthesiologists score.
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(PFC; 182 knees; DePuy Synthes, Warsaw, IN, USA) or 
Nexgen (45 knees; Zimmer Biomet, Warsaw, IN, USA). 
In 12 (5.3%) of the TKAs, patella was resurfaced. Of 
the 227 TKAs, 218 (96%) were cruciate retaining (CR) 
and the rest 9 were posterior stabilized (PS). UKA was 
performed for 27 patients using the uncemented 
Oxford phase 3 (Zimmer Biomet) prosthesis.
OUTCOME MEASURES
Four different PROMs were used to measure the effec-
tiveness of knee arthroplasty in these patients: Oxford 
Knee Score (OKS), Knee Injury and Osteoarthritis 
Outcome Score (KOOS), High-Activity Arthroplasty 
Score (HAAS), and the RAND-36 general QoL ques-
tionnaire. Primary outcome was defined as the effect 
of knee arthroplasty on pain and function as measured 
with OKS and KOOS. Secondary outcomes were as 
follows: the effect of knee arthroplasty on QoL (RAND-
36), physical activity (HAAS), and satisfaction. A 
background questionnaire included information on 
working status and physical activities. The Visual 
Analog Scale (VAS) was measured with scale from 0 to 
100 and it was used to evaluate pain and satisfaction 
caused by knee arthroplasty both before and after sur-
gery. The VAS satisfaction scale was divided into four 
sections: 0 to 25, dissatisfied; 26 to 50, unsure; 51 to 75, 
satisfied; and 76 to 100, very satisfied as proposed pre-
viously by Scott et al. (1).
The severity of knee OA was assessed from preop-
erative standing fixed flexion view (FFV) radiographs 
using the Kellgren–Lawrence (KL) classification.
QUESTIONNAIRES
The OKS score comprises 12 items regarding pain and 
ADL. Scores vary from 0 to 48, with 48 being the best 
possible score. The minimal clinically important dif-
ference (MCID) for the OKS score is 3 to 5 points.
KOOS comprises five subscales: pain, other symptoms, 
ADL, function in sport and recreation (sport/rec), and 
knee-related QoL. A normalized score (100 indicating 
no symptoms and 0 indicating maximal symptoms) is 
calculated for each subscale. The MCID is suggested 
to be 8 to 10.
The HAAS was specifically developed to assess the 
subtle variations in functional ability after lower limb 
arthroplasty with particular regard to highly active 
individuals. The score covers the four domains: walk-
ing, running, stair climbing, and general activities. 
Possible score ranges from 0 to 18 points. The MCID 
has not been defined for HAAS.
The RAND-36 comprises 36 items that assess eight 
health concepts. The Physical Component Scale (PCS) 
and the Mental Component Scale (MCS) are also 
derived from the eight RAND-36 scales. Scores range 
from 0 (lowest) to 100 (best). The MCID for the sub-
scales is suggested to be 3 to 5 points.
ETHICS
The study protocol (R11178) was approved by the 
Ethics Committee of our hospital district. The study 
was registered with ClinicalTrials.gov (NCT03233620). 
All patients gave written informed consent to partici-
pate in the study.
STATISTICAL ANALYSIS
Data were presented as median with quartiles (Q1 to 
Q3) or as mean (SD) or (95% confidence interval (CI)). 
The Wilcoxon signed rank test and paired t-test for 
paired data were used to compare preoperative and 
postoperative values. The differences in distributions 
in the three measured time points were calculated 
with Friedman test. A p-value less than 0.05 was con-
sidered statistically significant. Data were analyzed 
using the SPSS (version 23) statistical package (IBM, 
Armonk, NY, USA.)
To prevent potential bias with TKA and UKA, the 
results were analyzed for both TKA and UKA together 
and also separately for TKA and UKA only (Table 2).
TABLE 2
Patient-reported outcome measure (PROM) scores preoperatively and at 2 years analyzed separately for TKA (n = 227) and UKA (n = 27).
TKA UKA  
 Preoperative 2 years Preoperative 2 years  
OKS 22 (21–23) 41 (40–42) <0.001 24 (21–28) 42 (40–43) <0.001
KOOS pain 45 (43–47) 86 (84–88) <0.001 46 (39–53) 86 (81–91) <0.001
KOOS symptoms 43 (41–46) 79 (76–81) <0.001 48 (40–55) 77 (70–84) <0.001
KOOS ADL 50 (48–52) 88 (86–90) <0.001 56 (50–62) 89 (84–94) <0.001
KOOS sport/rec 14 (12–17) 55 (51–59) <0.001 16 (10–23) 55 (44–67) <0.001
KOOS QoL 21 (19–23) 70 (67–73) <0.001 25 (18–31) 68 (58–77) <0.001
RAND-36 MCS 61 (58–64) 79 (77–81) <0.001 65 (56–73) 78 (69–87) 0.007
RAND-36 PCS 37 (34–39) 68 (65–71) <0.001 39 (34–45) 70 (61–79) <0.001
HAAS 6 (5–6) 11 (10–11) <0.001 7 (6–9) 12 (11–13) <0.001
TKA: total knee arthroplasty; UKA: unicondylar knee arthroplasty; OKS: Oxford Knee Score; KOOS: Knee Injury and Osteoarthritis 
Outcome Score; ADL: activities of daily living; sport/rec: function in sports and recreation; QoL: quality of life; MCS: Mental Component 
Scale; PCS: Physical Component Scale; HAAS: High-Activity Arthroplasty Score.
Significant increase was observed in all scores. The scores are shown as mean and 95% CI. Differences were evaluated using paired t-test.
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RESULTS
Mean OKS increased both statistically (18 points, CI = 
17–19, p < 0.001; TKA and UKA together) and clini-
cally (exceeding MCID) significantly from the preop-
erative situation to the 2-year follow-up. The mean 
increase did not differ between TKAs and UKAs 
(Table 2).
Significant increase (p < 0.001) was also observed in 
all KOOS subscales, all of which also exceeded MCID. 
The mean increase in scores between preoperative and 
2-year follow-up (TKA and UKA together) was as fol-
lows: KOOS pain 41 (CI = 39–43), KOOS symptoms 35 
(CI = 32–37), KOOS ADL 37 (CI = 35–40), KOOS 
sport/rec 40 (CI = 37–44), and KOOS QoL 48 (CI = 
45–51) (Table 2; Fig. 1).
The preoperative baseline (mean) in physical activ-
ity according to HAAS was moderate: 6/18 in patients 
in the TKA group and 7/18 in the UKA group, respec-
tively. The increase in mean HAAS (TKA and UKA 
together) was 5 points (CI = 4.6–5.5) over the 2-year 
follow up, and the improvement was significant 
(p < 0.001) (Table 2).
RAND-36 score was analyzed with mental (MCS) 
and physical (PCS) subscales. Over the 2-year follow 
up, the mean MCS (TKA and UKA together) increased 
18 points (CI = 15–20) and the mean PCS 31 points (CI 
= 28–34). The change seen in both subscales was sig-
nificant (p < 0.001) and also exceeded MCID (Table 2).
Pain relief was measured with the VAS (exercise 
and rest). A significant positive change of median 
value (in exercise: 80 (72,90) versus 13 (4,32), p < 0.001; 
in rest: 49 (26,71) versus 3 (0,7), p < 0.001) from the 
preoperative situation to the 2-year follow-up was 
detected (Fig. 2). In 16 (7%) patients, all of whom had 
undergone TKA, severe knee pain (VAS > 30) was still 
reported 2 years after knee arthroplasty.
At the time of the 2-year follow-up visit, 85% of 
patients were either satisfied (9%) or very satisfied 
(76%) with the outcome of their knee arthroplasty. 
Between 1- and 2-year follow-up evaluations, 16 
patients (6.7%), who had been either unsure or satis-
fied with the outcome at the 1-year visit, had become 
more satisfied by the 2-year follow-up evaluation. The 
number of patients who were dissatisfied with the 
outcome did not change between the 1- and 2-year 
follow-up evaluations (Table 3). At the 2-year follow-
up visit, 98% of all patients reported that they would 
choose to undergo knee arthroplasty again, and 96% 
reported that they would recommend this operation 
to their best friend. Regarding satisfaction, there was 
no difference between patients in the UKA and TKA 
groups.
Preoperative KL-grade significantly affected both 
satisfaction and PROM outcomes measured at 2 years. 
The median VAS satisfaction was significantly poorer 
in patients with preoperative KL grade 2 OA com-
pared to both patients with KL 3 (85 (51,97) versus 94 
(80,100) points, p = 0.006) as well as those with KL 4 
OA (85 (51,97) versus 91 (81,99) points, p = 0.015) at the 
time of the 2-year follow-up visit (Fig. 3). Furthermore, 
there was a significant difference in median OKS 
between the groups at the time of the 2-year follow-up 
visit: median OKS was worse in the KL 2 group than 
both in the KL 3 group (41 (36,44) versus 44 (38,46) 
points, p = 0.015) and in the KL 4 group (41 (36,44) ver-
sus 43 (40,45) points, p = 0.037). However, this differ-
ence fulfilled the MCID criteria only when the KL 2 
and KL 3 groups were compared. Similarly, patients 
with KL 2 OA preoperative, ended up with signifi-
cantly poorer median subscale scores than those 
patients with more advanced radiographic OA (KL 4) 
Fig. 1. Outcome measured with KOOS subscales (n = 254). Scores 
presented as median (Q1 to Q3). All differences between the 
preoperative and 2-year results were significant (p < 0.001 for all 
comparisons). Differences were evaluated using Friedman test.
Fig. 2. Pain in rest and exercise assessed with VAS scores (n = 254). 
Values presented as median (Q1 to Q3). All differences between the 
preoperative and 2-year results were significant (p < 0.001 for all 
comparisons). Differences were evaluated using Friedman test.
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at the time of the 2-year follow-up visit: KOOS symp-
toms (75 (61,89) versus 86 (78,93), p = 0.001), KOOS 
ADL (88 (76,96) versus 93 (85,97), p = 0.041), and KOOS 
sport/rec (40 (25,75) versus 60 (38,75), p = 0.028). 
However, the significant improvements between pre-
operative and 2-year follow-up were observed in all 
PROMs and also in the KL 2 patients (p < 0.001).
REVISIONS
Of the 254 knee replacements originally operated, 6 
(2.4%; 4 TKAs and 2 UKAs) had to be revised during 
the 2-year follow-up period. Two patients in the TKA 
group underwent secondary patellar resurfacing 
because of persistent anterior knee pain, one TKA was 
revised for prosthetic joint infection, and one TKA for 
stiffness due to arthrofibrosis. Of the two UKAs that 
underwent revision surgery, one was revised for dislo-
cation of the polyethylene insert and the other for 
impingement. Revised patients were excluded from 
the final outcome assessment.
DISCUSSION
Earlier research on the success of knee arthroplasty 
has tended to focus on the survival of the implant. The 
functional outcome of knee arthroplasty has tradition-
ally been measured using surgeon-driven clinical 
scores, such as the Knee Society Score (15–17). Recently, 
however, there has been an increasing demand for the 
subjective, patient-originated evaluation of the out-
come (11). In practice, however, only a few such stud-
ies have been published so far (2, 11, 12). In this study, 
we utilized a wide set of PROMs to assess the real-
world effectiveness of knee arthroplasty in a prospec-
tive non-selected cohort of patients undergoing TKA 
or UKA at our institution.
The increasing incidence of TKA also raises the 
question as to whether the financial resources invested 
in this treatment provide sufficient beneficial results in 
the face of the intensifying need for cost containment 
(9). Although we know that young age slightly 
increases the risk of revision, implant survival has 
been shown to be acceptable also in younger patients. 
Therefore, TKA is also a viable option for the treat-
ment of end-stage OA in this patient population (18). 
Younger patients form a specific group with longer 
life time expectancy and also often with high demands 
for the outcome of surgery (19). In this study, we found 
that patients aged 65 years or less benefited signifi-
cantly from knee arthroplasty in terms of pain relief, 
as well as in terms of improved physical activity and 
QoL. However, the total disappearance of knee symp-
toms was rare.
There have been earlier studies on functional gain 
following TKA in young patients but these have 
lacked true prospective follow up. These studies have 
used the upper age limits of 50 (11) or 55 (1) years of 
age. In everyday clinical practice, however, these sub-
groups are marginal. Instead, the rising incidence of 
TKA has occurred especially in patients aged 50 to 
59 years (20), which is among the target group of our 
study. In our study, 85% of patients were satisfied or 
very satisfied with the outcome at 2 years postopera-
tively, and an even higher proportion of patients (98%) 
reported a willingness to undergo knee arthroplasty 
again. In other recent studies, the subgroups who are 
dissatisfied with their surgery have been reported to 
range from 10% to 20% (1, 2, 11). In this respect, knee 
arthroplasty is clearly inferior to total hip arthroplasty, 
and the topic of dissatisfied knee arthroplasty patients 
clearly needs further research. Previous studies have 
shown that persistent pain after knee arthroplasty is 
strongly associated with psychological aspects and 
young age (21, 22). In our study, knee arthroplasty 
resulted in significant pain relief, and most of this 
effect was seen already during the first postoperative 
year. Moreover, between 1 and 2 years postoperative, 
the number of patients with persistent knee pain con-
tinued to decrease (Fig. 2). Thus, some patients experi-
enced a clearly delayed recovery, but the small 
subgroup (7%) of patients who reported severe knee 
pain persisted at the time of the 2-year follow-up.
Scott el al. (1) divided the satisfaction scale into four 
categories: very satisfied, satisfied, dissatisfied, and as 
the fourth group they included those patients who 
were unsure about their satisfaction. We found that a 
small proportion of patients who were “unsure” at the 
time of the 1-year follow-up reported being satisfied at 
the time of the 2-year follow-up (7 patients, 2.9%). 
Thus, in some patients, complete recovery after knee 
arthroplasty may take up to 2 years. Dissatisfied 
patients, however, still held the same view at the time 
of the 2-year follow-up. Satisfaction is clearly a multi-
dimensional experience, as 98% of patients reported 
being willing to undergo knee arthroplasty again 
despite the fact that 15% of patients were dissatisfied 
or unsure with the outcome of their surgery. The 
patient’s own perspective of the preoperative symp-
toms and functional disability may partly explain this 
difference, that is, they may still have considered the 
outcome of knee arthroplasty to be better than the pre-
operative situation despite their residual knee symp-
toms. The proportion of patients in our study who 
were satisfied with the outcome was in accordance 
with other recent studies on the subject (23–25).
Scott et  al. (1) reported high (59%) dissatisfaction 
rate of TKA in patients with KL 1–2 grade OA preop-
eratively. Also, in our study, satisfaction at 2 years was 
significantly lower in the KL 2 group, both when com-
pared to the KL 3 and the KL 4 groups. Significant 
improvement, however, was achieved in all KL 
subgroups as compared to the preoperative situation 
TABLE 3
Satisfaction Visual Analog Scale (VAS) preoperatively, 1- and 2-year 
follow-ups.
Pre 1 year 2 years
Very satisfied 1 68 75
Satisfied 7 13 9
Unsure 14 10 7
Dissatisfied 78 9 9
Scores are presented as percentage of satisfaction (0%–100%).
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(Fig. 3). As there was no difference in KOOS pain sub-
scale between the KL subgroups at 2 years, it seems 
that despite their higher dissatisfaction rate, also 
patients with milder OA (KL 2) achieved good pain 
relief. In patients with mild radiographic knee OA, 
there may be other factors than pain, such as depres-
sion or catastrophizing behavior, that would explain 
higher dissatisfaction rates despite good pain relief 
achieved with surgery.
The clinically significant improvement in physical 
activity in these younger knee arthroplasty patients is 
an important finding. Young patients may be self-evi-
dently considered physically active. This may restrict 
their access to knee arthroplasty because of the fear of 
compromised implant survival. A recent study by 
Keeney et  al. (26) showed that preoperatively there 
was no difference in physical activity levels between 
younger (55 years or less) and older patients (65 to 
75 years), and that physical activity increased in both 
groups after knee arthroplasty. In our study, only 42 
(17%) patients reported a preoperative activity level of 
over 50% according to the HAAS scale. Respectively, 
the preoperative physical activity level points were 
less than 50% when also measured with the KOOS 
(93% of patients) and 36-Item Short Form Health 
Survey (SF-36; 76% of patients) subscales (Table 2). 
However, significant improvement was seen postop-
eratively in physical activity in the HAAS as well as in 
the KOOS and SF-36 physical activity subscales. Thus, 
the ability to exercise can also be improved with knee 
arthroplasty in younger patients. To the best of our 
knowledge, our study is the first to assess the effect of 
knee arthroplasty on patient activity levels using a 
specific activity score in a prospective observational 
(real-world) study.
Scott et al. (27) reported that patients undergoing 
TKA consider climbing stairs, ability to walk, and 
kneeling to be especially important activities in their 
daily living. Because the preoperative physical activ-
ity of patients undergoing TKA has been shown to be 
low, more demanding activities, such as cycling or 
carrying heavy objects, have not been so important 
for them (28). In the working-age population, func-
tions related to daily living are associated with work-
ing capability. In our study, 104 (45%) patients were 
retired or about to retire preoperatively. Of the128 
(55%) patients who were working preoperatively, a 
high proportion (89%) returned to work during the 
2-year follow-up, and significant improvements in 
scores related to daily living supported this finding 
(Table 2).
Changes in QoL are based on both physical and 
mental improvements and are also related to pain 
relief. Even if physical scores improved more dis-
tinctly, it is notable that mental scores also improved 
significantly after knee arthroplasty. The Mental 
Component Score (MCS) of RAND-36 showed compa-
rable improvement with the Physical Component 
Score (PCS) of RAND-36, emphasizing comprehen-
sive improvement in outcomes (Table 2). Recently, 
Goh et al. (11) also reported significant albeit slightly 
smaller improvements in these scores than the scores 
we found in this study (PCS 16.9 versus 31.5 and MCS 
4.4 versus 17.5).
We recruited younger patients with knee OA who 
were scheduled for knee arthroplasty at our institu-
tion. Our study was an observational intervention 
study with the focus on effectiveness, and the study 
setup mirrored everyday clinical practice. This setup 
has previously been applied only by Klit et  al. (12), 
who conducted a prospective cohort study among 
patients aged less than 60 years. The difference 
between the study by Klit et al. and our study was that 
we included both patients who were listed for TKA 
and those who were scheduled for UKA. Furthermore, 
we applied a specific activity score (HAAS) to assess 
the effect of knee arthroplasty on patient activity lev-
els. In our setup, UKA and TKA yielded similar results. 
Thus, the theoretical advantages of UKA over TKA 
(29) did not result in either better clinical outcome in 
any of the PROMs used or higher satisfaction. This 
finding warrants further research, and future work 
should compare the outcome and effectiveness of 
UKAs and TKAs in RCTs.
Our study is not without limitations. We did not 
have a specific control group of patients above the age 
of 65 years which would have enabled the comparison 
of our results with the older patient population. The 
UKA group was also markedly smaller than the TKA 
group. The obvious strength of this study was the 
evaluation of the outcome using multiple PROM data 
that have not been included in previous studies, a 
non-selected real-world cohort of patients, and also 
the fact that only a very small proportion (7%) of 
patients was lost to follow-up during the 2-year study 
period. Our study is also the first to evaluate the real-
world effectiveness of TKA and UKA in younger 
patients utilizing a wide set of PROMs. To the best of 
Fig. 3. VAS satisfaction in different Kellgren–Lawrence groups 
(n = 254). Scores presented in median (Q1 to Q3). All differences 
between the preoperative and 2-year results were significant 
(p < 0.001 for all comparisons). Differences were evaluated using 
Wilcoxon signed rank test.
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our knowledge, our study is the first to assess both 
actual patient satisfaction and also their willingness to 
undergo the same surgery again. This approach 
showed that satisfaction is clearly a multidimensional 
issue that may not be adequately assessed with a sin-
gle question about satisfaction.
CONCLUSION
We found that knee arthroplasty provided patients 
aged 65 years or less with clinically significant pain 
relief as well as improvement in ADL and QoL. The 
patients’ physical activity was low or moderate preop-
eratively, but improved significantly during the 2-year 
follow-up. Some pain and functional deficiencies 
remained after knee arthroplasty, and this should be 
emphasized in the preoperative guidance given to 
patients who are considering or scheduled for such sur-
gery. Mild radiographic OA preoperatively is a clear 
risk factor for patient dissatisfaction with the outcome 
of knee arthroplasty. Future research is warranted to 
clarify the preoperative risk factors for severe residual 
symptoms and dissatisfaction after knee arthroplasty.
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Background — Randomized trials evaluating efficacy of local 
infiltration analgesia (LIA) have been published but many of 
these lack standardized analgesics. There is a paucity of reports 
on the effects of LIA on functional capability and quality of life.
Methods — 56 patients undergoing unilateral total knee arthro-
plasty (TKA) were randomized into 2 groups in this placebo-con-
trolled study with 12-month follow-up. In the LIA group, a mix-
ture of levobupivacaine (150 mg), ketorolac (30 mg), and adrena-
line (0.5 mg) was infiltrated periarticularly. In the placebo group, 
infiltration contained saline. 4 different patient-reported outcome 
measures (PROMs) were used for evaluation of functional out-
come and quality of life.
Results — During the first 48 hours postoperatively, patients 
in the LIA group used less oxycodone than patients in the pla-
cebo group in both cumulative and time-interval follow-up. The 
effect was most significant during the first 6 postoperative hours. 
The PROMs were similar between the groups during the 1-year 
follow-up.
Interpretation — Single periarticular infiltration reduced the 
amount of oxycodone used and enabled adequate pain manage-
ment in conjunction with standardized peroral medication with-
out adverse effects. No clinically marked effects on the functional 
outcome after TKA were detected.
■
The goal of local inﬁltration analgesia (LIA) after TKA is to 
provide simple, effective, and safe pain relief during the ﬁrst 
postoperative days, with reduced opiate consumption (Kerr 
and Kohan 2008). Adequate postoperative pain control is 
usually achieved using multimodal pain management, but it 
continues to be a challenge in many TKA patients. The rec-
ommended intraoperative anesthetic technique during TKA is 
either general anesthesia combined with femoral nerve block 
or spinal anesthesia combined with morphine (Fischer et al. 
2008). Femoral nerve block is effective in reducing pain, 
but may cause falls after TKA (Ilfeld et al. 2010). Opiates, 
although effective in reducing pain, have severe side effects 
(nausea, itching, reduced gut mobility, and urinary retention), 
which may markedly retard the postoperative recovery. Thus, 
in addition to providing better pain relief, multimodal analge-
sia is aimed at reducing the amount of opiates used.
Several techniques of inﬁltration analgesia have been pub-
lished, with enhanced pain relief for up to 48 hours (Kehlet 
and Andersen 2011). With longer follow-up time, the periop-
eratively administered LIA loses its efﬁcacy (Essving et al. 
2010). Furthermore, intra-articular LIA and extra-articular 
LIA have been reported to be equally effective in reducing 
postoperative pain (Andersen et al. 2008b). The beneﬁt of 
using an intra-articular catheter has been questioned by some 
authors—concerning both the effectiveness of pain treatment 
and the theoretical increased risk of infection (Busch et al. 
2006, Mullaji et al. 2010).
A recently published review divided LIA techniques into 2 
groups—single administration and multiple administration—
and it also compared different local inﬁltration techniques 
(Gibbs et al. 2012). Many studies included in that review were 
poorly controlled, with no standardization of oral analgesics. 
In the group of multiple administration methods, the reduc-
tion of opiate consumption was comparable to the results 
for the single administration group. Based on these ﬁndings, 
the authors of the review recommended the use of a single, 
intraoperative and systematic inﬁltration cocktail of high-
dose ropivacaine, adrenaline, and ketorolac to all exposed tis-
sues. Another review highlighted poor documentation of the 
long-term effect of LIA on knee function and quality of life 
(Ganapathy et al. 2011).
We studied the effects of a single, intraoperative periarticu-
lar inﬁltration on postoperative pain management after TKA.
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Patients and methods
We enrolled 60 patients undergoing unilateral TKA in this 
randomized, double-blind, placebo-controlled study. The 
inclusion criteria were: (1) need for primary TKA for primary 
osteoarthritis, and (2) age 18–75 years. Exclusion criteria were 
(1) rheumatoid arthritis or other inﬂammatory diseases, (2)
BMI > 35, (3) American Society of Anesthesiologists physical 
score > 3, (4) renal dysfunction, (5) allergy to any of the study 
drugs, (6) previous high tibial osteotomy or previous osteo-
synthesis, (7) > 15 degrees varus or valgus malalignment, and 
(8) physical, emotional, or neurological conditions that could
compromise the patient’s compliance to postoperative reha-
bilitation and follow-up. All patients who were included in the 
study were operated at our institution between March 2011
and March 2012 (Figure 1).
Randomization and blinding
In the morning of surgery, an independent research nurse not 
involved in patient care performed the randomization sequence 
by drawing 1 opaque, sealed envelope from a collection of 
60 alternatives (allocation ratio: 1:1). The nurse prepared 
the study solution and delivered it to the operation room just 
before surgery. In the LIA group, the study solution contained 
levobupivacaine (150 mg) mixed with ketorolac (30 mg) and 
adrenaline (0.5 mg). In the control (placebo) group, the study 
solution contained isotonic saline. The total volume of study 
solution was 100 mL in both groups. The allocation list was 
stored in the ofﬁce of the research nurse until all patients had 
been included and all 1-year follow-up procedures had been 
completed. Only the research nurse who opened the envelope 
and prepared the study solution was aware of the type of inﬁl-
tration, and all other personnel involved in the patient’s care 
remained blind throughout the study.
Ethics
The study protocol was approved by the local ethics com-
mittee (R10108). The Finnish Medicines Agency (Fimea) 
approved the study protocol regarding the drugs to be used 
(EudraCT 2010-024315-14). The study was registered with 
ClinicalTrials.gov (NCT01305733). All patients gave their 
informed consent before inclusion in the study.
Preparation and pain management
Oral paracetamol (1 g) was given approximately 1 h before 
operation as premedication. Single-shot spinal anesthesia was 
induced at the L4-5 or L3-4 level using a 27-G spinal needle 
with a dose of 15 mg bupivacaine in 3 mL. A single 3.0-g 
bolus dose of cefuroxime was used as antibiotic prophylaxis, 
and tranexamic acid (1 g) was given at the end of surgery. 
In the post-anesthesia care unit, ice pack was used for all 
patients. All of them were treated with oral paracetamol (1 
g) every 6 h and oral meloxicam (15 mg) every 24 h, start-
ing 2 h after surgery. Patient-controlled analgesia (PCA) with
oxycodone (dose: 2 mg; lock-out time: 8 min) was used in 
all patients to ensure adequate pain relief. No other analge-
sic drugs were used. If the pain management was insufﬁcient, 
a lumbar epidural catheter was inserted and levobupivacaine 
infusion was initiated as rescue analgesic, causing the patient 
to drop out from the study. Nausea was treated with intrave-
nous ondansetron (4 mg) when needed. As thromboprofylaxis, 
subcutaneous enoxaparin (40 mg) every 24 h was started 6–10 
h after the end of surgery.
Surgery and infiltration technique
All patients were operated with standard knee replacement 
technique by 4 experienced orthopedic surgeons. Both groups 
received a periarticular inﬁltration intraoperatively. All inﬁltra-
tions were done using 50-mL syringes and 7-cm long 20-G nee-
dles. The solution was inﬁltrated in 2 stages: the ﬁrst after the 
bone surfaces were prepared but before the components were 
inserted, and the second after the components were inserted 
but before release of both tourniquets and wound closure. The 
ﬁrst 50-mL inﬁltration was aimed from both sides through the 
posterior capsule and in the areas of resected menisci, and the 
second was aimed periosteally next to the resected bone sur-
faces and with parapatellar approach, but not in subcutaneous 
tissue. The tourniquet was released before closure and before 
hemostasis was ensured. Drainage and compression bandage 
were used in all patients.
Recovery
In the recovery room, all patients were mobilized by a phys-
Assessed for egilibility
n = 104
Randomized
n = 60
LIA group Placebo group
Excluded, n = 44:
– BMI, 21
– Medication or disease, 15
– Bilateral TKA, 7
– Refused to participate, 1
Refused to participate
n = 3
Periarticular inﬁltration
n = 29
Saline
Total volume 100 ml
Periarticular inﬁltration
n = 27
Levobupivacaine 150  mg
Ketorolac 30 mg
Adrenaline 0.5 mg
Total volume 100 ml
Monitoring 48 h
postoperatively
Functional outcome
after 1 year
Refused to participate
n = 1
Dropped out, n = 1:
– Nausea, 1
Dropped out, n = 4:
– Intense pain, 3
– Nausea, 1
Monitoring 48 h
postoperatively
Functional outcome
after 1 year
Figure 1. The study protocol.
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iotherapist soon after recovery of motoric function. Patients 
were advised to use a PCA pump for oxycodone delivery and 
the consumption of oxycodone was calculated at 6, 12, 24, and 
48 hours postoperatively. The visual analog scale (VAS) was 
used to quantify the pain intensity, with a target level under 3. 
VAS reading was recorded by a nurse or physiotherapist 3, 9, 
18, and 48 h postoperatively. The range of motion (ROM) was 
measured by a physiotherapist 6, 12, and 24 h postoperatively.
Outcomes
The primary outcome was oxycodone consumption over 48 h 
postoperatively. The secondary endpoint was functional out-
come 1 year after surgery. All patients were evaluated by a 
physiotherapist (who was blind regarding the study solution) at 
a routine follow-up visit 3 months postoperatively. Total knee 
function questionnaire (TKFQ), Oxford knee score (OKS), 
high-activity arthroplasty score (HAAS), and the 15D quality-
of-life instrument were used preoperatively, at 3 months, and 
at 1 year after surgery for prospective outcome analysis.
Statistics
Calculation of sample size was based on an expectation of 
40% difference in opiate consumption between the groups. 
The study was designed to have a power of 80% to detect a 
40% difference between the 2 groups (type-I error probabil-
ity: 0.05). Based on power calculation, 17 patients in each 
group would be needed. Demographics and results are shown 
as percentage, as mean value (SD), or as median (range). Dif-
ferences between the groups were analyzed using the Mann-
Whitney U-test. Bonferroni method was used to correct for 
multiple measures. IBM SPSS Statistics version 20.0 was 
used for statistical analysis.
Results
56 patients completed the study—27 patients in the LIA group 
and 29 patients in the placebo group. Baseline demographics 
showed similar values in both groups (Table 1). The cumula-
tive consumption of oxycodone was smaller in the LIA group 
to that in the placebo group, at all measured time-points until 
48 h (Figure 2). A trend of reduced consumption of oxycodone 
in the LIA group persisted up to 24 h postoperatively. The dif-
ferences in means of cumulative consumption of oxycodone 
were 17 mg (95% CI: 11–22) at 6 h, 20 mg (CI: 11–30) at 12 
h, 28 mg (CI: 11–45) at 24 h, and 35 mg (CI: 5–64) at 48 h.
In comparison of the different time intervals, the LIA group 
used statistically signiﬁcantly less oxycodone than the placebo 
group during the ﬁrst 6 h: mean 14 (2–34) mg as opposed to 
30 (6–57) mg (p < 0.001) (Figure 3). The differences in means 
according to time intervals were 17 mg (CI: 11–22) at the 0–6 
h interval, 4 mg (CI: –1 to 10) at the 6–12 h interval, 7 mg (CI: 
–2 to 16) at 12–24 h interval, and 5 mg (CI: –11 to 21) at the
24–48 h interval.
A median level of < 3 in VAS score was considered to be an 
adequate level of pain management, and this was achieved in 
both groups until 48 h postoperatively (Figure 4). The differ-
ences in means in VAS were 0.5 (CI: –0.3 to 1.4) at 3 h, 1.0 
(CI: –0.2 to 2.1) at 9 h, 0.5 (CI: –0.6 to 1.5) at 18 h, and 0.4 
(CI: –0.7 to 1.4) at 48 h.
The difference in mean ROM at 6 hours between the LIA 
group and the placebo group was –26 (CI: –39 to –12). At 24 
h (mean difference –10, CI: –21 to 1) and at 48 h (mean dif-
ference –1.5, CI: –13 to 10), the mean differences were not 
statistically signiﬁcantly different from that at 0 h.
Postoperatively, 3 patients in the placebo group discontin-
ued the study because of intense pain and they were treated 
with epidural analgesia. On the other hand, in the LIA group 
none of the patients discontinued the study because of pain. 1 
patient in each group discontinued because of nausea. There 
was no signiﬁcant difference in overall blood loss between the 
LIA group and the placebo group (441 mL vs. 540 mL; p = 
Table 1. Patient demographic data. Data are mean (SD), 
number, or median (range)
LIA Placebo
n = 27 n = 29
Age, years 65 (4.9) 64 (6.7)
Sex, male/female 12/15 15/14
Body mass index 29 (3.9) 30 (3.7)
Preoperative KSS 43 (16–69) 49 (26–89)
Preoperative KSS 
   function subscale 40 (15–90) 35 (15–90)
KSS: Knee Society score.
250
200
150
100
50
0
6 12 24 48
Cumulative comsumption of oxycodone, mg
Placebo
LIA
Time point (h) 
Figure 2. Median cumulative consumption of oxycodone over 48 h 
postoperatively. 6 h: p = < 0.001; 12 h: p = < 0.001; 24 h: p = 0.03; 48 
h: p = 0.03. The Bonferroni-adjusted p-value for the 48-h time point 
was 0.1. The line in the middle of the box represents the median. The 
lower and the upper edges of the box are the 1st and 3rd quartile, 
respectively. If an observation is beyond 1.5 times interquartile range 
it is considered as an outlier and marked by a dot. Whiskers are the 
lowest and highest values that are not outliers.
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0.3). No prosthetic joint infections were detected during the 
ﬁrst postoperative year.
The functional outcomes between the groups differed in 
mean values, but the difference was not statistically signiﬁcant 
as measured with HAAS and OKS or as measured with the 
15D instrument for quality of life (Table 2). However, there 
was a statistically signiﬁcant difference between the groups in 
1 subscale of the TKFQ questionnaire: at 12 months postop-
eratively, it was easier for patients in the LIA group to sit for a 
long period of time (Table 2). There was also a trend of higher 
mean values in OKS for patients in the LIA group 12 months 
postoperatively (Table 2).
Discussion
A single intraoperative drug inﬁltration containing levobupi-
vacaine, ketorolac, and adrenaline reduced the total consump-
tion of oxycodone during the ﬁrst 48 h postoperatively. The 
effect of LIA was most pronounced during the ﬁrst 6 h after 
surgery. The efﬁcacy of inﬁltration analgesia was highlighted 
by the fact that 3 patients in the placebo group discontinued 
the study because of intensive pain, while none of the patients 
in LIA group had to do the same. LIA also improved the early 
knee ROM, but no long-term functional beneﬁt was seen.
In previous studies, the most used local anesthetic drugs 
have been ropivacaine and racemic bupivacaine. Levobupiva-
caine is the S-enantiomer of bupivacaine. Compared to ropi-
vacaine, levobupivacaine has a longer duration of action (Bur-
lacu and Buggy 2008). Compared to bupivacaine, levobupiva-
caine appears to have a wider margin of safety in terms of car-
diovascular and central nervous system adverse effects when 
used in large doses (Morrison et al. 2000, Burlacu and Buggy. 
2008). A previous study compared intra-articularly adminis-
tered bupivacaine and levobupivacaine to placebo and both 
were found to be more effective than placebo (Bengisun et al. 
2010). Levobupivacaine has a longer effect time than ropiva-
caine—which might in theory prolong postoperative analge-
sia. To maximize the theoretical analgesic effect, we chose the 
combination of levobupivacaine, ketorolac, and adrenaline. A 
comparison of 4 different mixtures of LIA (Kelley et al. 2013) 
showed that adding ketorolac to the solution results in better 
analgesia, and it called into question the signiﬁcance of other 
drugs in extending the effect. In the present study, both levobu-
picaine and ketorolac were administered at maximum dose to 
ensure maximum effect. The concern with ketorolac—as with 
all non-steroidal anti-inﬂammatory drugs (NSAIDs)—has 
120
80
100
60
40
20
0
0–6 6–12 12–24 24–48
Consumption of oxycodone, mg
Placebo
LIA
Time interval (h) 
Figure 3. Consumption of oxycodone in differ-
ent time intervals. Consumption is presented as 
median with 25th and 75th percentiles. 0–6 h: 
p < 0.001; 6–12 h: p = 0.09; 12–24 h: p = 0.1; 
24–48 h: p = 0.4. For the 0–6 h interval, the Bon-
iferroni adjusted p-value was < 0.001. 
10
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2
1
0
3 9 18 48
VAS
Placebo
LIA
Time point (h) 
*
Figure 4. Postoperative pain at rest. VAS 
scores are presented as median with 25th 
and 75th percentiles. 3 h: p = 0.4; 9 h: p = 
0.2; 18 h: p = 0.4; 48 h: p = 0.5.
120
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Figure 5. ROM at measured time point. 
ROMs are presented as median with 25th 
and 75th percentiles. 6 h: p = 0.001; 24 h: p = 
0.08; 48 h: p = 0.6. The Bonferroni-adjusted 
p-value for the 6-h time point was 0.004.
Table 2. Functional and quality-of-life results with 1-year follow-up. 
Results are mean (SD) and mean difference with 95% CI
LIA Placebo Mean 95% CI
n = 27 n = 29 difference
15D
preop. 0.88 (0.08) 0.87 (0.07) –0.017 –0.056 to 0.023
3 months 0.92 (0.05) 0.92 (0.05)   0.001 –0.028 to 0.030
1 year 0.93 (0.07) 0.91 (0.07) –0.018 –0.056 to 0.020
HAAS
preop.   8 (3.1)   7 (2.7) –0.45 –2.01 to 1.12
3 months 11 (2.4) 11 (2.8) –0.05 –1.49 to 1.39
1 year 12 (2.4) 11 (3.5) –1.11 –2.74 to 0.52
OKS
preop. 23 (7.7) 22 (6.0) –1.36 –5.10 to 2.37
3 months 37 (6.9) 36 (5.4) –0.65 –4.09 to 2.79
1 year 44 (4.4) 41 (5.5) –2.70 –5.48 to 0.07
Sitting for a long period of time
preop.   2 (0.72)   2 (0.57) –0.26 –0.61 to 0.10
3 months   2 (0.58)   2 (0.50) –0.08 –0.23 to 0.38
1 year   1 (0.49)   1 (0.47) –0.30 –0.56 to –0.04Ac
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been the increased risk of bleeding problems postoperatively. 
However, in our study the total amount of blood loss was the 
same in both study groups.
We found that a single periarticular inﬁltration reduced 
total consumption of oxycodone for 48 h, although most of 
this effect was achieved during the ﬁrst 6 h. Sufﬁcient pain 
relief immediately after surgery aids in controlling the pain at 
a later stage also. In a recent review, the beneﬁts of delayed 
administration were questioned and the authors suggested 
the use of single intraoperative administration of anesthetic 
cocktail (Gibbs et al. 2012). On the other hand, the use of 
an intra-articular catheter for additional drug administration 
may reduce total consumption of opiates up to 48 h postop-
eratively, compared to the situation where an additional bolus 
is not given. This is supported by a recent randomized study 
with 48 h of follow-up and an intra-articular catheter (Essving 
et al. 2010). The total median consumption of opiate in the 
drug inﬁltration group was 54 (4–114) mg, as compared to 
86 (28–190) mg in our study. Whether or not the additional 
postoperative, intra-articular bolus is given, supplementary 
oral medications, e.g. NSAIDs, are needed as an adjunct to 
inﬁltration analgesia.
In a randomized study, use of a compression bandage was 
shown to improve pain control at rest at 8 h, and at 5, 6, and 8 
h postoperatively with 90 degrees of knee ﬂexion after TKA 
(Andersen et al. 2008a). We used a compression bandage in 
all patients (both groups) until the second postoperative day.
There have been few studies analyzing the long-term inﬂu-
ence of inﬁltration analgesia on the functional outcome. The 
only previous study to evaluate this effect found no difference 
in functional outcome in the placebo and drug inﬁltration 
groups at 3 months postoperatively, as measured with TUG 
test, OKS, and EQ5D (Essving et al. 2010). We found minor 
differences in functional outcomes as measured with the 15D, 
HAAS, and OKS instruments, but the clinical relevance of 
these ﬁndings is questionable. The TKFQ scoring system has 
many subscales for different functional capabilities. The only 
statistically signiﬁcant difference was observed at 12 months 
(sitting for a long period of time), but this was not evident ear-
lier. The statistically signiﬁcant difference in this TKFQ sub-
scale between groups probably occurred by chance, without 
any relation to LIA. Murray et al. (2007) concluded that the 
minimal clinically important difference (MCID) in OKS can 
be expected to be between 3 and 5 points. In our data, the dif-
ference in mean values in OKS between groups at 1 year was 
3 points, but the difference was not statistically signiﬁcant.
We acknowledge that the study had some limitations. 
Patients were treated according to a routine postoperative 
rehabilitation protocol, and the length of hospital stay between 
groups was not measured. Effective postoperative pain relief 
might have allowed a shorter length of hospital stay. Plasma 
concentrations of inﬁltration drugs were not measured, but 
none of the patients had any side effects identiﬁed during the 
1-year follow-up period.
In summary, this randomized double-blind study showed 
that a single perioperative inﬁltration of levobupivacaine, 
ketorolac, and adrenaline reduced opiate consumption until 
48 h after TKA. The effect was most apparent during the ﬁrst 
6 h, but persisted to some extent up to 24 h. We recommend 
routine use of perioperative inﬁltration analgesia as an adjunct 
to oral pain medication in patients undergoing TKA. However, 
use of LIA inﬁltration did not have any effect on the functional 
outcome of TKA during the ﬁrst postoperative year.
Design of the protocol: MN, JK, and AE. Enrollment of the patients and sur-
gery: MN, TM, and AE. Anesthetic procedures: JK and AA. Data collection: 
MN. Data analysis: MN, AE, JK, and AA. All the authors contributed to writ-
ing of the manuscript.
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